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ABSTRACT
The glutathione transferases (GSTs) represent a group of Phase II detoxication enzymes 
that catalyse the nucleophilic attack of reduced glutathione (GSH) on electrophilic 
centres of endogenous and xenobiotic compounds. Cytosolic GSTs from mammals can 
be divided into 4 distinct classes, Alpha, Mu, Pi and Theta. The Theta class GSTs in 
humans are unique from the other classes as they have low or lack of activity with the 
model substrate l-chloro-2,4-dinitrobenzene (CDNB) and they do not bind to 
immobilised glutathione affinity matrices. The absence of these two features has made 
the Theta class isoenzymes relatively difficult to study and as a result they have been 
largely overlooked. To gain a greater understanding of the human Theta class GSTs, 
the research carried out in this thesis described:-
1. The molecular cloning of a cDNA encoding the human Theta class GSTT2-2.
Three different cDNA libraries were screened and four distinct clones were identified. 
One clone contains the full open reading frame of GSTT2-2. While the other three 
clones are all truncated transcripts which showed evidence of alternative splicing.
2. The chromosomal localisation GSTT2. GSTT2 was mapped to chromosome 22 by 
somatic cell hybrid analysis and sublocalised to ql 1.2 by in situ hybridisation. There 
was no evidence for reverse transcribed pseudogenes of GSTT2 dispersed through out 
the genome. Southern blot analysis of human genomic DNA indicated that the GSTT2 
gene is less than 4kb in length.
3. The heterologous expression of GSTT2-2 from a cDNA clone. GSTT2-2 was 
expressed in Escherichia coli as a ubiquitin fusion protein. The ubiquitin moiety was 
co-translationally cleaved by a co-expressed yeast ubiquitin specific protease (Ubpl), 
generating an enzymatically active GSTT2-2 without any additional N-terminal 
residues. The recombinant isoenzyme was purified to apparent homogeneity using 
DEAE anion exchange, gel filtration, dye ligand and high resolution anion exchange
iv
(Mono Q f.p.l.c.) chromatography. The recombinant enzyme had significant activity 
with a range of substrates including cumene hydroperoxide, and 1-menapthyl sulphate 
(MS). The activity of GSTT2-2 with a range of secondary lipid peroxidation products 
such as the rra«s,//Yms-alka-2,4-dienals and fran.s-alk-2-enals as well as its glutathione 
peroxidase activity with organic hydroperoxides suggest that it may play a significant 
role in protection against the products of lipid peroxidation.
4. The tissue expression of GSTT2-2. Tissue expression of GSTT2-2 was studied 
using the cloned cDNA and also polyclonal antibodies raised against purified GSTT2-2. 
Northern and Western blots showed that GSTT2-2 appears to be predominantly 
expressed in liver and placenta although detectable levels were also observed in kidney, 
pancreas, lung, spleen, heart, and skeletal muscle but not in brain. The weak 
hybridisation signals from both studies indicate that, GSTT2-2 is not expressed 
abundantly in any of these tissues.
5. The structure-function studies of GSTT2-2. A conserved serine residue in the 
N-terminal domain of Theta GSTs has been implicated in catalysis by activating the 
enzyme-bound GSH. In GSTT2-2, the role of the equivalent serine (residue 11) in 
catalysis was examined by site-directed mutagenesis. Mutating Seri 1 to Ala, Thr or 
Tyr abolished the catalytic properties of GSTT2-2 with cumene hydroperoxide and 
ethacrynic acid. However, two of the mutants, S11A and SI IT, retained appreciable 
activities with MS. The mechanism of the reaction between MS and GSH was 
investigated in greater detail. It is proposed that the SÜ4 2' group of MS is removed by 
GSTT2-2 in a mechanism similar to the action of a sulphatase. It is also proposed that 
this reaction is preceded by a conformational or charge modification to the enzyme 
upon the binding of glutathione or S-methylglutathione. This is followed by the binding 
of MS and the subsequent removal of the SÜ4 2- group, giving rise to the carbonium ion 
of 1-methylnapthelene (the electrophile) to react with GSH or other thiols (the 
nucleophile). The reaction mechanism of GSTT2-2 with MS may represent a novel 
function of GSTT2-2 as a glutathione dependent sulphatase.
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CHAPTER 1 : THE GLUTATHIONE TRANSFERASES — AN
OVERVIEW
1
1.1 INTRODUCTION
The well being of living cells is governed by their ability to combat the lethal 
effects of the cytotoxic or genotoxic compounds they are exposed to. These toxic 
compounds can be by-products of normal cell metabolism, or exogenous compounds 
which are introduced into the body through absorption, inhalation or ingestion. To 
protect against the harmful effects of these compounds, the detoxication, inactivation and 
elimination of these compounds are crucial. It is now understood that there are at least 
three different phases in the metabolism of toxic compounds from endogenous and 
exogenous sources.
Phase I metabolism involves oxidation, reduction and hydrolysis reactions as 
mediated by cytochrome P450 or flavin mixed-function oxidases (Cooper et al., 1965; 
White and Coon, 1980; Pelkonen and Nebert, 1982). Many xenobiotics are lipophilic 
compounds which will remain in the cells indefinitely if they are not converted to more 
hydrophilic derivatives. During Phase I metabolism, foreign compounds are converted 
into reactive species by the introduction of an electrophilic centre. In Phase II 
metabolism, products from Phase I or other endogenous substrates undergo conjugation 
reactions. Recently, a Phase III metabolic system was proposed by Ishikawa (Ishikawa, 
1992). Phase III metabolism is an elimination process where glutathione 5-conjugates 
are exported out of the cells via an ATP-dependent glutathione 5-conjugate export pump, 
originally described by Board (198 lk).
Phase II enzymes are known for their capacity to catalyse conjugation reactions. 
This group of enzymes includes glutathione transferases (GSTs), sulfotransferases, 
UDP-glucuronosyl transferases and N-acetyl transferase, that catalyse the conjugation of 
glutathione (GSH), sulphate, gluctjronate, or acetyl group respectively to a wide variety 
of second substrates. The GST isoenzymes are of particular interest because their role in
fr-*«, c\
GSH conjugation has been proposed as the
for xenobiotics.
most important detoxication pathways
1.2 TH E  G LU TA TH IO N E TRANSFERASES
The glutathione transferases (GSTs, E.C. 2.5.1.18) are a group of Phase II 
conjugating enzymes which belong to a supergene family. They are ubiquitous in nature, 
existing in aerobic bacteria, fungi, yeast, plant, and all vertebrates. Mammalian cytosolic 
GSTs are divided into four different classes, namely, Alpha, Mu, Pi and Theta. The 
GSTs found in plants do not fall into any of these classes and are grouped into a special 
class termed, Phi (Blocki et al., 1993). The amino acid sequence of plant GSTs indicate 
that they are most closely related to the Theta class in mammals. Another class of GSTs 
termed Sigma, is composed of the GST from squid (Harris et al., 1991a; Tomarev et al., 
1993) and parasitic helminths (Schistosoma) (Henkle et a l, 1990; Liebau et al., 1994a; 
Liebau et al., 1994b) as well as the lens crystallins from the eyes of cephalopods 
(Tomarev and Zinovieva, 1988). The squid digestive gland GST is believed to be the 
ancestral gene of the lens crystallins, which have evolved to provide a structural role (Ji et 
al., 1995). Recently, a rat spleen GST that exhibited prostaglandin H D-isomerase 
activity was found to be related to the Sigma class GSTs (Meyer and Thomas, 1995). 
This is the first example of the existence of a Sigma class GST in a vertebrate.
Additional GSTs, which can be purified from the microsomal fraction of cells, 
belong to a group of membrane bound GSTs. They include microsomal GST, which has 
a wide substrate specificity and leukotriene C4 synthase, which specifically catalyses the 
conversion of leukotriene A4 to leukotriene C4. There is little amino acid sequence 
identity between the membrane bound GSTs and the cytosolic GSTs, indicating that these 
two groups of GSTs probably arose from different ancestral genes.
GST research has progressed immensely since GSTs were discovered in 1961 
(Booth et al., 1961; Combes and Stakelum, 1961). A selective chronological overview 
of some significant events in GST research is presented in Table 1.1.
3Table 1.1 : A Selective Chronological Overview of GST Research
Year Events Reference
1961 Discovery o f GSH conjugating activity with DCNB on Booth et al. &
cytosolic fraction o f homogenised rat liver Com bes et al.
1965 Enzym e characterisation o f GSTs Boyland et al.
1974 Ligandin is a GST Habig et al.
1975 Separation o f various isoform s of GSTs from  hum an liver Kam isaka et al.
1976 Rat liver GST exhibits selenium independent glutathione 
peroxidase activity
Lawrence et al.
1976 Conversion o f prostaglandin endoperoxides to C hrist-H azelhof
prostaglandin is m ediated by GST et al.
1977 Cytosolic GSTs are dim eric proteins Bass et al.
1977 Expression o f GST is inducible by drugs Hales and 
Neim s
1979 Leukotriene C4 synthase is a GSH conjugating enzym e M urphy et al.
1981 First genetic analysis o f hum an GSTs and identification o f Board 
polym orphism  in the M u class GSTs
1982 Purification and characterisation o f rat m icrosom al GST M orgestem  et al.
1985 N om enclature of GSTs using the alpha, mu and pi 
designation
M annervik et al.
1986 Isolation o f first human A lpha class cD N A  (GSTA1) Tu et al.
1987 Expression o f m am m alian G ST in prokaryotic host B oard and 
Pierce
1987 Isolation o f first hum an Pi class cDNA (GSTP1) Kano et al.
1988 Isolation o f first hum an M u class cD N A  (GSTM 1) DeJong et al.
1990 O ver expression o f GSTs conferred resistance to anti­
cancer drugs
Black et al.
1991 Characterisation o f Theta class GSTs M eyer et al.
1991 First three dim ensional structure o f Pi class GST 
(pG S T P l-1 )
Reinem er et al.
1992 C onsensus nom enclature for human GSTs M annervik et al
1992 First three dim ensional structure of M u class GST 
(rat 3-3)
Ji et al.
1993 First three dim ensional structure o f A lpha class GST 
(hG ST A l-1)
Sinning et al.,
1994 Isolation o f first hum an Theta class cD N A  (GSTT1) and 
identification o f GSTT1 polym orphism
Pem ble et al.
1995 Three dim ensional structure resolution o f a Theta-like 
G ST from Lucilia cuprina.
W ilce et al.
41.3 THE ROLE OF GLUTATHIONE TRANSFERASES
GSTs are involved in conjugating reduced glutathione (GSH, y-glutamyl- 
cysteinyl-glycine) to a wide range of electrophilic compounds, alkylating agents and 
hydrophobic substrates (collectively termed as the second substrate). Besides the 
conjugating activity, several groups of GSTs also participate in the reduction of organic 
hydroperoxides (Lawrence and Burk, 1976; Prohaska and Ganther, 1977), thiolysis 
(Ohkawa and Casida, 1971; Keen and Jakoby, 1987) and reduction of organic nitrates 
(Heppel and Hilmore, 1950; Jensen and Stelman, 1987). These reactions represent 
examples of nucleophilic attack by the glutathione thiolate anion (GS~) on electrophilic 
centres of oxygen, sulfur and nitrogen. GST is also known to exhibit isomerase activity, 
converting A5-3-ketosteroids to oc-ß-unsaturated A4-3-ketosteroids (Benson et al., 1977) 
and maleylacetoacetic acid to fumarylacetoacetic acid (Keen and Jakoby, 1987). The 
isomerase activity may be due to the formation of a short-lived glutathione-conjugate that 
undergoes rearrangement to form the isomer and GSH (Beckett and Hayes, 1993). 
Figure 1.1 gives examples of reactions catalysed by GSTs. Apart from their catalytic 
properties, GSTs also bind to non-substrate ligands in a covalent or non-covalent 
manner.
Many excellent reviews have been written in recent years on the broad field of 
GST research. They focus on aspects such as enzymology (Mannervik, 1985a; 
Mannervik and Danielson, 1988); toxicology (Coles and Ketterer, 1990); gene structure 
and regulation (Pickett and Lu, 1989; Reed and Mann, 1985; Hayes and Pulford, 1995); 
protein structure and function (Dirr et a l, 1994; Wilce and Parker, 1994; Armstrong,
1994) ; molecular genetics (Board et a l, 1990; Board et a l, 1990), biomedical application 
(Beckett and Hayes, 1993), tissue distribution (Mannervik and Widersten, 1995) and 
GSTs contribution to cancer chemoprotection and drug resistance (Hayes and Pulford,
1995) . The following sections will attempt to present a general overview of previous 
investigations on the function and structure of GSTs as they relate to the scope of this 
thesis.
Figure 1.1 : Reaction Catalysed by GSTs
1. Aromatic carbon substitution 
Cl
NO2
1 -chloro-2-4-dinitrobenzene
SG
NQ>
+ h f + c i -
2. Aromatic side chain substitution
H
H-C-SG
010 *S O 4 -  + 2 K 4-
1-menaphtyl sulphate
3. a ,ß-unsaturated carbon addition : Michael addition
CH2II CH2SG
C-CH2CH31 C-CH2CH3
0 0
r ^ r c l
GSH
0 0
OCH2OOOH OCH2COOH
Ethacrynic acid
[2,3-dichloro-4-(2-methylene-butyryl)phenoxy]acetic acid
4. Epoxide ring opening : Addition
l,2-epoxy-3-(p-nitrophenoxy)propane
GSH G>N\0 / 1OCHbaH-CH2
CH
65. Reduction
GSH
cumene hydroperoxide 
(a,a-dimethylbenzyl hydroperoxide)
►
+ GSOH
G90H + GSH ; GSSG + H2O
6. Positional Isomerisation
A5-androstene-3,17-dione
7. Thiolysis
CH3
Ic=o
p-nitrophenyl acetate
8. Denitrosation
H2 - C- O- N02 H2 - C- O- N02
GSH
H2 -C-O-NO2 ------------------- ► H2 -C-OH + NO2 -SG
H2 -C-O-NO2 H2 -C-O-NO2
nitroglycerine
71.3.1 Conjugating Role of GSTs
The most important role of GSTs as a group of detoxication enzymes is catalysing 
the conjugation of reduced glutathione to a wide variety of second substrates containing 
an electrophilic carbon centre. Among these substrates are hydrophobic compounds, 
strong alkylating agents, potential carcinogens, therapeutic drugs and environmentally 
derived mutagens which include epoxides (Boyland and Williams, 1965), oc-ß- 
unsaturated compounds (Boyland and Chasseaud, 1967) and aromatic hydrocarbons 
(Habig et al., 1974b; Jakoby, 1978; Coles and Ketterer, 1990).
The conjugation of GSH to a second substrate serves as the first step towards
the formation of mercapturic acids (Habig et al., 1974b, Boyland and Chasseaud, 1969). 
acids are
Mercapturic the generic name of thioethers of N-acetyl-cysteine which are the
metabolic producj resulting from the sequential breakdown of glutathione-conjugates. It 
has been demonstrated that the N-acetylated cysteine moiety of mercapturic acid is derived 
from glutathione (Bray et al., 1959), and the enzymes that catalyse the conjugation of 
GSH to the original compound are GSTs (Booth et al., 1961). Glutathione-conjugates 
are either excreted from the cells by active transport (Board, 198 lb) or undergo further 
hydrolysis (Bray et al., 1959). In the latter case, the glutamate and glycine moieties are 
sequentially removed by y-glutamyl transpeptidase and cysteinylglycine dipeptidase to 
form a cysteine-conjugate. Subsequent acetylation of the amino (NH2) group of the 
cysteine moeity forms a mercapturic acid. Alternatively, the cysteine-conjugate can be 
cleaved by ß-lyase to form a mercaptan. The thiol group of the mercaptan may undergo 
glucuronidation to form thioglucuronide or be methylated to form a methylthio-conjugate. 
Methylthio-conjugates may be oxidised to methylsulfinyl and methylsulfonyl derivatives. 
All these end products are in readily excreted forms. Figure 1.2 shows the involvement 
of GSTs in the biosynthetic pathway of mercapturic acid.
8Figure 1.2 : Biosynthetic Pathway of Mercapturic Acid
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1.3.2 Selenium Independent GSH Peroxidase Activity
The selenium-independent glutathione peroxidase activity is a unique characteristic 
of the Alpha (Mannervik and Danielson, 1988; Singhal et al., 1994b) and Theta class 
GSTs (Meyer et al., 1991; Hussey and Hayes, 1992). The non-selenium glutathione 
peroxidase activity was reported by Lawrence et al. (1976) and Prohaska et al. (1977) 
when an enzyme purified from rat liver exhibited activity towards cumene hydroperoxide 
but only negligible activity with hydrogen peroxide (H2O2 ). The fractions from ion 
exchange chromatography that showed non-selenium GSH peroxidase activity also had 
GST activity. Recently, Bartling et al. (1993) also purified a GST with GSH-peroxidase 
activity from Arabidopsis thaliana which is structurally and enzymatically unrelated to the 
selenium-dependent GSH-peroxidase, but was found to be closely related to the Theta 
class of the GST supergene family.
As GSTs catalyse the reduction of electrophilic oxygen in the presence of GSH, it 
is not surprising that similar reaction can take place with organic hydroperoxides. Under 
oxidative stress, lipid biomembranes and DNA can be peroxidised by reactive oxygen 
radicals such as superoxide anion, hydrogen peroxide and hydroxyl radicals. The 
peroxidation of polyunsaturated fatty acyl moieties can cause damage to the integrity of 
lipid biomembranes. It has been demonstrated that fatty acid hydroperoxides (Tan et al., 
1984; Hiratsuka et al., 1994) and peroxidised DNA such as thymine hydroperoxides (Tan 
et al., 1986; Tan et al., 1988) are substrates for GSTs and these compounds may 
represent a category of endogenous substrates. GSTs are also known to detoxify toxic 
compounds that arise from lipid peroxidation (Berhane et al., 1994). In view of their 
conjugating role and GSH-peroxidase activity, it is obvious that GSTs play an important 
role in detoxifying toxic compounds derived from lipid peroxidation (Alin et al., 1985; 
Berhane et al., 1994) as well as protecting cells from oxidative damage to lipids and DNA 
(Ketterer et al., 1988; Ketterer and Meyer, 1989).
1.3.3 GSTs in Prostaglandin Biosynthesis
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The conversion of prostaglandin endoperoxides (PGH2) to prostaglandin F2a 
(PGF2a), prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2) in the presence of GSH 
(Christ-Hazelhof et al., 1976; Burgess et al., 1989) are additional examples of reduction 
reactions catalysed by GST. The proportion of PGF2a, PGE2 and PGD2 produced from 
PGH2 is dependent on the type of GST isoenzymes catalysing the reaction (Burgess 
et al., 1989). GSTs also catalyse the conjugation reaction between prostaglandin (PGAi 
and 15-keto-prostaglandin F2a) and GSH (Cagen et al., 1975; Chaudhari et al., 1978). 
Although the physiological significance of these glutathione-conjugates is not clear, the 
conjugated products are rendered more water soluble. These observations suggest that 
GSTs play an important role in the biosynthesis of prostaglandins and may facilitate their 
intra/inter cellular transportation and/or excretion. A schematic diagram of arachidonic 
acid metabolism and the role of GSTs in prostaglandin conversion and conjugation is 
shown in Figure 1.3.
1.3.4 GST in Leukotriene Synthesis
The conversion of leukotriene A4(LTA4) to leukotriene C4(LTC4) involves a 
membrane-bound GSH conjugating enzyme called Leukotriene C4 synthase (Murphy 
et al., 1979; Söderström et al., 1988; Nicholson et al., 1993). LTC4 is a glutathione- 
adduct and this suggests that LTC4 synthase is an enzyme with GST activity. Cytosolic 
GSTs have also been reported to catalyse the conversion of LTA4 to LTC4 (Söderström 
et al., 1985; Mannervik et al., 1984). LTC4, LTD4 and LTE4 are pro-inflammatory 
mediators in diseases such as bronchial asthma. They induce the contraction of smooth 
muscle, attraction and activation of leucocytes and increase vascular permeability. As 
LTC4 is the precursor of LTD4 and LTE4, the role of LTC4 synthase may have a 
profound effect on the aetiological factors in a number of inflammatory disorders. Figure 
1.3 presents a schematic diagram of leukotriene biosynthesis from arachidonic acid and 
the involvement of GSTs in the pathway.
1 1
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traspeptidase v
LTD4
I
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I
I
PGA2
PGF2a^==^ PGD2 Throm boxane
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Figure 1.3 : Biosynthesis of Leukotrienes and Prostaglandins.
Involvement of GSTs or leukotriene C4 synthase are in bold. The involvement 
of Y-glutamyl transpeptidase in the conversion of LTC4 to LTD4 is 
highlighted. Abbreviations : LT : leukotriene; PG : prostaglandin; 5-HPETE : 
5-hydroperoxy-6,8,l 1,14-eicosatetraenoic acid.
1.3.5 Binding Role of GSTs
In addition to their catalytic roles, GSTs are also involved in the direct binding of 
non-substrates (see Table 1.2). The binding properties of GSTs have been identified in 
rat liver cytosol even before it was officially known to be a GST (Habig et al., 1974a). 
In these early studies, GSTs were known by different names such as azo-dye carcinogen­
binding proteins (Ketterer et al., 1967; Ketterer and Christodoulides, 1968; Ketterer, 
1971), corticosteroid binding proteins (Morey and Litwack, 1969), Y and Z proteins 
(Reyes et al., 1971) and ligandin (Litwack et al., 1971). Rat liver GST A A, A, B and C 
(Habig et al., 1974a; Ketley et al., 1975) and the basic human GSTs (Kamisaka et al., 
1975) bind non-covalently to a number of non-substrate ligands which include 
endogenous compounds such as bilirubin, haematin, bile acids, hormones, and 
neurotransmitters (Litwack et al., 1971; Reyes et al., 1971; Ketley et al., 1975; Hayes 
et al., 1979; Abramovitz et al., 1988). It has been proposed that the binding of such 
compounds to GSTs may facilitate their transfer between intracellular compartments 
(Tipping and Ketterer, 1981; Senjo et al., 1985; Harvey and Beutler, 1982) or provide 
temporary storage before their further metabolism and excretion (Wolkoff et al., 1979).
In addition to their non-covalent binding, GSTs also bind covalently to some 
reactive xenobiotics. Xenobiotics such as the carcinogenic aminoazo dyes, polycyclic 
aromatic hydrocarbons and other reactive electrophiles can form covalent bonds with the 
cysteine residue of GSTs (Ketterer, 1971; Sarrif et al., 1975). The human lung Pi class 
GST was found to bind ethacrynic acid (Awasthi et al., 1993). The ethacrynic acid 
bound to the Pi class GST is a non-competitive inhibitor of the enzyme, suggesting that 
the covalent binding site is different from the catalytic site. Although GSTs may lo$fse 
their catalytic activity as a result of covalent binding, this suicidal attempt may prove to be 
an additional protective mechanism for cells. Table 1.2 presents a list of non-substrate 
ligands for GSTs.
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Table 1.2 : Compounds Bound by Rat GSTs
Heme and metabolites:
Haematin
Bilirubin
Bile acid and salts:
Deoxycholate 
T aurodeoxycholate 
Chenodeoxycholate 
Cholate
Hormone, neurotransmitters and steroids: 
Corticosterone 
Dexamethasone 
Progesterone 
Androsterone 
Prednisolone 
Estrone 
Estradiol 
Testosterone 
Estrone sulphate
Dihydroepiandrosterone sulphate 
Pregnenolone sulphate 
2-hydroxyestradiol-glutathione 
Estrone glucuronide
Dmgs:
Apomorphine 
Caffeine 
Chlorpromazine 
B romsulphthalein 
Tetracycline
Carcinogens and metabolites:
N, N-dimethylaminoazobenzene
N, N-dimethylaminoazobenzene metabolites
A^-methylaminoazobenzene-glutathione
3-methylcholanthrene
3-methylcholanthrene metabolite
Diethylstilbestrol
Anions:
Sulphate 
Glutathione 
Glucuronic acid
Source : Smith et al, 1977; Homma et al, 1986 and Abramovitz et al., 1988.
1.3.6 Bioactivation of Glutathione-conjugates
It is generally believed that the conjugation of compounds to GSH results in their
deactivation and detoxication. However, in several cases the conjugation reaction leads to
bioactivation instead of deactivation (Andres et al., 1989; Bakke and Gustafsson, 1984;
Dekant and Vamvakas, 1993). Most of the compounds which become activated after
conjugation to GSH form a reactive episulfonium ion which can form an adduct with the
adduct between DNA and the
N7 atom of guanine in DNA (Pickett and Lu, 1989). The / glutathione derivative cannot 
undergo DNA repair, thus causing mutations and DNA rearrangement. Another mode of 
bioactivation involves the formatiory toxic cysteine 5-conjugates after the sequential 
breakdown of glutathione-conjugates or the formation of reactive sulphur species when 
the corresponding cysteine 5-conjugates of the glutathione-conjugate are cleaved by ß- 
lyase (Elfarra and Anders, 1984; Anders, 1995).
1.4 NOMENCLATURE OF GST
There are numerous nomenclature systems for GSTs reported in the literature. 
They are based on different criteria as well as the preference of individual groups. Before 
the agreement of a unifying nomenclature for the human isoenzymes (Mannervik et al., 
1992), comparison of the GST isoenzymes identified in various laboratories was difficult 
and the discovery of "novel" GSTs could only be ascertained when their physical, 
immunochemical and enzymatic properties were fully characterised.
In 1969, Boyland and Chasseaud, classified the various forms of rat GSTs 
according to their substrate specificity. Hence, a series of names such as GSH 
5-aryltransferase, GSH 5-epoxidetransferase, GSH S-alkyltransferase, GSH 
5-aralkyltransferase, GSH S-alkenetransferase were proposed to identify the GST 
isoforms. However, homogeneous preparations of several enzymes displayed broad and 
overlapping substrate specificities (Pabst et al., 1973; Pabst et al., 1974). For example, 
purified "epoxidetransferase" also exhibited alkyltransferase and aralkyltransferase 
activities. The nomenclature based on substrate specificity is unable to address this 
discrepancy and it also lacks biological significance because most of the substrates used
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are not of endogenous origin. A similar nomenclature was also used to described several 
human GSTs (Grover and Sims, 1964; Johnson, 1966; Boyland and Chasseaud, 1967).
Kamisaka et al. (1975) originally described 5 basic GSTs from human liver 
cytosol. They were given Greek letter designations of a, ß, y, 8, and e in the order of 
increasing isoelectric points. Transferases a-e shared similar enzymatic and 
immunological properties. For this reason, they were often categorised as transferases 
a-e or "basic transferases". An enzyme with a near-neutral isoelectric point called GST ji  
was purified from human liver (Warolm et al., 1981) while acidic transferases were 
purified from human erythrocytes (GST p) (Marcus et al., 1978), human lung (GST X) 
(Stockman et al., 1987) and human placenta (GST rc) (Polidoro et al., 1980). 
Guthenberg and Mannervik (1981) suggested that transferase n and transferase p were 
closely related, if not identical. Other GSTs with Greek letter designation include the 
acidic glutathione transferases to (pI4.6), £ (pI5.2), \\r (pI5.4). (Awasthi et al., 1980; 
Singhal et al., 1991; Singh et al., 1987). Recently, Meyer et al. (1991) purified a novel 
class of GST from human liver cytosol termed GST 0. This class of GST has no 
significant N-terminal amino acid sequence similarity to the earlier reported GSTs and 
was believed to be a unique class of its own (see Section 1.5.4 for more details).
Board (1981b) has taken a genetic approach to classify GSTs by their gene loci. 
By using a non-denaturing electrophoresis system, a direct comparison of GSTs 
expressed in different tissues and individuals became possible under the same conditions. 
This experiment suggested that the GST isoenzymes are products of 3 different loci 
designated GST 1, GST 2 and GST 3. Other laboratories have confirmed similar 
findings (Strange et al., 1984). Under this nomenclature, allelic variants of GST 1 are 
designated as GST1 type 1 and GST1 type 2, each representing the homodimer of type 1 
and type 2 subunit. Consequently, a heterodimer between type 1 and type 2 is termed as 
GST1 type 1-2. A study by Suzuki et al. (1987) on other human tissues revealed that 
there are at least another 3 separate gene loci termed, GST 4, 5 and 6, which encode 
GSTs. GST 4 was found to be expressed abundantly in skeletal muscle, with detectable
levels of expression also found in heart, liver kidney, lung, spleen, thymus and brain 
tissues (Laisney et al., 1984). GST 5 is a brain specific GST, whereas GST 6, the most 
acidic one among the three, was purified from a number of tissues (Suzuki et al., 1987).
Mannervik et al (1985b) proposed a different classification system based on the 
comparison of the N-terminal amino acid sequences, immunological cross-reactivities, 
substrate specificities and enzyme inhibition studies. The proposed nomenclature divided 
mammalian cytosolic GSTs into 3 evolutionary classes termed alpha, mu and pi. A 
similar grouping of isoenzymes was also found in mouse and rat and the GSTs from the 
same class, though from different species, showed greater similarity than GSTs from the 
same species but different classes. Therefore, the alpha, mu and pi classification system 
is species-independent and can be applied to the GST isoenzymes in mouse, rat, human 
and probably other mammals. In this classification, the previously described GST 1, 4, 
5, and 6 fall into the mu class; GST2, the alpha class and GST 3, the pi class.
Since mammalian GSTs are dimeric proteins composed of either identical 
(homodimer) or non-identical (heterodimer) subunits, the enzymes properties are largely 
determined by the combination of subunits. A nomenclature based on subunit 
composition has also been adopted. Under this nomenclature, the human alpha class 
GSTs were named as BiBi or B1B2 based on the composition of subunit Bi and B2 
(Stockman et al., 1985; Stockman et al., 1987) or subunits Hai/Ha2 (Rhoads et al., 1987; 
Rozen et al., 1992) and subunits ax/ay (Ostlund-Farrants et al., 1987) in other cases. 
The human Mu class GSTs in this nomenclature were named as GST NN, with different 
Roman number subscript under the letter 'W , indicating the different subunits of the 
class (Hussey et al., 1991) or was named subunit Hb by another laboratory (DeJong et 
al., 1988a; DeJong et al., 1991). Consequently, subunits Ni, N2 correspond to GST jx 
and GST 4. The acidic GST n or GST 3 belonging to the pi class was called GST YfYf 
under the criteria of this nomenclature (Carmichael et al., 1988).
Recently, a consensus nomenclature for the human GST isoenzymes has been 
agreed (Mannervik et al., 1992). In this new nomenclature, the names of the enzymes 
reflect their evolutionary class, subunit composition and allelic variants. Furthermore, the 
product of a discrete gene has its own designation and no novel GST is to be included in 
this nomenclature until its complete primary structure is fully known. For example, GST 
2 type 1 is now called GSTA1-1. "A" represents the Alpha class and "1-1" indicates it is 
a homodimer of subunit 1. G STM la-lb represents a GST from Mu class with an allelic 
variant of subunit 1 (the lower case letter indicates the allelic forms of the same gene loci). 
Consequently, the newly discovered theta class GSTs (Meyer et al., 1991; Hussey and 
Hayes, 1992; Pemble et al., 1994; see Chapter 3 and 4) were designated as GSTT1-1 
and GSTT2-2. The same nomenclature can also be applied to other mammalian species 
by having a lower case letter prefix before the name of the enzyme. For example, a rat pi 
class GST can be termed rGSTPl-1. For a more comprehensive prefix, the Latin name 
of the species can be adopted. However, this nomenclature has not been fully 
implemented in other mammalian species (for previous nomenclature of rat and mouse 
GSTs see review by Mannervik and Danielson, 1988; Hayes and Pulford, 1995). Table 
1.3 summarises the various nomenclatures described above.
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1.5 GST ISOENZYMES
Mammalian cytosolic GSTs are dimeric proteins (either homo- or heterodimers) 
with functionally independent subunits. A heterodimer can be formed from members of 
the same class but inter-class dimers have not been identified (see Table 1.3). GSTs are 
subject to developmental (Hales and Neims, 1976; Strange et a l,  1985) and sex- 
dependent expression (Ryberg et a l,  1994; Egaas et a l,  1995), induced by different 
chemical compounds (Benson et al,  1978; Pickett et a l,  1982; Clapper et al,  1994) and 
expressed in different tissues (Board, 1981b; Strange et a l,  1984; Suzuki et a l,  1987); 
or cell types (Toffoli et al,  1992; Green et al, 1993; Anttila et al, 1993).
With the adoption of a consensus nomenclature (Mannervik et a l ,  1992), 
mammalian cytosolic GSTs have been grouped into 4 different evolutionary classes — 
Alpha, Mu, Pi and Theta, each differing in their primary amino acid sequence. With the 
exception of the Theta class (see Section 1.5.4), amino acid sequence similarity within 
a class tends to be around 70% or greater while inter-class sequence similarity is usually 
less than 30%. The subunit size of human cytosolic GSTs ranges from 24,700 
(GSTP1-1) to 27,000 Da (GSTT2-2).
On the other hand, the mammalian microsomal GSTs are a group of membrane- 
bound enzymes which have evolved separately to the cytosolic GSTs. The recent 
nomenclature designated the microsomal GSTs as a class of its own. Microsomal GSTs 
are believed to be a convergent evolutionary product, rather than a divergent product of 
the cytosolic GSTs.
For the remaining sections in this chapter, the 1992 nomenclature will not be 
strictly applied to describe the human Alpha, Mu and Pi class GSTs. Instead, the original 
names when they were first described will be used to reflect their originality. A 
comparison between the previous nomenclatures and the consensus nomenclature reached 
in 1992 is given in Table 1.3. Other GST classes have been suggested for non­
mammalian species such as bacteria (Nishida et al,  1994), fungus (Casey et a l,  1991),
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yeast (Coschigano and Magasanik, 1991), plant (Moore et al., 1986; Takahashi and 
Nagata, 1992), insect (Toung et al., 1991; Wang et al., 1991; Board et al., 1994), 
cephalopods (Tomarev and Zinovieva, 1988; Tomarev et al., 1993) and helminths 
(Brophy et al., 1989). However, the present review is focused on the human GSTs.
1.5.1 Alpha Class GSTs
The human Alpha class GSTs encompass the basic isoenzymes a, ß, y, 5 and e 
isolated by Kamisaka et al. from human liver (Kamisaka et al., 1975). These workers 
suggested that these isoforms were products of a single gene but may have risen as a 
result of in vivo deamination. However, Board (1981b) demonstrated that the 3 human 
liver Alpha class GSTs were homo- and heterodimers of two subunits, namely GST2 
type 1 and GST2 type 2. Similar observations made by Stockman et al. showed that the 
basic GSTs were formed from two subunits, Bi and B2 which differ from one another 
catalytically (Stockman et al., 1985; Stockman et al., 1987). Based on their isoelectric 
points, it is evident that GST2 type 1 is equivalent to Bi and GST 2 type 2 is the same as 
B2 (Stockman et al., 1985; Suzuki et al., 1987).
Evidence that the multiple isoforms of the human Alpha class GSTs are products 
of separate genes came from the isolation of two human Alpha class cDNAs, termed 
GTHi and GTH2 from a human liver cDNA library (Tu and Qian, 1986; Rhoads et al., 
1987). Independently, Board and Webb isolated an Alpha class cDNA clone, ?iGST2-3 
(Board and Webb, 1987), which was the same cDNA as GTHi. The deduced amino acid 
sequences of GTHi and GTH2 are very similar and differ in only 11 amino acids. Direct 
amino acid sequencing showed that the amino acid sequence of subunits Bi and B2 were 
the same as those deduced from GTHi and GTH2 respectively (Hayes et al., 1989). 
From the present understanding, it can be concluded that the Alpha class subunits are 
products of 2 different gene loci.
The genes for the two human Alpha class GSTs have been isolated from different 
genomic libraries (Rozen et al., 1992; Klone et al., 1992; Suzuki et al., 1993). The
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genes span approximately 12kb, containing 7 exons, separated by 6 introns. A separate 
gene for a third Alpha class GST, GSTA3 has also been reported (Suzuki et al., 1993). 
However, the cDNA and protein derived from this gene has yet to be isolated and it is not 
clear where or when GSTA3 is expressed. DNA sequence around the vicinity of the 
GSTA1 gene reveals several pseudogenes belonging to the same class (Suzuki et al., 
1993).
The Alpha class genes appeared to be heterogenous from results of Southern blot 
analysis (Board et al., 1990). Besides the cDNA cloning of GSTA1, GSTA2 and the 
identification of a putative GST A3 gene and other Alpha class pseudogenes, it is notable 
that there have been reports of the isolation of additional human Alpha class isoenzymes 
from various tissues although their cDNAs have not been identified. They include the 
basic human skin GST with a pi of 9.9 (Del Boccio et al., 1987) and an acidic GST 
(pI5.8), designated as hGST5.8, which is known to be expressed in several human 
tissues (Singhal et al., 1994b; Singhal et al., 1994a; Singhal et al., 1995). hGST5.8 is 
closely related to the rat GST8-8 (Jensson et al., 1986) and mouse mGSTA4-4 (Zimniak 
et al., 1992) of the Alpha class in terms of amino acid sequence identity and substrate 
specificity. Singhal and co-workers proposed that these orthologous isoenzymes in 
mammalian species represent a subclass within the Alpha class isoenzymes (Singhal 
et al., 1994b) which are characterised by their high activity towards 4-hydroxy-2- 
nonenal and probably other 4-hydroxyalk-2-enals.
Alpha class GSTs have several distinct characteristics. They all show selenium- 
independent GSH peroxidase activity towards hydroperoxide substrates (Mannervik and 
Danielson, 1988; Singhal et al., 1994b). In rodents, the Alpha class GSTs are 
responsible for the detoxication of hepatocarcinogens, aflatoxin Bi-8,9-epoxide and 
several diol epoxides of polycyclic aromatic hydrocarbons (Ramsdell and Eaton, 1990; 
Hayes et al., 1991; Hayes et al., 1992). GSTs in human liver cytosol also conjugate 
aflatoxin Bi exo- and endo-epoxides to GSH although the activities were much lower 
compared to that in rodents (Raney et al., 1992).
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1.5.2 Mu Class GSTs
The human Mu class of GSTs is the largest family among the mammalian 
cytosolic GSTs identified, with at least six distinct subunits that are the products of five 
different loci (Table 1.3). Many other Mu class GSTs have been characterised at the 
protein level, but their relationships with the other Mu class GSTs remain ambiguous 
until further information is available (Tsuchida et al., 1990; Suzuki eta l, 1991).
Two hepatic Mu class GSTs, GST p and GST y, are well characterised 
(Warholm et al., 1981; Warhoim et al., 1983; Singh et al., 1987). Both proteins are
homologous and the amino acid sequences deduced from their cDNAs showed that 
they only differ at residue 173, which substitutes a lysine residue in GST p for an 
asparagine in GST y. It is now apparent that GST p and GST vj/ are allelic variants of the 
GSTM1 gene locus, and were initially characterized genetically by Board (1981b) as 
GST1 type 1 (GST v) and GST1 type 2 (GST p).
Extrahepatic Mu class GSTs include GST 4, GST 5, GST 6 and GT-tSBO. 
GST 4 is a muscle specific GST purified from skeletal muscle (Suzuki et al., 1987). A 
cDNA clone was isolated from a myoblast cDNA library (Vorachek et al., 1991) and the 
deduced amino acid sequence was found to be similar to that of GST 4 (now known as 
GSTM2), confirming the gene product of GST 4 locus. The cDNA encoding GSTM3 
[formally known as GST 5 (Suzuki et al., 1987)] have been isolated from testis and brain 
cDNA libraries (Campbell et al., 1990). The deduced amino acid sequences from these 
cDNA clones have 72% amino acid sequence identity with the human liver GST p, but 
unlike GST p, GSTM3 has little activity towards trans-4-phenyl-3-buten-2-one (tPBO) 
and the N-terminus of the protein is blocked. A highly acidic Mu class isoenzyme GST 6 
(pi 4.25), was purified from various human tissues (Suzuki et al., 1987; Suzuki et al., 
1991). The first 24 N-terminal amino acid residues of GST 6 were found to be identical 
to GST 4 and differed in only one residue from GST 1, indicating a close relationship 
between these 3 isoenzymes (Suzuki et al., 1991). As the cDNA encoding GST 6 has yet 
to be discovered, its genetic relationship with the other Mu class GSTs remains uncertain
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at this stage. GT-tSBO which is identical to GST p. and GST1 type2, is expressed in 
human mononuclear leucocytes (Seidegard et al., 1987; Seidegard et al., 1989).
Various groups of workers have isolated and characterised a fourth member of the 
Mu class GST, GSTM4 (Ross and Board, 1993; Zhong et al., 1993; Comstock et al., 
1993). Its gene structure and its heterologous expression have been described (Ross and 
Board, 1993; Zhong et al., 1993; Comstock et al., 1993). The recombinant GSTM4 
protein appeared to have low activity with most substrates (Ross and Board, 1993). 
Partial cDNA clones of GSTM4 showed evidence of alternative splicing, which may 
represent a novel form of post-transcriptional regulation in the GST supergene family 
(Ross and Board, 1993). Recently, the cDNA of a fifth member of the Mu class GSTs, 
GSTM5, has been cloned from a human brain cDNA library (Takahashi et al., 1993). 
GSTM5 was found to be expressed in brain, testis and lung but little is known about its 
protein at this stage. This may represent the GST 6 that was previously purified by 
Suzuki et al. (1991).
The Mu class GSTs is heterogeneous and polymorphism has been observed in the 
GSTM1-1 isoenzyme (Board, 1981b; Seidegard and Pero, 1985; Seidegard et al., 1988). 
Non-denaturing gel electrophoresis, Southern blot analysis and GT-tSBO activity assays 
in blood monocytes have shown that about 40-50% of the European population are 
deficient in GSTM1. Board suggested this deficiency is due to a null allele at the GSTM1 
locus (Board, 1981b). The existence of a null allele corresponds to a deletion of the 
GSTM1 gene (Seidegard et al., 1988). This polymorphism appears to be widely spread 
among different ethnic groups (Board et al., 1990). Several studies have been carried 
out to determine if the GSTM1 polymorphism is related to an increased risk of cancer 
among smokers, but each giving variable results (Seidegard et al., 1990; Nazar-Stewart et 
al., 1993; Zhong et al., 1991). Numerous other studies of the potential relationship 
between GSTM1 deficiency and susceptibility to various cancers have been undertaken 
but are beyond the scope of this review.
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1.5.3 Pi Class GSTs
The human Pi class is the smallest family among the GST supergene family, with 
only one member, GSTP1-1, identified at the cDNA and protein level (Kano et al., 1987; 
Moscow et al., 1988). The Pi class GST has a low pi value and was identified as the 
cationic GST 3 in human erythrocytes (Board, 1981b). In humans, Pi class GST was 
purified from placenta (GST 7t), lung (GST X) and erythrocytes (GST p) (Marcus et al., 
1978; Polidoro et al., 1980; Stockman et al., 1987). Although GST n is not expressed in 
adult liver, it is expressed abundantly in foetal liver (Strange et al., 1985). Elevated 
levels of GST k were detected in certain preneoplastic tissues and its overexpression has 
been associated with resistance to chemotherapeutic drugs (Nakagawa et al., 1990; 
Kuzmich etal., 1992).
GST K, GST X and GST p are closely related and thought to be the products of 
GSTP1. There is evidence that the GSTP1 locus is polymorphic, with at least 2 allelic 
variants (Board et al., 1989; Ahmad et al., 1990). In fact the cDNA cloned by Kano 
et al., differs from the partial cDNA clones isolated by Board et al. (1989), and Wang et 
al., (1989) at two position, Ii05—'►V and Aii4->V respectively. It is most likely that these 
conservative substitutions represent allelic variation of the GSTP1 gene locus. Recently, 
Bora et al. (1989; 1991) reported a protein which has fatty acid ethyl ester synthase III 
(FAEES III) and GST activity. Its cDNA clone has only 4 amino acid substitutions 
compared to that of GSTP1. This raised the speculation of novel role for the GST 
family. However, this speculation was proven to be unlikely when a FAEES III cDNA 
clone constructed by site-directed mutagenesis of a GSTP1 cDNA and expressed in E. 
coli was found to be inactive as a FAEES enzyme (Board et al., 1993).
1.5.4 Theta Class GSTs
The Theta class GSTs were only recently recognised as a distinct GST class 
(Meyer et al., 1991). The Theta class GSTs were largely overlooked due to their low or 
lack of activity with the model substrate l-chloro-2,4-dinitrobenzene (CDNB) and their 
failure to bind to immobilised glutathione affinity matrices.
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However, the discovery of the Theta class GSTs can be traced back to the partial 
purification of rat transferase E (GST 5-5) (Pabst et al., 1973) and a rat liver enzyme that 
catalysed the conjugation of GSH to 1-menapthyl sulphate (Gillham et al., 1970). For a 
period of time, these two isoenzymes were not assigned to any class because there was 
insufficient knowledge of them. Recently, a novel class of GSTs with distinct 
characteristics were purified from rat and human liver (Hiratsuka et al., 1990; Meyer 
et al., 1991; Hussey and Hayes, 1992). They included the rat GST 5-5, rat GST 12-12, 
rat GST Yrs-Yrs (see Section 1.5.4.2 below), as well as human GST 0 and 
GSTT2*-2*. The primary structures, immunochemical properties and substrate 
specificities of these enzymes have little similarity with the existing Alpha, Mu and Pi 
class GSTs. In view of their distinct characteristics, they were assigned as a new class in 
the GST supergene family, termed Theta.
Subsequently, other mammalian Theta class GSTs were also characterised from 
mouse, dog and human (for references see Table 1.4). Several GSTs from insects (see 
review by Wilce and Parker, 1994) and plants (Moore et al., 1986; Takahashi and 
Nagata, 1992) were also shown to have sequence similarity with the Theta class GST and 
Theta-like GSTs were also purified from subcellular compartment such as matrix of 
mitochondria and nucleus. Table 1.4 presents a list of GSTs which have been classified 
as Theta class or termed Theta-like in the literature.
Comparison of the characteristics of all the mammalian Theta class GSTs studied 
so far suggests that the Theta class may be subdivided into two subfamilies based on their 
overall amino acid sequence identity (Ogura et al., 1991; Pemble and Taylor, 1992; 
Pemble et al., 1994; Tan et al., 1995) and substrate specificities (Hiratsuka et al., 1990; 
Meyer et al., 1991). In spite of their amino acid sequence identity in the N-terminal 
domain, their C-terminal sequences show greater diversity. Within the same subfamily, 
overall amino acid sequence identity is greater than 78%, e.g. rat GST Yrs-Yrs and 
human GSTT2-2. However, overall amino acid sequence identity is less than 52% 
between a subfamily even from the same species, e.g. rat GST 5-5 and rat GST Yrs-Yrs.
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The percentage of sequence identities between subfamily 1 and subfamily 2 members are 
shown in Table 1.5.
1.5.4.1 Subfamily 1
Subfamily 1 comprises the rat GST 5-5 (Meyer et al., 1984; Meyer et al., 1991; 
Pemble and Taylor, 1992) [previously known as rat transferase E (Habig et al., 1974b; 
Meyer et al., 1984)] and its human orthologue GSTT1-1 (Pemble et al., 1994) 
[previously termed GST 0 (Meyer et al., 1991)]. Recently, a mouse Theta class GST 
belonging to this subfamily was detected in cytosol of mouse liver (Hiratsuka et al., 
1995). Unfortunately, due to its instability during purification, the protein was not 
available for further characterisation.
1.5.4.1.1 Substrate specificity for subfamily 1
GST 5-5 has significant activities towards l,2-epoxy-3-(p-nitrophenoxy)propane 
(EPNP), p-nitrobenzyl chloride (PNBC), p-nitrophenethyl brom ide (PNPB), 
dichloromethane (DCM), cumene hydroperoxide (Cu-OOH) and DNA hydroperoxide 
(Tan et al., 1988; Meyer et al., 1991). As for GSTT1-1, the partially purified sample 
(90% pure) lost significant activity during purification. Nevertheless, in the crude 
cytosolic fraction which was not retained by GSH affinity matrix, detectable activity was 
observed with CDNB, EPNP, PNBC and PNPB. It was proposed that the specific 
activity of GSTT1-1 would be of the same order as that of rat GST 5-5 (Meyer et al., 
1991).
In vivo expression of GST 5-5 in Salmonella typhimurium TA1535 has been 
implicated in the production of base-pair revertants upon exposure to ethylene dihalides or 
dihalom ethanes (Thier et al., 1993). This mutagenic effect is caused by the 
S-(l-haloalkyl)GSH intermediates, formed through the GST catalysed conjugation of 
GSH with dihalomethanes. These substances are genotoxic and are known to form DNA
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Table 1.5 : Amino Acid Sequence Comparison of the Mammalian Theta
Class GSTs. Amino acid sequence are deduced from cDNA clones. GSTT1-1 : 
Pemble et al., 1994; GSTT2-2: Tan et al., 1995 (see Chapter 3); rat 5-5 : Pemble et al., 
1992; rat Yrs-Yrs : Ogura et al., 1991. mGSTT2-2 (mYrs-Yrs): Whittington et al., 1996.
Subfamily 1 
GSTT1-1 rat 5-5 GSTT2-2
Subfamily 2 
rYrs-Yrs mYrs-Yrs
GSTT1-1 100% 82.0% 55.0% 55.4% 55.2%
rat 5-5 100% 50.2% 51.1% 51.1%
GSTT2-2 100% 78.3% 77.0%
rYrs-Yrs 100% 91.8%
mGSTT2-2 100%
adducts with 2'-deoxyguanosine (Pickett and Lu, 1989). Mice, but not rats, exposed to 
dihalomethanes were found to develop liver tumours (Wong et al., 1982). In view of 
this, the risk assessment of dihalomethanes to humans becomes important (Ramsey et al., 
1979).
1.5.4.1.2 Dihalomethane metabolism and GSTT1 polymorphism
In humans, there is an inter-individual variation on the conjugation of 
dihalomethane with GSH (Schroder et al., 1992). About 60-85% of the individuals 
studied were termed "conjugators" while the other are "non-conjugators". The enzyme 
responsible for this conjugation is a GST present in erythrocytes as well as liver 
(Schroder et al., 1992; Bogaards et al., 1993). It was only recently, that this 
polymorphism was clearly attributed to the Theta class GSTT1-1 isoenzyme (Pemble 
et al., 1994; Halber et al., 1994). The GSTT1 polymorphism is due to a null allele 
caused by a gene deletion as indicated by PCR-based genotyping and Southern blot 
analysis (Pemble et al., 1994). In a recent study, the GSTT1 polymorphism was shown 
to vary substantially across different ethnic groups (Nelson et al., 1995). By a PCR- 
based genotyping assay, the homozygous deletion of GSTT1 was found to have the 
highest prevalence in the Chinese (64.4%) and Korean (60.2%), followed by African- 
Americans (21.8%), Caucasians (20.4%) and Mexican-Americans (9.7%). It seems 
likely that the GSTT1 null genotype is associated with gene-environment interaction. 
Since GSTT1-1 is involved in the dihalomethane metabolism, individuals with the 
GSTT1 normal allele may have a greater risk of cancer when exposed to dihalomethanes 
while individuals homozygous for the null alleles may have a lower risk.
However, whether this polymorphism is deleterious or beneficial is still 
debatable. For example, sister chromatid exchanges in lymphocytes of "non- 
conjugators" were markedly increased upon exposure to methyl bromide, ethylene oxide 
and dichloromethane (Halber et al., 1993). In a separate study, individuals carrying a 
homozygous deletion of the GSTT1 gene showed a marked increase in spontaneous 
(background) as web as diepoxybutane induced sister chromatid excahnges (Wiencke et
al., 1995). It appears that the expression of GSTTl-l in the "conjugator" group grants 
protection against this cytogenetic damage (Hallier et al., 1993).
Studies on the importance of GSTT1 allele on the risk assessment of cervical 
intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) did not indicate a role 
for GSTTl-l in the aetiology of these diseases, nor was there a correlation between the 
interactive effect of GSTM1 null and GSTT1 null in the incidence of CIN and SCC 
(Warwick et al., 1994). Risk assessment of the GSTT1 null genotype and colorectal 
cancer did not show any significant difference with the control group (Chenevix-Trench 
et al., 1995). However, the homozygous GSTT1 null was more common in individuals 
diagnosed with colorectal cancer before age 70. Other studies on the GSTT1 genotype 
show that the GSTT1 positive genotype conferred some protective effect against total 
ulcerative colitis (Duncan et al., 1995), while in another study, the positive genotype was 
associated with an increased risk of astrocytoma (Elexpuru-Camiruaga et al., 1995). 
These mixed results suggest that it may be important to evaluate GSTT1 polymorphism as 
a risk factor in other malignancies.
1.5.4.2 Subfamily 2
The subfamily 2 of the mammalian Theta class consists of rat GST Yrs-Yrs 
(Hiratsuka et al., 1990; Meyer et al., 1991), mouse GST mYrs-mYrs (or mGSTT2-2) 
(Hiratsuka et al., 1995; Whittington et al., 1996) and their human orthologue GSTT2-2 
(Hussey and Hayes, 1992; see Chapter 3). Several additional closely related 
isoenzymes have been purified from this subfamily in rats (Meyer et al., 1991; Hiratsuka 
et al., 1994) and there is evidence at the DNA level of heterogeneity of this subfamily in 
mice (Whittington et al., 1996).
1.5.4.2.1 Heterogeneity within the subfamily 2
In recent publications, the rat GST 12-12 is commonly equated to rat GST 
Yrs-Yrs. However, Hiratsuka et al. (1995) noted that although rat GST 12-12 and rat 
GST Yrs-Yrs are structurally similar, they are not identical and represent two distinct
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members of subfamily 2 in the rat. Indeed, comparison of the partial amino acid 
sequence of rat GST 12-12 (Meyer et al., 1991) with the amino acid sequence deduced 
from a cDNA clone of rat GST Yrs-Yrs (Ogura et al., 1991) showed the following 
substitutions: Cysl3-*Ser, Arg35—►Leu, Cys36-*Lys and a glutamine deletion in rat 
GST 12-12 at position 43 of rat GST Yrs-Yrs. In fact, heterogeneity in the rat GST 
12-12 was first observed when N-terminal sequencing of rat GST 12-12 yielded both 
serine and cysteine at residue 13 suggesting two proteins were being sequenced (Meyer 
et al., 1991). Cyanogen bromide cleavage of rat GST 12-12 (Meyer et al., 1991) 
produced 2 similar but distinct fragments that also differed from the deduced amino acid 
sequence of rat subunit Yrs cDNA (Ogura et al., 1991). These results suggest that there 
are at least 2 members of subfamily 2 in rats.
Recently, Hiratsuka et al. (1994) purified another rat Theta class GST which is 
closely related to subunit Yrs. This subunit, termed Yrs', has comparable substrate 
specificities to subunit Yrs, with the exception of lower activity towards mono­
hydroperoxides of endogenous polyunsaturated fatty acids. Although amino acid 
sequencing of the first 40 residues of subunit Yrs' showed that it is identical to subunit 
Yrs, the two subunits have different pi values and have different retention time on reverse 
phase HPLC. Subunit Yrs and Yrs' can exist as homodimers, as well as the heterodimer 
Yrs-Yrs'. This observation suggests that Yrs and Yrs' are possibly post-translational 
modified products from the same gene locus (Hiratsuka et al., 1994).
In the process of isolating the rat GST 5-5 cDNA, Pemble and Taylor (1992) 
reported a partial clone of a Theta family member which shares high N-terminal amino 
acid sequence similarity with cDNAs of subunit Yrs and subunit 5. It is not known if the 
3' region of this partial cDNA shares greater identity to subunit Yrs or subunit 5. 
However, from the deduced N-terminal sequence, this cDNA clone is likely to be a 
member of subfamily 2.
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Recently, the cDNA and gene for a mouse Theta class GST belonging to the 
subfamily 2 has been cloned (Whittington et al., 1996). Heterogeneity in this mGSTT2 
has also been observed. Comparison of the amino acid sequence deduced from genomic 
sequence and cDNA sequence revealed a single amino acid change at position 206 which 
substituted a cysteine for a tyrosine. This substitution may be the result of allelic 
variation of the locus. The heterogeneity occurring in the subfamily 2 of Theta class GST 
in rats and mice suggests that similar heterogeneity may also exist in human and other 
mammals.
1.5.4.2.2 Substrate specificity for subfamily 2
The rat GST Yrs-Yrs was originally discovered because of its GSH-conjugating 
activity towards reactive sulphate esters formed from carcinogenic polycyclic 
arylmethanols (Hiratsuka et al., 1990). A less mutagenic aralkyl sulphate ester, 
1-menapthyl sulphate was the best substrate among the arylmethyl sulphates tested. 
Recently, Hiratsuka et al. (1995) purified and characterised the equivalent of rat GST 
Yrs-Yrs in mouse, termed GST mYrs-mYrs (Hiratsuka et al., 1995). Of particular 
interest with GST mYrs-mYrs is its high specific activity towards MS (4.24 pmol/mg 
protein/min), the highest known value among the members of subfamily 2. The high 
activity of GST mYrs-mYrs towards reactive sulphate esters may grant protection against 
the carcinogenic effects of 5-hydroxymethylchrysene (5-HCR) which when converted to 
reactive sulphate, is highly carcinogenic in mouse skin where the activity of GST 
mYrs-mYrs is low but is not carcinogenic in mouse liver where GST mYrs-mYrs activity 
is relatively high (Hiratsuka et al., 1995).
The human GSTT2-2 was first characterised by Hussey and Hayes (1992). As a 
member of the subfamily 2, GSTT2-2 utilises MS as a substrate but has no detectable 
activity with CDNB, EPNP and DCM (see Chapter 5). Apart from this initial 
characterisation, nothing is known about the genetics, structure and function of
GSTT2-2.
1.5.4.2.3 The cDNAs and gene structure of subfamily 2
33
cDNAs encoding members of the rat, mouse and human subfamily 2 have been 
cloned (Ogura et al., 1991; Whittington et al., 1996, see Chapter 3). They all contain 
an open reading frame of 732bp, encoding a polypeptide of 244 amino acids (subfamily 1 
members have a polypeptide of 240 amino acids), which is the longest mammalian GST 
characterised so far. The rat gene spans approximately 4kb (Ogura et al., 1994) while the 
mouse gene is approximately 3.1kb (Whittington et al., 1996). Nevertheless, both genes 
have similar gene structure, consisting of 5 exons and 4 introns. This structural identity 
suggests that the gene organisation of the subfamily 2 is conserved in mammalian species 
and the human GSTT2 gene can be expected to share the same structure as its rat and 
mouse orthologue.
1.5.4.3 Summary
The current understanding of the Theta class GSTs groups them into two 
subfamilies. Heterogeneity within the subfamilies has been observed. From the 
enzymological point of view, subfamily 1 and subfamily 2 can be distinguished by 
subfamily-specific substrates. Members of subfamily 1 are characterised by their activity 
towards EPNP and DCM while members of subfamily 2 can be characterised by their 
activity towards MS. Substantial differences in the amino acid sequence in exons 4 and 5 
may explain the different substrate preferences between subfamily 1 and subfamily 2. 
The secondary structural elements encoded by exons 4 and 5 form the C-terminal half of 
a-helix 4, a-helices 5, 6 ,1  and the remaining C-terminal structure of the enzyme (see 
Section 1.10.2, Figure 1.6). Differences in this region will significantly affect the 
substrate specificities as these structural elements contribute to the architecture of the 
hydrophobic binding site (H-site) (see Section 1.8.5). Members of subfamily 1 and 
subfamily 2 have some common characteristics, in that they are not retained by GSH- 
affinity matrices, exhibit low activity towards CDNB and both demonstrate selenium- 
independent GSH peroxidase activity.
Polyclonal antibodies raised against one subfamily member cross-react with 
members of the same subfamily (Meyer etal., 1991; Hiratsuka et al., 1995) but not with 
members of the other subfamily (Watabe et a l, 1995). Members of subfamily 1 are 
generally more labile and lose activity upon storage (Meyer et al., 1991), while the 
members of subfamily 2 are more robust during purification and retain appreciable 
activity during storage (Hiratsuka et al., 1995).
1.5.5 Membrane-Bound GSTs
Membrane-bound GSTs can be divided into the general microsomal GST which 
has a broad substrate specificities, and leukotriene C4 synthase which is specific for the 
addition of GSH to leukotriene A?. Although they are both involved in GSH 
conjugation, they share little amino acid sequence similarity to the cytosolic GSTs.
Most of the initial investigations of microsomal GST were conducted by 
Morgenstern and co-workers on enzyme from rat-liver microsomes (Morgenstern et al., 
1979; Morgenstern et al., 1980; Morgenstern et al., 1982). The microsomal GST is 
distinct from the cytosolic GSTs in its primary amino acid sequences (Morgenstern et al, 
1985; DeJong et al., 1988b), kinetic parameters and substrate specificities (Morgenstern 
and DePierre, 1983). It can be activated by sulfhydryl reagents (Morgenstern et al., 
1980; Morgenstern and DePierre, 1983), heat (Aniya and Anders, 1989), radiation 
(Boyer et al., 1986) and partial trypsin digestion (Morgenstern et al., 1989), and exhibit 
detergent-dependent activity (Morgenstern and DePierre, 1983). Microsomal GST exists 
as a trimer in its native form and the integrity of the trimer is essential for enzymatic 
activity (Boyer et al., 1986; Lundqvist et al., 1992). In rat liver, around 80% of the total 
microsomal GST is localised in the endoplasmic reticulum. The outer membrane of 
mitochondria contains another 5% of the total microsomal GST (Morgenstern et al., 
1984.
McLellan et al. first described the purification of human liver microsomal GST 
(McLellan et al., 1989). The subunit of the purified protein co-migrates with the rat
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microsomal GST on SDS/PAGE with an Mr value of approximately 17,300. Both 
proteins are immunologically related and show activity towards the neph rotoxin and 
hexachlorobuta-1,3-diene (Wolf et al., 1984; McLellan et al., 1989). Understanding of 
the rat and human microsomal GSTs at the molecular level was made possible when 
cDNA clones from both species were isolated from liver cDNA libraries (DeJong et al., 
1988b). The cDNAs share 77% nucleic acid identity and encode polypeptides of 154 
amino acids with 83% amino acid identity. It is confirmed that only one cysteine residue 
is present in the mature protein and this cysteine residue is thought to be involved in the 
activation of the protein by sulfyldryl reagents (Morgenstern et al., 1980; Morgenstern 
and DePierre, 1983).
The second membrane-bound GST, leukotriene C4 synthase, is involved in the 
biosynthetic pathway of this pro-inflammatory mediator (see Section 1.3.4). 
Leukotriene C4 synthase has been purified to homogeneity and shown to be a dimeric 
protein composed of two identical 18kDa subunits (Nicholson et al., 1993). The cDNA 
encoding leukotriene C4 synthase has been subsequently cloned and expressed (Lam 
et al., 1994; Welsch et al., 1994). The deduced amino acid sequence shares no obvious 
similarity with the cytosolic GSTs.
1.6 CHROMOSOMAL LOCALISATION
Chromosomal localisation of the GST genes has been studied using rodent-human 
somatic cell hybrid analysis, gene-specific PCR and in situ hybridisation approaches. 
However, the precise gene loci were determined using the latter approach. The human 
Alpha class gene, GSTA1, has been mapped to the short arm of chromosome 6 at band 
12 (6pl2). As there was 95% identity between cDNAs of GSTA1 and GSTA2 (Rhoads 
et al., 1987) and no significant hybridisation signal was observed elsewhere in the 
genome, it can be concluded that human Alpha class GSTs genes are clustered on a single 
chromosome. These results rule out the possibility of reverse transcribed pseudogenes 
on other chromosomes, although several pseudogenes have been found upstream and 
downstream of the GSTA1 gene (Suzuki et al., 1993).
36
Prior to the current understanding of the Mu class GST gene cluster, the mapping 
of the Mu class genes was complicated by their heterogeneity and the existence of a 
GSTM1 null allele. The mapping of Mu class GSTs by somatic cell hybridisation 
approach have yielded mixed results (chromosome 3, by Islam et al., 1989 and 
chromosome lp31, 6 and 13 by DeJong et al., 1991). In situ hybridisation of a GSTM4 
cDNA clone to prophasic human chromosomes mapped the Mu class genes to lpl3 in 
individuals with or without the GSTM1 gene (Ross et al., 1993). In a separate in situ 
hybridisation study, Pearson et al. (Pearson et al., 1993) demonstrated that the Mu class 
genes cluster around the lpl3.3 region by using a yeast artificial chromosome clone 
which contained the GSTM1-GSTM5 genes as a probe. Taken together, these results 
indicate that the Mu class GSTs are not dispersed throughout the human genome but exist 
as a gene cluster on chromosome 1 at lpl3.3.
Previous studies using rodent-human somatic hybrid cell lines and electrophoretic 
isoenzyme fractionation have assigned the GSTP1 gene to chromosome 11 (Laisney 
et al., 1984; Islam et al., 1989; Suzuki and Board, 1984). Subsequently, the precise 
gene location of GSTP1 was refined to band 1 lql3 by in situ hybridisation (Board et al., 
1989; Moscow et al., 1988). A strong secondary peaks of grains was also observed over 
chromosome band 12ql3-14 (Board et al., 1989). This hybridising sequence was later 
confirmed to be a partial reverse-transcribed pseudogene of GSTP1 (Board et al., 1992).
The gene loci of the human Theta class GSTs, GSTT1 and GSTT2, have been 
mapped to the long arm of chromosome 22 at subband ql 1.2 (see Chapter 4 and Webb 
et al., 1996). The chromosomal localisation of GSTT2 by somatic cell hybridisation 
analysis and in situ hybridisation will be discussed in greater detail in Chapter 4 of this 
thesis.
Lastly, the gene which encodes the human microsomal GST (DeJong et al., 
1988b) has been assigned to chromosome 12 using somatic cell hybridisation analysis 
(DeJong et al., 1990). Its gene locus has been designated as GST12.
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In summary the human GSTs exist as gene clusters which reside on five different
chromosomes: 6pl2 (GSTA); lp l3  (GSTM), l lq l3  (GSTP), 22 q ll.2  (GS7T) and 12
Although pseudogenes have been identified 
(GST12, microsomal GST). ^ in me Alpha and Pi classes, no
pseudogenes have been unambiguously identified in the Mu and Theta classes.
1.7 TISSUE DISTRIBUTION OF HUMAN GSTs
The expression of human GSTs are subject to variation between tissues (Strange 
et al., 1984; Suzuki et al., 1987), cell types (Toffoli et al., 1992; Green et al., 1993; 
Anttila et al., 1993) and stages of development (Strange et al., 1985). Studies on the 
tissue distribution of human GSTs were carried out using specific staining of 
electrophoretic gels (Board, 1981b; Strange et al., 1984; Suzuki et al., 1987; Laisney 
et al., 1984), Northern blotting with the respective cDNA clones (Takahashi et al., 1993; 
DeJong et a l, 1988a), Western blotting with polyclonal antiserum (Campbell et al., 1990; 
Takahashi et al., 1993), m onoclonal (K antor et al., 1991) or polyclonal 
immunohistochemical staining (Anttila et al., 1993) and also direct purification and 
characterisation of GST proteins from natural tissues (Tsuchida et al., 1990; Hussey and 
Hayes, 1993. For comprehensive review, see Table 8 of Hayes and Pulford, 1995). 
Due to the close relationship between members of £ same class, cross hybridisation of 
cDNA probes or antibodies can occur within a given class and the interpretation of results 
are to be treated with great caution.
The differential expression of multiple GST isoforms in tissues may alter the 
levels of protection against some carcinogens. For example, Hiratsuka et al. (1995) has 
attributed the differential carcinogenicity of 5-HCR in skin and liver of mouse to the 
different levels of expression of GST mYrs-Yrs in those tissues. On the other hand, the 
high level of expression of Alpha class GSTs in liver and kidney, provides a useful 
biomarker to evaluate liver and kidney damage by assaying Alpha class GST released into 
the plasma (Beckett and Hayes, 1993). The tissue distribution of human GSTs has been 
studied extensively by various groups; an excellent review on this subject has been 
compiled by Mannervik and Widersten recently (Mannervik and Widersten, 1995).
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1.8 PROTEIN ARCHITECTURE
The structural resolution of GSTs at the atomic level was made possible when
high quality protein crystals were analysed by X-ray diffraction. The crystal structures of
GSTs either in complex with substrate, substrate analogues, products or in the apo-form,
revealed the general protein architecture and the interaction between enzyme and
substrate-products. In concert with site-specific mutagenesis, modular mutagenesis and
construction pf chimfM r^ pyvmes, Structural studies are a powerful tool in understanding 
the the catalytic properties ot '
these enzymes.
The first three-dimensional GST structure solved was that of a porcine Pi class 
GST in complex with the substrate analogue, glutathione sulphonate (Reinemer et al, 
1991). Subsequently, the three dimensional structure of rat Mu class GST3-3 in complex 
with the physiological substrate, GSH, was also resolved (Ji et al., 1992). The 
homogenous preparation of GSTs from human tissue or heterologous expression systems 
enabled the crystallisation and solution of the structures of the human Alpha (Sinning et 
al., 1993), Mu (Raghunathan et a l, 1994) and Pi (Reinemer et a l, 1992) class GSTs.
The first three dimensional structure of an invertebrate GST comes from the crystal 
structure of a Theta-like representative from the Australian sheep blowfly, Lucilia cuprina 
(Wilce et a l, 1994; Wilce et a l, 1995). The three dimensional structure of L  cuprina 
GST shall provide some structural information about the Theta class family until the 
crystal structure of mammalian Theta isoenzyme is available. The three dimensional 
structure of a Sigma class GST from squid has also been solved recently (Ji et a l, 
1995).
From the structures solved so far it is evident that the mammalian cytosolic GSTs 
are composed of two subunits which interact with one another to form a dimer. Each 
subunit functions independently in catalysis and the topology of the subunits can be 
divided into two domains. The protein architectures of the cytosolic GSTs are shown in 
Figure 1.4.
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Figure 1.4 : Protein Architectures of Cytosoloc GSTs
A
C
Theta-class B Pi-class
Domain II Domain I
Mu-class D Alpha-class
Modified from Wilce et al. (1995)
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1.8.1 Domain I
Domain I comprises the first third of the polypeptide (except for the cc9 helix in 
the Alpha class GSTs). It contains four strands of mixed ß-sheets (ßl to ß4) flanked on 
one side by two a-helices (al and cc3) and another a-helix (a2) on the solvent-facing 
side. The topology of the secondary structure in Domain I is in a ßaßaßßa arrangement. 
Domain I, which is often referred to as the G-site, contributes to a larger extent to the 
binding of GSH. Sinning et al. (1993) noted that its secondary structure mimics other 
GSH binding proteins such as E. coli thioredoxin (Holmgren et al., 1975), T4 
glutaredoxin (Soderberg et al., 1978) and glutathione peroxidase (Epp et al., 1983). A 
distinctive characteristic of the Mu class GSTs in this domain, is the presence of an 
extended and mobile loop between ß2 and a2, termed the Mu loop (Figure 1.4). The Mu 
loop occurs as a result of a short peptide insertion between ß2 and cc2. A structural 
characteristic which is unique to the Alpha class GSTs is also found in this domain. The 
extra amino acids at the C-terminus of the Alpha class GSTs fold into an additional alpha 
helix (a9) and form a lid over the active site when a hydrophobic substrate occupies the 
active site (Sinning et al., 1993).
1.8.2 Domain II
Domain II comprises the C-terminal two thirds of the polypeptide and is joined to 
Domain I by about 6 amino acids. The topology of the secondary structure in Domain II 
consists of five right-handed a-helices (a4 to a8). The interface between these two 
domains forms a V-shape cleft (or a more parallel interface for the L. cuprina GST) which 
make up the wall of the active site subunit (Wilce et al., 1995).
Domain II of the Alpha, Mu and Pi class GSTs shares a very similar folding 
topology. However, detailed comparison of root mean square (r.m.s.) deviations 
between protein units, r.m.s. deviations between the ligands and rotations between 
structural units has shown significant differences in the Alpha, Mu and Pi enzymes 
(Sinning et al., 1993). A dominant feature of Domain II is the two long helical segments 
a4 and a5 which form the wall of the central channel. The crescent-shape of the a5 helix
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is due to the presence of c/s-proline residue(s) in the helix. In the Alpha class, the a5 
helix is slightly longer than that in the Pi and Mu class due to an insertion near the middle 
of this helix. However, in the case of the L. cuprina GST, the cc5 helix is shorter and is 
not bent. The L. cuprina model may only reflect the general structure of the Theta class 
GSTs as there is only 25% of overall amino acid identity between GSTT2 and the Theta­
like GST from L. cuprina .
Based on amino acid sequence alignment, Wilce et al. (1995) suggested that the 
insertion of 8 residues in the cc5 helix in the mammalian Theta class GSTs would result in 
a longer a5 helix. While C-terminal of the L. cuprina GST is disordered in the crystal 
structure, secondary structure prediction of the extended C-terminus of the mammalian 
Theta class GSTT2 suggests that it might adopt an amphipathic helical structure similar to 
the oc9-helix of the Alpha class (Wilce et al., 1995; Chelvanayagam et al., 1996).
1.8.3 Subunit Dimerisation
Subunit interactions stabilise the dimeric structure of the enzyme and the tertiary 
structures of individual subunits. The mammalian enzymes are only fully functional as 
dimers. Although the active sites of each subunit are kinetically independent in the dimer 
(Mannervik and Jensson, 1982; Tahir and Mannervik, 1986), there are contributions to 
the binding of GSH from residues in Domain II of the other subunit (see Section 
1.8.4). The subunits come into contact with each other through interaction between 
Domain I of one subunit (peptide loop connecting oc2 and ß3; one side each of a3 and ß4) 
and Domain II of the other subunit (one face of ot4 and one side of a5) via electrostatic 
and hydrophobic interactions. As the result of dimerisation, around 14% of the total 
hydrophobic surface is buried at the subunit interface. The dimeric protein is globular in 
shape with approximate dimensions of 6.2nm x 5.1nm x 4.6nm (Dirr et al., 1994) and 
the distance between the active sites of the subunits is approximately 1.4nm in the human 
GSTP1-1, based on the closest distance between the GSH molecules (Wilce and Parker, 
1994).
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1.8.4 G-Site
The G-site refers to the GSH binding domain of GST. Secondary structures 
forming the G-site consist of the ocl and a3 helices (which assist in attracting and 
orientating the GSH through helix dipoles); the ß l-a l peptide loop (forming part of the 
architecture of the G-site as well as the H-site, consists of the non-polar residues 
surrounding the conserved tyrosine residue at the N-terminal domain) and the sharp bend 
in the peptide loop connecting oc2 and ß3 (which contributes to the proper folding and 
packing of G-site substructure). For review see Dirr et al., (1994) and Wilce and Parker 
(1994).
The tripeptide GSH binds in an extended conformation through electrostatic 
interactions with various residues of the enzyme (Figure 1.5). Domain I of the protein 
contributes most of these interactions with the exception of one (Mu and Pi class) or two 
(Alpha class) interactions from Domain II of the other subunit in the dimer. In the Mu 
and Pi classes, the a-amino group of the glutamyl residue of GSH interacts with the 
carboxylate of an aspartate from the adjacent subunit (Mu: Asp 105; Pi: Asp96). Mutating 
this aspartate to alanine or asparagine has been shown to reduce the affinity of the enzyme 
for GSH significantly (Wang et al., 1992; Kong et al., 1993). In the Alpha class, 
besides Asp 100 which interacts with the y-Glu moiety of GSH, the glycyl's a-carboxyl 
group of GSH also interacts with Arg 130 from the adjacent subunit. Therefore, the 
contribution of the neighbouring subunit on GSH binding is important in conferring the 
full functional properties of the dimeric enzyme.
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Figure 1.5 : Schematic Diagram of Electrostatic Interaction Between
Glutathione and Amino Acid Residues in the G-site of Human Glutathione 
Transferases. Peptide sites of GSH are represented by PI, P2...P8 etc., and the 
corresponding G-site ligands interacting with the peptide sites are represented by 
Gl, G2...G8 etc.. Carbonyl and amide groups in parenthesis are ligands from the 
main-chain polypeptide. H20  in parenthesis are water molecules which mediate 
hydrogen bond with the corresponding residues. Residues marked with an asterisk 
are G-site ligands from the other subunit in the dimer. The numbering of amino acid 
does not include the initiator methionine (Source taken from Dirr et al., 1994 and 
Wilce et al., 1995).
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1.8.5 H-Site
The H-site which is known as the hydrophobic binding site or xenobiotic binding 
site, situated adjacent to the G-site of the same subunit. Structural elements which 
contribute to the architecture of the H-site come from both Domain I and Domain II of the 
same subunit. They consist of the peptide loop connecting ßl to a l ;  the C-terminal half 
of a4 and the C-terminal tail of the polypeptide. In the Mu and Alpha class GSTs 
additional secondary structures such as the Mu loop (Thr33 to Arg42) (Ji et al., 1992; 
Raghunathan et al., 1994), as well as the cc9 helix of the Alpha class (Sinning et al., 
1993), also form part of the structural components of the H-site. The C-terminal 
sequence of GSTs which are generally more diverse, account for the variability of the 
H-site topology and could explain the broad substrate specificity of GSTs. Moreover, the 
binding of the second substrate involves hydrophobic interactions and therefore is less 
constrained to any particular residues in the H-site. The understanding of the H-site 
topology mostly came from the three dimensional structure of substrate-product 
analogues in the crystal structures of the GSTs (Reinemer et al., 1992; Ji et al., 1992; 
Sinning et al., 1993; Raghunathan et al., 1994). Site directed mutagenesis and deletional 
mutagenesis further confirmed the involvement of essential residues or region of the 
H-site in catalysis (Board and Mannervik, 1991; Johnson et al., 1993).
1.9 CATALYTIC MECHANISM
The role of GST in GSH dependent catalysis depends on the activation and the 
stabilisation of the thiol group of enzyme-bound GSH. Site directed mutagenesis, 
chemical modification, fluorescence emission, fluorescence excitation, UV difference 
spectral studies and also three dimensional structure studies of GSTs indicate that a 
conserved tyrosine residue at the N-terminal domain is involved in activating the thiol 
group of GSH by lowering its pKa from about 9.0 in free aqueous solution (Jung et al., 
1972) to 5.7-6.9 for class Mu (Graminski et al., 1989b; Liu et al., 1992; Graminski et 
al., 1989a), 6.7-7.0 for class Alpha (Wang et al., 1992; Huskey et al., 1991) and 6.3 for 
class Pi (Kong et al., 1992) in the enzyme-bound GSH. The lowering of pKa by about 2 
units corresponds to a stabilisation energy of at least 2.7kcal/mol (Armstrong, 1994). In
the Alpha class, besides the conserved Tyr8, additional electrostatic interaction between 
the sulfhydryl group of enzyme-bound GSH with Arg 14 also plays an important role in 
the activation of GSH (Bjomestedt et al., 1995).
The activation mechanism of the Theta class GSTs seems to involve residues 
other than the conserved N-terminal tyrosine. Although there is an N-terminal tyrosine 
residue in most of the Theta class GSTs, a similar residue is absent in the human GSTT2 
(Hussey and Hayes, 1992, see Chapter 3). In fact, a recent three dimensional structure 
of a Theta-like GST from L. cuprina suggests that the topologically equivalent tyrosine 
(Tyr5) is 13.9Ä away from the sulfhydryl group of GSH and is unlikely to participate in 
hydrogen bonding with GSH (Wilce et al., 1995). On the other hand, amino acid 
sequence comparison of the Theta class GSTs showed a conserved serine residue in the 
N-terminal domain which could possibly act as a general base to abstract the sulfhydryl 
proton from GSH (Wilce et al., 1995). Site directed mutagenesis of Ser9 in L. cuprina 
GST resulted in mutants with severely impaired activity with CDNB (Board et al., 1995). 
The involvement of the conserved serine residue in the catalysis of the Theta class GSTs 
is a subject of interest in this thesis and shall be discussed in greater detail in Chapter 7, 
using GSTT2-2 as an example.
Other contributing factors which have been taken into consideration in the analysis 
of GST catalytic activity include solvation energy, effect of positive electrostatic field 
generated by the helix dipole and second-sphere electrostatic interactions between amino 
acids (Karshikoff et al., 1993; Dirr et al., 1994; Armstrong, 1994).
1.10 EVOLUTIONARY PERSPECTIVE OF GSTs
In the broad spectrum of living organisms, GSH exists only in aerobes. 
Likewise, other enzymes which utilise GSH as their substrate or co-enzyme are also 
found only in aerobic organisms. This suggests that GSH and GSTs play an important 
role in the survival of living cells in an aerobic environment. This is supported by the fact 
that GSTs of the Alpha, Pi and Theta class GSTs are involved in conjugating GSH to the
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products of lipid peroxidation as well as the reduction of fatty acid hydroperoxides (Alin 
et al., 1985; Berhane et al., 1994; Hiratsuka et al., 1994). Consequently, GSH and 
GSTs are believed to have evolved in prokaryotes as a protection mechanism against 
oxygen toxicity (Pemble and Taylor, 1992). Recently, it has been proposed that the 
Theta class GSTs represent the ancestral gene of the GST supergene family (Pemble and 
Taylor, 1992). This proposal suggests that the Alpha, Mu and Pi class GSTs are the 
results of gene duplications from a GST progenitor gene which in the course of 
evolution, retained its function while allowing the duplicated gene to develop novel 
functions. Two views are presented below in relation to the evolution of the GST 
supergene family of GSTs.
1.10.1 Inference From Amino Acid Sequence
Amino acid sequence comparisons between homologous proteins provide a useful 
means to investigate their phylogenetic relationships. Comparison of available amino acid 
sequence from existing databases has shown that the Pi and Alpha classes share greater 
sequence identity than the Pi and Mu or Alpha and Mu classes (Pemble and Taylor, 1992; 
Blocki et al., 1993). On the other hand, the Theta class GSTs have little amino acid 
identity with the Alpha, Mu and Pi class but share relatively high sequence identities with 
the Methylobacterium, D. melanogaster and L. cuprina GSTs, several plant GSTs as well 
as GSTs purified from mitochondria matrix (Harris et al., 1991b) and nucleus (Tan et al., 
1988) of rat liver. However, the 3’ non-coding sequence of the rat subunit 5 cDNA 
shares a high level of sequence identity with the 3’ non-coding sequence of three human 
Mu class cDNA. This suggests that the Mu class is more closely related to the Theta class 
and may have diverged from an ancestral GST gene after the Alpha/Pi lineage (Pemble 
and Taylor, 1992). While the Alpha, Mu and Pi class GSTs are restricted to only fungi 
and mammals, Theta-like GSTs are found distributed in insects, plants, yeast, 
archaebacteria, cyanobacteria, purple bacteria and mitochondria. In this regard, the Theta 
class appears more like the ancestral GST and the Alpha, Mu and Pi class could have 
arisen from the Theta class GSTs through gene duplication events (Pemble and Taylor, 
1992)
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1.10.2 Inference From Exon/Intron Boundaries
The evolutionary perspective of proteins deduced from comparing the exon/intron 
boundaries of homologous proteins is based on the theory that proteins were built from 
structural (Gilbert, 1978) or functional (Blake, 1978) blocks, corresponding to the exons 
of proteins. Therefore, novel proteins arise from the event of exon shuffling through 
homologous recombination and the structural/functional modules were brought together 
by alternative splicing of heterogenous nuclear RNA. The question whether exons code 
for structural or functional units in proteins has been discussed by Traut (1988). It 
appears that certain proteins follow this rule while others show no such correspondence 
[for review see Traut (1988) and references therein] and inference of protein structural or 
functional units from exons are not conclusive at this stage.
The relationship between gene and protein structures of the mammalian GSTs has 
been reviewed recently (Armstrong, 1994). It is obvious from the gene structures, that 
the Mu and Pi classes are more closely related than the Mu and Alpha or Pi and Alpha. 
The exon/intron boundaries of the Mu and Pi classes differ only in two positions. 
Firstly, it appears that the loss of intron 2 and part of exon 3 (which encodes the p loop 
of the Mu class) have resulted in a larger exon 3 in the Pi class. Secondly, intron 7 of the 
Mu class is missing in the Pi class and a larger exon 7 is found in the Pi class (equivalent 
to exon 7 and 8 of Mu class) (see Figure 1.6). Therefore, the Pi class appears to have 
evolved from the Mu class as a result of intron loss. In the Alpha class, the gene 
structure is rather different from that of the Mu and Pi classes. Except for the exon/intron 
boundaries between exon 3 and 4, the other boundaries do not coincide with those found 
in the Mu and Pi class. More distinctly, the a4, a5 and a7 helices of the Alpha class are 
interrupted by introns 3, 4 and 5, perhaps through junction sliding or intron loss/addition 
events.
Based on the mouse Theta class gene structure (mGSTT2) (Whittington et al., 
1996) and a homology model of the human GSTT2 structure (Chelvanayagam et al., 
1996) constructed based on the structure of the L. cuprina GST (Wilce et al., 1995), the
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relationship between protein secondary structure and gene organisation of a Theta class 
GST is presented in Figure 1.6. Compared to other GST classes, the mGSTT2 gene has 
fewer exons and introns though it encodes the longest polypeptide among the GST 
classes. The cc4 helix is interrupted by intron 3 at the last helical turn and the a6 helix is 
interrupted by intron 4 (Chelvanayagam, personal communication). The gene 
organisation encoding secondary structural elements of the Theta class GST are very 
different from the Alpha, Mu and Pi classes. None of the exon/intron boundaries of 
mGSTT2 gene coincide with those of the Alpha, Mu and Pi genes. The only similarity is 
the boundary between Domain I and Domain II of the Theta, Mu and Pi isoenzymes, 
which correspond to the end of exon 4 (Chelvanayagam, personal communication). It is 
not obvious from the inference of exon/intron boundaries that the Theta class is the 
progenitor gene of the Alpha, Mu and Pi class genes.
The evolution of GSTs supergene family had commonly been studied by comparing 
their amino acid sequences (Tan et al., 1988; Harris et al., 1991; Pemble and Taylor, 
1992; Blocki et al., 1993). Recently, the evolution of GSTs was also evaluated from 
the position of their exon/intron boundaries and protein structures (Armstrong, 1994). 
This hypothesis is based on the assumption that proteins were built from structural 
(Gilbert, 1978) or functional (Blake, 1978) blocks, corresponding to the exons of 
proteins. It appears, while some proteins abide to this rule, others show no such 
correspondence. At this stage, the evolution of proteins inferred from the exon/intron 
are not conclusive (Traut, 1988 and references therein).
Based on amino acid sequence identity, the Theta class GST have been proposed as 
the progenitor of other classes (see Pemble and Taylor, 1992 for its argument). 
Comparison of the GSTT2 sequence, which is the cDNA isolated in the course of this 
study, found many similarities in amino acid sequence with other Theta class GSTs 
(see Table 1.5, page 28) Thus by inference the Theta class enzyme studied here can 
be related to the GST super family. However, when the homology model of GSTT2 
and the mouse gene structure were compared with the Alpha, Mu and Pi GSTs, the 
exon/intron boundaries of mGSTT2 showed little correspondence with the other 3 
classes. Therefore the intron/exon boundaries do not reflect the same evolutionary 
relationships as are apparent from sequence alignments Furthermore it is now 
apparent that the members of the Alpha, Mu, Pi and Theta classes all have a similar 
structure despite significant differences in their intron/exon organization. Thus it 
seems that sequence alignment methods may provide a more reliable strategy for 
deriving an evolutionary history of the GSTs
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Figure 1.6 : Schematic Diagram of Exons and the Corresponding Secondary 
Structural Elements of GSTs. Exons are roughly drawn to scale. The exon/intron 
boundaries are deduced from gene structure of (Whittington et al., 1996; 
Telakowski-Hopkins et al., 1986; Okuda et al 1987; Lai et al, 1988). Secondary 
structural elements are derived from three dimensional structure of (Reinemer et al, 
1991; Ji et al, 1992; Sinning et al, 1993), except for the Theta class GST which 
was derived from a homology model of GSTT2 (Chelvanayagam, et al., 1996) 
based on the structure of a L. cuprina GST (Wilce et al, 1995) and the gene 
structure of mGSTT2-2 (Whittington, et al., 1996). Intron interuption of secondary 
structural elements are marked by X.
1.11 OBJECTIVES AND SCOPE OF THESIS
The multifunctional role of GSTs is a subject of great interest in view of their 
involvement in the Phase II detoxication pathway and the existence of polymorphism in 
the supergene family. As a group of detoxication enzymes, understanding of their 
substrate specificities will help to identify the categories of compounds that are substrates 
of GSTs. Considerable effort has been made in the studies of the Alpha, Mu and Pi class 
GSTs at the protein and genetic levels. However, knowledge of mammalian Theta class 
GSTs is still in its infancy in comparison to the other GST classes, especially for the 
Theta class GSTs in humans. The objective of the research reported in this thesis is to 
attain a greater understanding of the human Theta class GSTs through the approaches of 
molecular genetics and enzymology .
Chapter 3 describes the molecular cloning of a cDNA encoding a human Theta 
class GST, GSTT2. It also describes the cloning of several truncated cDNA transcripts 
which correspond to the exon/intron boundaries of its orthologous gene in mouse 
(Whittington et al., 1996). The possibility that GSTT2 is regulated at the post- 
trascriptional level by alternative splicing is discussed.
To gain a greater understanding on the chromosomal location of GSTT2 in 
relation to the other GST classes, mapping of GSTT2 was carried out using rodent- 
human somatic cell hybrid analysis as well as in situ hybridisation techniques. Chapter 
4 is devoted to the description and discussion of these studies in detail.
Chapter 5 describes the heterologous expression and purification of GSTT2-2 
as a ubiquitin-fused protein and the co-translational removal of the ubiquitin moiety by a 
cloned ubiquitin-specific protease, Ubpl. The enzymatically active recombinant 
GSTT2-2 was used for protein characterisation. Polyclonal antibodies were raised 
against purified GSTT2-2 and the tissue expression of GSTT2-2, determined using the 
antiserum as well as Northern blot analysis, is detailed in Chapter 6.
In Chapter 7, the catalytic function of GSTT2-2 as studied by site-directed 
mutagenesis is discussed. A conserved serine residue (Seri 1) at the N-terminal domain 
is mutated to alanine, threonine, or tyrosine and the activity of the wild type and mutant 
proteins are compared using cumene hydroperoxide, ethacrynic acid and 1-menapthyl 
sulphate as substrates. The role of Seri 1 in catalysis is discussed and a novel functional 
role of GSTT2-2 as a glutathione-dependent sulphatase is proposed.
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CHAPTER 2 : ROUTINE MATERIALS AND METHODS
The materials and methods described in this chapter are those commonly used 
throughout this research. Specific research materials, chemicals and procedures will be 
described in the respective chapters.
2.1 MATERIALS
All routine chemical compounds used in the preparation of culture media, buffers 
and reagents were of analytical grade. They were purchased from Difco laboratories 
(USA), Sigma Chemical Co. (USA), Ajax Chemical Co. (Australia), Aldrich Chemical 
Co. (USA), BDH Chemicals Ltd. (England), Merck (Germany), Progen (Australia). 
Other source of materials were : radioisotopes [a-32P]dATP and [a-33P]dATP, from 
Bresatec (Australia); X-ray film Rx or NCII, from Fuji Photo Film Co. (Japan); black 
and white polaroid film (T667), from Polaroid Corp. (USA); nitrocellulose and 
Hybond-N+ nylon membrane, from Bio-Rad Laboratories (USA) and Amersham (UK) 
respectively; Sequenase™ Version 2.0 DNA sequencing kit, from USB (USA); 
Rainbow™ coloured protein molecular weight markers, from Amersham (UK); Lambda 
DNA-HindUl digest DNA size markers, from Pharmacia (Australia) and dNTPs, from 
Boehringer-Mannheim (Australia).
Oligonucleotides were synthesised on an Applied Biosystems 380B DNA 
synthesiser, Applied Biosystems Inc. (USA) by the Australian National University 
Biomolecular Resource Facility. Sources for cloning vectors, restriction endonucleases, 
cloning enzymes and their buffers are summarised in Table 2.1.
2.2 METHODS
2.2.1 Preparation of Competent Cells
Com petent Escherichia coli TGI cells were prepared by the
calcium/maganese/potasium chloride method as described by Sambrook et al. (Sambrook 
et al., 1989). They were dispensed into 100|il aliquots and frozen at -70°C if not used 
immediately.
2.2.2 Transformation and Selection
Transformation of competent cells by plasmids or RF M13 phage were achieved 
using the heat shock method. Competent cells were mixed with the ligated DNA and 
incubated on ice for 30 minutes. The cells were heat shocked for 50 seconds at 42°C and 
returned to ice. For E.coli transformed with plasmids containing the ß-lactamase gene, 
500jil of Luria Broth (1% tryptone, 0.5% yeast extract, 1% NaCl) was added to the heat 
shocked cells and incubated at 37°C for 30-60 minutes before plating on Luria Broth agar 
media (1% tryptone, 0.5% yeast extract, 1% NaCl, 1.5% agar, pH 7.4) supplemented 
with ampicillin (lOOjig/ml). In the case of blue/white colony selection utilising the 
ß-galactosidase gene, IPTG (lOjil of lOOmM stock) and X-Gal (50pl of 2% stock) were 
spread on the agar surface. For M l3 phage transformation, E. coli transformed with 
M13 phage were added to a test tube containing 3ml of Top Agar (1% tryptone, 0.5% 
yeast extract, 0.8% NaCl, 1% agar, pH7.4); IPTG (lOjil of lOOmM stock); X-Gal (35|il 
of 2% stock) and 200jil of exponentially growing TGI cells. The components were 
mixed and poured on a prewarmed minimal agar plate. [Minimal plates were prepared 
using 50ml of 10xM9 salts (60g Na2H P 0 4, 30g KH2P 0 4, 10g,NH4Cl, 5g NaCl in 1L 
of ddH20), 0.5ml of IM M gS04, 0.5ml 0.1M CaCl2, 5.0ml 20% glucose, 0.5ml 1M 
thiamine, 7.5g Bacto agar in 450ml of ddH20  and autoclave]. Plates were incubated at
37°C overnight and transformed host cells containing non-recombinant or recombinant
ed
plasmids or M13 phage can be distinguish^ by a blue/white colour selection. Transformed 
host cells containing recombinant plasmid or M13 were identified by white colonies or
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opaque plaques as a result of disruption of the ß-galactosidase gene by the insertion of 
cloned DNA.
2.2.3 DNA Sequencing
Single-stranded DNA was prepared and sequenced by the dideoxy termination 
method (Sanger et al., 1977; Sanger et al., 1980) and separated on a 6% polyacrylamide 
gel containing 7.4M urea in lx TBE (0.09M Tris-borate, 0.002M EDTA, pH8.0) buffer.
2.2.4 Agarose Gel Electrophoresis
Routine DNA separations were performed by electrophoresis in 0.8% or 1.5% 
agarose gels in either TAE (0.04M Tris-acetate, 0.001M EDTA, pH8.0) or TBE buffers 
(0.09M Tris-borate, 0.002M EDTA, pH8.0). Gels were stained with ethidium bromide 
and viewed under fluorescent UV light at 254nm or 312nm wavelength. DNA fragments 
excised from gels were purified using Geneclean™ II reagents supplied by Bio 101 
(USA).
2.2.5 Capillary Transfer and Hybridisation of Nucleic Acid (Southern 
blot)
DNA transfer from agarose gels to nylon membranes utilised the capillary transfer 
method as described by Southern (Southern, 1975) and modified by Reed and Mann 
(1985). Following agarose gel electrophoresis and ethidium bromide staining, the gel 
was soaked in 0.25M HC1 (results in partial depurination) with gentle agitation until the 
bromophenol blue tracking dye turned yellow (approximately 8 min) and then rinsed 
briefly in distilled water. After depurination, the gel was placed on a blotting paper, 
prewet with Transfer Solution (0.4M NaOH, 0.6M NaCl) and covered with the 
Hybond™ N+ nylon membrane (Amersham, UK). The membrane was covered 
sequentially with 2 sheets of wet blotting paper, 6 sheets of dry blotting paper, a 3 inch 
stack of paper towels and finally with a 0.5kg weight on the top. Capillary transfer was 
carried out with Transfer Solution. Transfer of DNA was allowed to proceed for at least 
2 hours in the case of plasmid DNAs, or overnight for human genomic DNA digests.
Following capillary transfer, the membrane was placed in Neutralising Solution (0.5M 
Tris-HCl, pH7, 1M NaCl) for 15 minutes, with occasional shaking. Membranes were 
blotted dry and DNA was cross-linked to the membrane under long-wave UV (365nm) 
for 5 minutes. Hybridisation probes were labelled with [a32P] dATP by random priming 
using a Megaprime DNA labelling kit (Amersham, UK) following the manufacturer's 
protocol. Hybridisation was carried out in Nasmyth's Solution (Nasmyth, 1982) at 
65°C for 18 hours. Filters were washed sequentially with 2xSSC and 2xSSC, 0.1% 
SDS at room temperature (A 20x SSC stock is made of 3M sodium cloride, 0.3M 
sodium citrate). For more stringent washes, filters were washed in 2xSSC ,0.1% SDS 
at 65°C and/or the concentration of SSC was reduced to lx or 0.2x. Filters were then 
exposed to X-ray film at -70°C.
2.2.6 Protein Analysis by SDS/PAGE
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS/PAGE) of 
protein (Laemmli, 1970) was performed with a 12% gel on a Mini-PROTEAN II Dual 
Slab Cell electrophoresis unit, Bio-Rad Laboratories (USA). Alternatively, the 
Pharmacia PhastSystem™ was used for routine screening. Gels were stained using 
Coomassie Brilliant Blue R250 or a Silver Staining Plus kit (Bio-Rad, CA. USA), 
following the manufacturer's protocol. Pierce Albumin standard was used as a protein 
standard and protein concentrations were determined using the method described by 
Bradford (Bradford, 1976).
2.2.7 Computer Software for DNA Analysis
DNA and protein sequence alignment and comparison was carried out using the 
GCG software (Version 8, 1994, Genetics Computer Group, Madison WI, USA) 
provided through the Australian National Genomic Information Service (ANGIS). 
Generation of DNA restriction map and cDNA sequence translations were performed by 
DNA Strider™ version 1.0, Commissariat al'Energie Atomique (France).
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Table 2.1 : Sources for cloning vectors, restriction endonucleases, cloning enzymes 
and their buffers
E nzym e S o u rce
Restriction endonucleases
Alkaline phosphatase 
Polynucleotide kinase 
Klenow fragment 
T4 DNA ligase 
Taq polymerase
Ribonuclease A type 1- As (RNase) 
M l3 vectors 
pUC vectors 
pGEM™-T vector
Boehringer-Mannheim (Australia) 
Pharmacia (Australia)
Progen (Australia)
Boehringer-Mannheim (Australia) 
Pharmacia (Australia)
Pharmacia (Australia)
Pharmacia (Australia)
Promega (Australia)
Sigma (USA)
Boehringer-Mannheim (Australia) 
Pharmacia (Australia)
Promega (Australia)
CHAPTER 3 : cDNA CLONING AND SEQUENCING OF A HUMAN
THETA CLASS GSTT2
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3.1 INTRODUCTION
Little is known about the molecular genetics of the Theta class GSTs in human. 
From an enzymological point of view, their existence was largely overlooked due to their 
low activity with the model substrate l-chloro-2,4-dinitrobenzene (CDNB) and their 
failure to bind to immobilised glutathione affinity matrices which are common 
characteristics of the Alpha, Mu and Pi class GSTs. The cDNAs encoding Theta class 
GSTs from rat and mouse have been cloned recently and further information on their 
gene structures has also been reported during the course of this present study (see Table 
1.4). However, at the start of this investigation, the human Theta class GSTs were still 
largely unexplored.
3.2 OBJECTIVES
Evidence from protein characterisation suggests that the human Theta class GSTs 
are the products of at least 2 different gene loci (Meyer et al., 1992; Hussey and Hayes 
1992). During the course of this study, Pemble et al. (1994) reported the cDNA cloning 
of a human Theta class GST, termed GSTT1, which appeared to be the cDNA encoding 
GST0 (Meyer et al., 1991). The objective of this chapter is to gain a greater 
understanding of the second human Theta class isoenzyme GSTT2*-2* (Hussey and 
Hayes, 1992) through cDNA cloning.
3.3 MATERIALS
The source of chemical compounds and materials for routine use were provided in 
Chapter 2. The XgtlO and Xgtl 1 human liver cDNA libraries were provided by Dr G. 
Howlett (University of Melbourne, Australia). The kgt 11 human liver 5' stretch cDNA 
library was purchased from Clonetech Laboratories (Palo Alto, CA, USA). PCR primers 
which were designed to amplify across putative exon/intron boundaries were
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HTA3 (sense primer) : 5' TT AG ACGTGCGC ACCGTG 3'
HTB2 (antisense primer): 5' ATCCTTGAGCGTCGGCAG 3’
HTIPF (sense primer) : 5' GGGGACAGGCCCTTCCTC 3'
HTIPR (antisense primer): 5' CATCAGCTCCTCCAGGGC 3'
3.4 METHODS
3.4.1 Development of a Theta Class GST Probe
Total RNA was isolated from rat liver as described by Chomczynski and Sacchi 
(Chomczynski and Sacchi, 1987), and poly(A)+ RNA was prepared by oligo(dT) affinity 
chromatography using a mRNA Purification Kit (Pharmacia, Australia). Two primers :- 
RGTTH1 (sense primer): 5' GGAATTCACCATGGGTTTGGAGCTCTAC 3’. 
RGTTH2 (antisense primer) : 5’ ACAAGCTTCAGGGAATCCTGGCAATTCG 3', 
based on the cDNA sequence of rat subunit Yrs (Ogura et al., 1991), were synthesised. 
RGTTH1 contains an additional EcoRI site while RGTTH2 has a HindHl site to facilitate 
cloning. These primers were used to amplify the coding region of the rat subunit Yrs 
from rat liver cDNA prepared by reverse transcription of rat liver poly(A)+ RNA using a 
Riboclone® cDNA Synthesis Kit (Promega, Australia), procedure as described by the 
manufacturer’s protocol.
A 50|il reaction mix containing 500ng of first-strand cDNA, 200fiM dNTPs, 
20pmol of each primer, 1.5u of Taq polymerase, and 1 xTaq polymerase buffer were 
subjected to DNA amplification by the Polymerase Chain Reaction (PCR) in an oil-bath 
thermal cycler (Bartelt Instruments, Australia). PCR conditions were 5 cycles of initial 
amplification (95°C, lmin; 45°C, lmin; 72°C, lmin) followed by 30 cycles of (95°C, 
lmin; 64°C, lmin; 72°C, lmin). The resulting PCR product was 740bp in length and 
was cloned into the EcoRUSmal sites of pUC18 to give the plasmid pRTHl. The 
pRTHl cDNA fragment was sequenced to confirm its identity as a copy of the rat subunit 
Yrs cDNA (Ogura et al., 1991). The insert in pRTHl was excised by EcoRl-BamHl 
digestion and used as a probe to screen human cDNA libraries.
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3.4.2 cDNA Library Screening by Filter Hybridisation
A Xgt 10 human liver cDNA library and a k g tll human liver 5'-stretch cDNA 
library were screened for Theta class clones by filter-lift hybridisation. The libraries were 
plated out at a density of approximately 27,000 pfu per 150mm LBM plate (1% tryptone, 
0.5% yeast extract, 1% NaCl, lOmM MgS0 4 and 1.5% Bacto agar) on the Esherichia 
coli host strain Y1090. The resulting plaques were screened using the filter 
hybridisation method of Benton and Davis (Benton and Davis, 1977). The cDNA insert 
in pRTHl was labelled with [a32P]dATP by the use of a Megaprime random primer 
labelling kit (Amersham, UK). Hybridisation was carried out at 65°C for 18h in 
hybridisation solution containing lOx Denhardt's solution (Sambrook et al., 1989), 4x 
SSC, 0.1% SDS, 10% dextran sulphate and 500|i.l (in every 25ml of hybridisation 
solution) of boiled salmon sperm DNA (10mg/ml). Filters were washed sequentially in 
2xSSC; 2xSSC, 0.1% SDS and a final wash of 2xSSC, 0.1% SDS at 65°C. Filters 
were exposed to X-ray film over night at -70°C. Plaque purification was achieved by 
replating positive clones and rescreening with the rat Theta class cDNA probe. The 
cDNA inserts in cross-hybridising clones were excised from the X phage by FcoRI 
digestion and cloned into pUC18 and M 13mpl8. DNA sequencing was performed by 
the dideoxy chain termination method (Sanger et al.y 1977; 1980).
3.4.3 cDNA Library Screening by PCR
Human liver cDNA libraries in Xgt 10 and Xgt 11 were screened by a PCR based 
method. Total DNA from the amplified library lysate was subjected to PCR with the rat 
primer RGTTH2 (RGTTH2 sequence was sufficiently similar to the corresponding 
region of the human cDNA clone XHT1 to use it as a PCR primer) and a primer based on 
the sequence from the left arm of either XgtlO or Xgtl 1:- 
Xgtll (5' GTGTTAACGGTGGCGACGACTCCTGGAGCCCG 3') or 
JtgtlO (5' CCCGGGATCCAGCAAGTTCAGCCTGGTTAAG 3').
The amplified products were cloned and sequenced as described in Chapter 2.
3.5 RESULTS
3.5.1 Characterisation of Four Human Theta Class GST cDNAs
Four distinct cDNA clones were identified by either direct hybridisation to cDNA 
libraries or by a PCR approach. kHTI was originally isolated from a Xgt 10 human liver 
cDNA library by hybridisation with a rat subunit Yrs cDNA sequence. This clone 
contains an open reading frame of 621bp encoding a peptide which shares homology 
with rat subunit Yrs after the first 37 residues of the rat sequence. The 5' sequence 
upstream of the start of homology with rat subunit Yrs does not contain any recognisable 
sequence and contains an in frame termination codon (TGA*) that would cause a 
premature termination of translation. The 3' non-coding region of XHT1 extends for 
222bp and lacks a poly-A tail. The basic structure of XHT1 is shown schematically in 
Figure 3.1.
Because XHT1 was clearly missing the 5' end of the cDNA that encodes the 
N-terminal amino acid sequence, an attempt was made to use an oligonucleotide primer 
RGTTH2, and primers located in the X vector arms, to amplify cDNAs that encode the 
full length 5' sequence. pHT2 was generated by this PCR approach from a Xgtl 1 human 
liver cDNA library lysate and contains a considerable region of coding sequence that is 
identical to XHT1. However, within the 3' end of the coding region there is an apparent 
deletion of 42bp that does not alter the reading frame but results in a deletion of 14 
residues. The 5' non-coding sequence of pHT2 extends for approximately 800bp before 
it enters an open reading frame that corresponds to the coding sequence of XHT1 (Figure 
3.1). The open reading frame of pHT2 starts at residue 67 of the rat subunit Yrs. 
Therefore, in terms of its coding region, pHT2 is also a truncated clone which is even 
shorter than XHT1. The sequence of pHT2 ends after a TGA termination codon which 
was incorporated in the PCR primer.
Another clone pHT3, was generated from a XgtlO human liver cDNA library 
using the same PCR approach. pHT3 is very similar in structure to pHT2 (Figure 3.1).
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Although the 5' non-coding sequence of pHT3 is shorter (165bp), it is identical to the 5’ 
non-coding sequence of pHT2. Similarly, the open reading frame corresponding to the 
rat subunit Yrs sequence starts at residue 67. Unlike pHT2, pHT3 does not contain a 
42bp deletion. Like pHT2, pHT3 ends after a termination codon (TGA) which was 
incorporated in the reverse PCR primer.
A human Theta class GST cDNA clone encoding the complete amino acid 
sequence was isolated from a Xgtl 1 human liver 5'-stretch cDNA library by hybridisation 
with the pRTHl cDNA. This clone A.HT4 is 3.5kb in length and is a fusion of at least 3 
different cDNA species. Sequencing from each end of MTT4 revealed that the Theta class 
GST cDNA was flanked by identifiable and unrelated cDNA clones (H. Sapiens TL25 
mRNA from LNCaP cell line and human group-specific component Vitamin D-binding 
protein), presumably as a result of a cloning artefact. The complete sequence of the 
human Theta class GST cDNA within XHT4 was determined by the use of several 
internal oligonuleotide primers, based on the sequence of XHT1, and further restriction 
enzyme digestion. The structure of XHT4 and the sequencing strategy on both strands is 
shown in Figure 3.1. The sequence of the cDNA was determined on both strands and is 
shown in Figure 3.2. The human Theta class GST cDNA clone, here termed pHT4, has 
a coding sequence of 732bp. The exact length of the 5' non-coding region is unclear 
because of the presence of other flanking cDNAs and in Figure 3.2 only 132bp is 
presented. The 3' non-coding region of pHT4 is the same as XHT1 except for a poly-A 
tail that is clearly evident in pHT4.
3.5.2 Evidence for Alternate Splicing
The divergence of XHT1, pHT2 and pHT3 from the coding sequence of XKT4 
clearly suggests that these clones may represent examples of alternate splicing. 
Examination of the three clones suggests the position of three potential exon/intron 
boundaries. The first one is at the start of the recognisable coding sequence in Ä.HT 1. 
The second is at the start of the recognisable coding sequence in pHT2 and pHT3. It is 
notable that although pHT2 and pHT3 diverge from the expected coding sequence at the
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Figure 3.1 : Characterisation of four human Theta class GST cDNAs
Four distinct cDNA clones encoding GSTT2 were identified either by direct 
hybridisation to cDNA libraries or by a Polymerase Chain Reaction (PCR) 
approach. >.HT1, pHT2 and pHT3 are all incomplete transcripts which 
showed evidence of alternate splicing. The complete open reading frame of 
GSTT2 was found in the clone >.HT4. The open boxes indicate the open 
reading frame in each clone. The hatched region in pHT2 and pHT3 
indicates identical 5' non-coding sequence that extends from approximately 
800bp in pHT2 and 165bp in pHT3. The arrows above and below >.HT4 
indicate the sequencing strategy on each strand.
5'
TGA* TGA
5' I_______________________________
H  XHT1 —
EcoRI------------------------------------------------
42 bp deletion
3'
---- 1
EcoRI
5*
TGA
----------------------------------------------------- O'
pHT3
I_____ I
100 bp
ATG "^ Tga
XHT4
5' AAAA.... 3'
Figure 3.2: DNA Sequence of pHT4 and Its Deduced Amino Acid Sequence
The inverted arrows mark the positions of putative introns derived from Ä.HT1, pHT2 and 
pHT3. The vertical arrows indicate the positions of introns in the mouse GSTT2 gene 
(Whittington et al., 1996). The termination codon of pHT4 is marked by three asterisks, 
and the poly(A) addition signal is in bold. The position of the 42bp deletion in pHT2 is in 
bold and italics. Position of PCR primers HTA3/HTB2 and HTIPF/HTIPR are 
underlined. The DNA sequence of pHT4 has been deposited in GenBank (Accession No. 
L38503).
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gcggcaagctga -121
ctggctgctaggctgctggctgcttggccacagacgggcgcacggagacactcgacgccg -61 
ctcccgccgccgccgcgctcagcgccgtctgccatccccgctgtccttgccgcccccgcc -1
ATGGGCCTAGAGCTGTTTCTTGACCTGGTGTCCCAGCCCAGCCGCGCCGTCTACATCTTC 6 0 
M G L E L F L D L V S Q P S R A V Y I F  20
4
HTA3 ><
GCCAAGAAGAATGGGATCCCCTTAGAGCTGCGCACCGTGGATTTGGTCAAAGGGCAGCAC 120 
A K K N G I  P L E L R T V D L V K G Q H  40
<- HTB2
AAGAGrAAGGAGTTGTTGCAGATCAACAGCCTGGGGAAACTGCCGACGCTCAAGGATGGT 180 
K S K E F L Q I N S L G K L P T L K D G  60
4
> <
GATTTCATCTTGACCGAAAGCTCGGCCATCCTGATTTACCTGAGCTGTAAGTACCAGACG 240 
D F I L T E S S A I L I Y L S C K Y Q T  80
CCGGACCACTGGTATCCATCTGACCTGCAGGCTCGTGCCCGTGTTCATGAGTACCTGGGC 300 
P D H W Y P S D L Q A R A R V H E Y L G  100i
TGGCATGCCGACTGCATCCGTGGCACCTTTGGTATACCCCTGTGGGTCCAGGTGTTGGGG 360 
W H A D C  I R G T F G  I P L W V Q V L G  120
CCACTCATTGGGGTCCAGGTGCCCGAGGAGAAGGTGGAACGCAACAGGACTGCCATGGAC 420 
P L  I G V Q V P E E K V E R N R T A M D  140
HTIPF ->
rAnnrrrTGGAATGGCTGGAGGACAAGTTCCTGGGGGACAGGCCCTTCCTCGCTGGCCAG 480 
Q A L Q W L E D K F L G D R P F L A G Q  160i
> <- HTIPR <
GAG gtgacactggctgatctcatggccctggaggagctgatgcagcc g g t g g c t c t c GGC 540
Q V T L A D L M A L E E L M Q P V A L G  180
TACGAAC TGTTTGAGGGACGGCCAC GAC TGGCAGCATGGC GTGGAC GAGTGGAGGCTTTC 600 
Y E L F E G R P R L A A W R G R V E A F  200
CTGGGTGCTGAGCTATGCCAGGAGGCCCACAGCATCATCTTGAGCATCCTGGAACAGGCG 660 
L G A E L C Q E A H S I I L S I L E Q A  220
GCCAAGAAAACCCTCCCAACACCCTCACCAGAGGCCTATCAGGCTATGCTGCTTCGAATC 720 
A K K T L P T P S P E A Y Q A M L L R I  240
GCCAGGATCCCCTGAagggtctgggatgggggccaggagattagcaacaaggattcattc 780 
A R I P ***
tgttacttacttgcccctttttatctttccctcttgccccagtcccttctctccagcttc 840 
atgtgaagctctgcacagacaagacactcagtgtccttggcagtgctgctactcctcagg 900 
tgcagcatacataaccagtaagagactaaatctgcaatatataaagagctcctacaaatc 960 
agtaacatgaagaacactcaaaaattggcaaatgtcatcagtgttttaaacagaataaag 1020 
attccaaacactttgaaaaaaaaaaaaaaaaa 1052
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same point, they were amplified from separate libraries and represent distinct cloning 
events. The third potential exon/intron junction is at the site of the 42bp deletion in the 3' 
end of the coding region of pHT2. This same 42bp deletion has been discovered 
independently by Mannervik et al. in a partial GSTT2 cDNA clone (unpublished data, see 
review by Mannervik and Widersten, 1995). Taken together, the 42bp deletion is not an 
isolated event arising from an artefact of cDNA library construction or introduced during 
the course of the PCR amplification.
PCR primers, HTA3 and HTB2, based on the XHT4 sequence, flanking the 
putative exon/intron junction at the 5' end of the coding sequence of AHT1 were used to 
amplify human genomic DNA (Figure 3.3) (PCR conditions are described in Section 
4.4.2). DNA sequencing indicated that this fragment of about 600bp, spanned an intron 
of approximately 520bp (Figure 3.4). The sequence of this intron has not been fully 
determined. This result showed that the 5' termination of coding sequence of kHTl 
corresponds exactly with the position of an exon/intron junction. Comparison with the 
equivalent mouse gene revealed the existence of an intron at the same position 
(Whittington et al., 1996). Similarly, the structure of the mouse gene confirmed the 
presence of an intron at the 5' end of coding sequence in pHT2 and pHT3.
The potential third exon/intron junction could be located at the 5' or 3' end of the 
42bp deletion in the pHT2 clone. Oligonucleotide PCR primers, HTIPF and HTIPR, 
flanking the 5’junction of the 42bp deletion in pHT2 were used in an attempt to amplify a 
possible intron in this position (Figure 3.2). No amplified product was obtained, 
suggesting that there is no intron at this position. As shown in Figure 3.2, the position 
of PCR primers, HTIPF and HTIPR, did not flank an intron, when compared to the 
mouse gene. However, the 3' end of the 42bp deletion corresponds to the 3’ splice site 
of intron 4 in the mouse gene (Whittington et al., 1996). As a whole, these results 
suggest that the GSTT2 gene structure is very similar to the mGSTT2 gene with regards 
to the positions of exons/introns.
Figure 3.3 : DNA Amplification of a Putative Intron at the 5* End of 
^HTl. An inframe termination codon at the 5' end of Ä.HT1 is marked 
TGA* and the existence of a putative intron at this position was 
suspected. PCR primers, HTA3 and HTB2, based on the sequence of 
Ä.HT4 were used to investigate this possibility by amplifying human 
genomic DNA.
5'
XHT1
HTA3
ATG.
5' C H
< —
AHT4
TGA
l
1-----------------A(A)nA..... 3'
HTB2
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Figure 3.4 : Evidence for Alternate Splicing
The existence of an intron at the 5' end of the coding sequence of XHT1 
was confirmed by PCR, using primers HTA3/HTB2 that flanked the 
putative exon/intron junction. The existence of an intron at this position 
was also confirmed by comparison with the equivalent mouse gene 
(Whittington et al., 1996).
5’ HTA3 primer -------------------- >
TTAGACGTGCGCACCGTGGAT T T G G T C A A A G a tq a c rc c c a a c c c a tt tc G c c a c a
L D V R T V D L V K G
(~520bp of intronic sequence)
t g t c c a c a a a c c a g .......................................................... ............................................
................. t t t t t a t t c t g a a g a c c t t t t c t g a c t t c t t c c t c t t c a g G G C A G C A C
Q H
< ---------------------3'HTB2 primer
AAGAGCAAGGAGTTCTTGCAGATCAACAGCCTGGGGAAACTGCCGACGCTCAAGGAT
K S K E F L Q I N S L G K L P T L K D
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3.5.3 Properties of the Encoded Protein
The complete amino acid sequence deduced from clone pHT4 is shown in Figure 
3.2. The open reading frame of pHT4 encodes a polypeptide of 244 amino acids. The 
first 21 amino acid residues of this peptide share almost complete identity with the amino 
terminal sequence of GSTT2*-2* described by Hussey and Hayes (1992), except for a 
valine to glycine substitution at position number 2. As discussed in detail in the 
Discussion section, it was concluded that the peptide encoded by pHT4 is the same as 
the one purified by Hussey and Hayes (1992). For clarity we therefore refer to the 
subunit encoded in pHT4 as GSTT2.
GSTT2 is the longest human GST subunit when compared to the known Alpha, 
Mu and Pi class GSTs and a human Theta class GSTT1 subunit which was reported 
recently by Pemble et al. (1994). A comparison of the amino acid sequences of 5 
mammalian Theta class GSTs is shown in Figure 3.5. These Theta class GSTs which 
can be divided into 2 subfamilies (see Section 1.5.4) have well conserved N-terminal 
sequences and show greater divergence in the C-terminal half. The percentage of amino 
acid sequence identity between subfamily 1 and subfamily 2 has been presented in Table 
1.5 of Chapter 1.
The 244 amino acid residues of GSTT2 have a calculated molecular mass of 
27,489 Daltons. Although Hussey and Hayes (1992) estimated the molecular mass of 
GSTT2*-2* subunit at 25,100 Daltons, the discrepancy may reflect the non-ideal 
migration of the subunits in SDS/PAGE and is within the expected experimental range
Figure 3.5: Amino acid sequence comparison of mammalian Theta
class GSTs
Five Theta class GSTs from subfamily 1 and subfamily 2 have well conserved 
N-terminal sequences and show greater divergence in the C-terminal half. The 244 
amino acid residues of GSTT2 have a calculated molecular mass of 27,489 Da. The 
conserved serine residue at position 11 is highlighted. Identical amino acids are 
marked with a period.
GSTT2 M G L E L F L D L V S Q P S R A V Y I F A K K N G I P L E L R T V D L V K G Q H K S K E F L Q I N S 50
r a t Y r s ..... Y. 50
m G S T T 2 ..... Y. . . L..... ....F Q T ....I L ....L .E Q .S .V .C 50
G S T T 1 ..... Y. . . L . . .C. ......... . D . . F . . . I . . . I . . . . L . D A .A .V .P 50
rat 5 . V . . .Y. . . L . . .C. . 1 ....... . N . .F Q M H ..E . R . . E . L . D A . A . V . P 50
GSTT2 L G K L P T L K D G D F I L T E S S A I L I Y L S C K Y Q T P D H W Y P S D L Q A R A R V H E Y L G 100
r a t Y r s .K.V.V ____s.v. . . . T ..... . .S. . . V A ..... A ....... Q ....... 100
m G S T T 2 .N.V.V ____s.v. . . . T ..... . .S. . . V A ..... A ....... Q ....... 100
G STT1 .K.V.A .......T. . . . V . . .L. . T R . . K V . . Y . . . Q ......... D . . . A 100
rat 5 M K .V .A M . . .G .T . ( . A H  . . K V .......Q ..........D . . . A 100
GSTT2 W H A D C I R G T F G I P L W V Q V L G P L - I G V Q V P E E K V E R N R T A M D Q A L Q W L E D K 149
r a t Y r s ____ N. ..... VL. . T K ..... - ................. N S .V L . . .R ____ 149
m G S T T 2 . . . .N. ..... V L . . T K ..... - .......Q ....... DRS . V L V . . Q . . . . 149
G S TTl .Q H T T L .R S C L R A . .H K .M F .V F L .G P .S P Q T L A A T L A E L .V T . . L . ... 150
rat 5 .Q H T T L .R S C L R T . . H K . M F .V F L .E Q I R P .M L A A T L A D L .V N V . V . . .Q 150
GSTT2 F L G D R P F L A G Q Q V T L A D L M A L E E L M Q P V A L G Y E L F E G R P R L A A W R G R V E A 199
r a t Y r s . .R. .A . 1 ....... ..... S. . . . 1 .......C N .......Q . T . . . E . . . . 199
m G S T T 2 . .R..A ...........N ....... Q.T. . . E ____ 199
G S T T l ..Q N K A . .T.PHIS ____ V .I T . . .H. . G A . C Q V ..... K . . T . . Q ____ 200
rat 5 ..Q .KD ..V .PHIS . . . W .  IT. . .H. . G G . C P V ......... A.YR. . . . 200
GSTT2 F L G A E L C Q E A H S 1 1 L S I L E Q A A K K T L P T P S  P E A Y Q A M L L R I -A R I P  244
r a t Y r s ..... ..... NP. M . V . G . .. . . . . V . P . ..H A S .M ........ 244
m G S T T 2 Y ..... T. . . . . G . ..., .M . .V .P . .V H A S .Q ....... . 244
G S T T l A V .E D .F ____ EV. . K A --------.D F .P A D .T I K .K L M P W V L .M .R 240
rat 5 A V .K D .F L ...E V . . K V --------RDC.P A D .V I K .K L M P .V L T M .Q 240
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3.6 DISCUSSION
The mammalian Theta class GSTs do not utilise l-chloro-2,4-dinitrobenzene as a 
substrate and do not bind to immobilised glutathione affinity matrices. The absence of 
these two key properties that are such useful characteristics of the Alpha, Mu, and Pi 
classes resulted in the existence of the Theta class GSTs being largely overlooked. 
Although two distinct Theta class cDNA clones have been isolated from rat liver cDNA 
libraries (Ogura et al., 1991; Pemble and Taylor, 1992), the first clear evidence for the 
Theta class in humans has come from the purification of two apparently distinct proteins 
(Meyer et al., 1991; Hussey and Hayes, 1992). During the course of this thesis, Pemble 
et al., (1994) reported the cloning of a cDNA encoding a human Theta-class GST subunit 
termed GSTT1. This subunit appears to be the orthologue of the rat subunit 5 and 
encodes the protein GST8 purified earlier by Meyer et al. (1991). In this study, the 
molecular cloning of a cDNA encoding the second human Theta class GST, GSTT2-2 is 
reported.
3.6.1 Characterisation of a cDNA Clone Encoding GSTT2
The complete cDNA clone encoding GSTT2 was isolated from a Xgtll human 
liver 5’-stretch cDNA library, subcloned into pUC18 plasmid, and termed pHT4. The 
amino acid sequence identity between rat subunit Yrs (78.3%) and mouse GSTT2-2 
(77.0%) with the protein encoded in pHT4 suggests that they may be orthologous. The 
deduced amino acid sequence from pHT4 shares almost complete identity with 
GSTT2*-2* (Hussey and Hayes, 1992) over the first 21 amino acid, except for the 
substitution of valine for glycine at position 2. This disparity is probably explained by 
the reported ambiguity of valine in the amino acid sequence analysis (Hussey and Hayes, 
1992). Since both the rat GST Yrs-Yrs and human GSTT2*-2* have activity with 
1- menaphthyl sulphate (Hiratsuka et al., 1990; Hussey and Hayes, 1992; and Chapter 4 
of this thesis) and both have close similarities to the sequence encoded in pHT4, it seems 
highly likely that pHT4 encodes the GSTT2*-2* isoenzyme described by Hussey and 
Hayes (1992). Therefore, in line with the GST nomenclature guidelines (Mannervik
et al., 1992), the protein encoded by pHT4 will be referred to as GSTT2-2, and its gene 
locus as GSTT2.
It is noteworthy that the residue at position 6 in GSTT2 is phenylalanine instead 
of tyrosine, as compared with the other mammalian Theta class GSTs (Figure 3.5). 
Structural studies of all mammalian Alpha, Mu and Pi class GSTs have suggested that a 
tyrosine near the N-terminal domain is the most significant residue involved in the 
activation of glutathione by the formation of a hydrogen bond between its phenolic 
hydroxyl and the cysteinyl sulphur of glutathione (Dirr et al., 1994; Wilce and Parker, 
1994). Site directed mutagenesis of this tyrosine residue in the Alpha, Mu and Pi class 
GSTs resulted in mutant enzymes which are severely impaired in CDNB conjugating 
activity (Stenburg et al., 1991; Liu et al., 1992; Kolm et al., 1992). Due to the fact that 
GSTT2 lacks this tyrosine residue, it is probable that non-tyrosine residues may play a 
more important role in the catalytic function of GSTT2. This possibility is explored in 
greater detail in Chapter 7 of this thesis.
3.6.2 Implications of Alternative Splicing
In the present study, evidence of alternative splicing was found in at least 3 sites 
in transcripts of GSTT2. The presence of exon/intron junctions at these sites was 
confirmed by PCR analysis and comparison with the structure of an equivalent mouse 
gene (Whittington et al., 1996). It is unlikely that either of the alternatively spliced 
transcripts encodes a catalytically active enzyme as the amino terminal residues that are 
important in catalysis in all the other cytosolic GSTs are missing from both forms. In 
addition, there is a termination codon (TGA*) within the 5’ non-coding sequence of 
XHT1 which falls in the same reading frame as the protein coding region of the cDNA. 
This in-frame termination codon would be expected to either prohibit or greatly reduce the 
efficiency of translation of the truncated transcript if there is an upstream translation start 
codon in the same reading frame.
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When the position of the 42bp deletion was compared with the mouse gene, the 3’ 
end of the 42bp deletion corresponds to the 3’ splice site (acceptor site) of intron 4. 
However, the 5’ splice site (donor site) selection falls on a cryptic donor site in exon 4 
(42bp upstream of the actual donor site). This cryptic donor site fulfils the consensus 
sequences of the general 5' splice junction of an intron as compiled by Mount (Mount, 
1982) and Iida and Sasaki (Iida and Sasaki, 1983). Therefore, the observed 42bp 
deletion appears to result from an alternate 5’ splice site selection (Figure 3.6). Ohshima 
and Gotoh (1987) suggest that the selection of donor and acceptor sites based on 
consensus sequence might be an over simplified model to explain the mechanism of RNA 
splicing. The existence of numerous of 5' donor-like sequences within the introns of a 
gene, makes the proposal of a simple scanning mechanism in splice sites selection 
difficult to reconcile (Ohshima and Gotoh, 1987). Caceres et al. (1994) proposed that the 
selection of 5' splice sites is governed by the intracellular levels of antagonistic splicing 
factors. The results of their studies suggest that the SF2 alternative splicing factor, which 
belongs to the SR family of non-snRNP splicing factors promotes the use of proximal 5' 
splicing sites, hence preventing exon skipping and preserve splicing fidelity in vivo. On 
the other hand, the hnRNP A l splicing factor acts in an antagonistic manner to promote 
distal 5' splice sites. The 42bp deletion at the 3’ end of exon 4 may represent an event 
where antagonistic splicing factors play an important role in determining the 5’ splice site.
It has been suggested that the GSTP1 gene may be regulated by a post- 
transcriptional mechanism (Morrow et al., 1992). In a recent study, Ross and Board 
(1993) reported the first evidence of alternative splicing in a human Mu class GST, 
GSTM4. The discovery of alternatively spliced transcripts in different GST classes 
suggests that alternative splicing may play a regulatory role in the expression and function 
of GSTs. In this study, the discovery of alternatively spliced transcripts of GSTT2 from 
more than one cDNA library as well as from independent laboratories suggests that this is 
not an uncommon event and may reflect a more important process than the chance 
mistaken splicing of illegitimate transcripts (Chelly et al., 1989). Andreadis et al. (1987) 
proposed that alternative splicing can give rise to new gene products without changing the
nucleotide sequence of the original gene. This process could possibly play an important 
role in the evolution of novel enzyme functions in detoxication enzymes such as the 
GSTs and cytochrome P450s (Ding et al., 1995). It is not clear at this stage if the 
presence of A.HT1, pHT2 and pHT3 represent such experimental processing or as 
suggested above, represent another form of post-transcriptional gene regulation.
Figure 3.6 : Alternative 5' splice site selection on pHT2
42bp deletion
<— ¥
3' acceptor site
Exon 4 ^ ---------- Exon 5
5’ donor site 
5' ryptic splice site
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3.7 CONCLUSION
A cDNA encoding the Theta class isoenzyme GSTT2-2 which was originally 
purified by Hussey and Hayes (1992), was cloned from a human liver cDNA library. 
The full length cDNA clone, Ä.HT4, with an open reading frame of 732bp, encodes a 
polypeptide of 244 amino acids with a deduced molecular mass of 27,489 Da. 
Comparison of amino acid sequence deduced from the cDNAs of GSTT2, mGSTT2 
(Whittington et al., 1996) and rat subunit Yrs (Ogura et al., 1991) showed that they are 
orthologous and belong to subfamily 2 of the Theta class GST.
As compared with the other members in the supergene family of GSTs, one
distinct feature of the GSTT2-2 is the absence of a conserved N-terminal tyrosine. In the
Bjomstedt et al., (1995)
Alpha class GSTs, non-tyrosine residue (Argl4)^has been shown to act in concert with 
the conserved tyrosine residue (Tyr8) to activate the enzyme bound GSH. However, the
present characterisation of the GSTT2 cDNA provides the first example in the GST 
supergene family, where catalytic mechanism can be independent from the conserved
a
tyrosine. This possibility is exploreTn greater detail in Chapter 7 of this thesis.
The isolation of 3 other partial cDNA clones of GSTT2-2 showed evidence of 
alternative splicing. The existence of introns in these truncated cDNA clones was 
confirmed by comparison to the equivalent mouse gene (Whittington et al., 1996) and 
also elucidated by a PCR approach. This is the second reported case of alternative 
splicing in the GST supergene family. The possibility of GSTT2 gene regulation at post- 
transcriptional level by alternative splicing is proposed. It can also be considered from 
these results that the human GSTT2 gene organisation is similar to the equivalent mouse
gene.
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CHAPTER 4 : CHROMOSOMAL LOCALISATION OF GSTT2
4.1 INTRODUCTION
The gene loci for human cytosolic GSTs have been studied using PCR based 
screening, human-rodent somatic hybrid analysis or in situ hybridisation techniques. The 
genes encoding the Alpha, Mu and Pi class GSTs have been mapped and localised to 
chromosomes 6pl2, lp 13 and 1 lq 13 (see Section 1.6 for review). It appears that 
human cytosolic GST genes occur in class specific gene clusters which are dispersed 
through out the human genome.
4.2 OBJECTIVES
To gain a greater understanding of the chromosomal location of the GSTT2 gene, 
its relationship with the gene loci of other human cytosolic GSTs and the possible 
existence of related pseudogenes, by using somatic cell hybrid and in situ hybridisation 
mapping. This study also seeks to investigate the extent of heterogeneity of the Theta 
class gene family through Southern blot analysis of human genomic DNA.
4.3 MATERIALS
The source of chemical compounds and materials for routine use were as stated in 
Chapter 2. The tritiated bases [3H]dATP, [3H]dCTP, [3H]dTTP, were purchased 
from and Amersham (UK). Human-rodent somatic cell hybrid cell lines containing 
individual human chromosome were obtained from the NIGMS human mutant cell 
repository: GM07299 (Chr 1, Chr X), GM10826B (Chr 2), GM10253 (Chr 3), 
GM10115 (Chr 4), GM10114 (Chr 5), GM10629 (Chr 6), GM10791 (Chr 7), 
GM10156C (Chr8), GM10611 (Chr 9), GM10926B (Chr 10), GM10927A (Chr 11), 
GM10868 (Chr 12), GM110926B (Chr 13), GM10479 (Chr 14), GM11418 (Chr 15), 
GM10567 (Chr 16), GM10498 (Chr 17), GM11010 (Chr 18), GM10449 (Chr 19), 
GM10478 (Chr 20), GM10323 (Chr 21), GM10888 (Chr 22), GM06318C (Chr X), and
GM06317 (Chr Y). DNA from these cell lines were prepared by the methods of 
Grunebaum et al (1984).
4.4 METHODS
4.4.1 Southern Blot Analysis
Human genomic DNA samples prepared from peripheral blood leucocytes were 
digested using EcoRl, BamHl, and Hindlll. Digested DNAs from 7 individuals were 
separated by agarose gel electrophoresis and blotted to Hybond™ N+ nylon membrane 
(Reed and Mann, 1985). A 767bp cDNA fragment extending from the initiation codon 
of pHT4 to 35bp 3' to the translation stop signal was labelled with [oc32P]dATP by 
random priming and used as a hybridisation probe. Detailed procedures for Southern 
blotting have been described in Chapter 2.
4.4.2 Human-Rodent Somatic Cell Hybrid Analysis
A 700bp fragment was amplified from human DNA using primers based on the 
Ä.HT4 cDNA sequence. The sense primer, HTA3 (5TTAGACGTGCGCACCGTG3') 
and antisense primer, HTB2 (5'ATCCTTGAGCGTCGGCAG3') were selected to 
amplify across a putative exon/intron boundary, the position of which was predicted 
from the 5' termination of coding sequence in >.HT1 (see Figure 3.4 Chapter 3). The 
DNA amplification (PCR) was performed using an oil-bath thermal cycler (Bartelt 
Instruments, Australia) in a 50|il reaction mix containing 250ng of genomic DNA, 
200|iM dNTPs, 20pmol of each primer, 1.5u of Taq polymerase and IxTaq polymerase 
buffer. PCR conditions were 30 cycles of (94°C, lmin; 56°C, lmin; 72°C, 80sec). The 
PCR product was cloned into pGEM-T vector (Promega, Australia) according to the 
manufacturer's protocol and subcloned into the Sphl and Sad  sites of M13mpl8 and 
mpl9 to generate single-stranded DNA template for sequencing. DNA sequencing 
confirmed that the fragment encodes an intron of approximately 600bp (Figure 3.4). The 
amplified intron was used as a specific hybridisation probe on Southern blots of BamHl-
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digested human-rodent somatic cell hybrid cell lines that retain a single human 
chromosome.
4.4.3 In situ Hybridisation
A 872bp cDNA insert was excised from pHTl by EcoRI digestion and after nick 
translation with [3H]dATP, [3H]dCTP and [3H]dTTP to a specific activity of 9 x 107 
cpm/pg, the fragment was used as a probe for in situ hybridisation. Chromosome slides 
were prepared from four individuals of both sexes and each gave essentially identical 
results. The slides were treated with RNase, denatured, probed and stringently washed. 
They were then dipped in Ilford L4 emulsion diluted 1:1 and exposed for 12-16 days. 
Following the processing of emulsion and staining to give G-banded chromosomes 
(Buckle and Craig, 1986), silver grains in the emulsion were scored onto computer 
drawn 550 band ideograms of the G-banded chromosomes (Chromo Map, P. Board 
unpublished program).
The precise chromosomal location assignment of G STT2  using in situ 
hybridisation was carried out in collaboration with Dr. G. C. Webb of the Genetics 
Department, Queen Elizabeth Hospital, Woodville, South Australia where all the 
experiments were performed. My contribution in this collaboration was limited to the 
construction of the recombinant plasmid (pHTl) and preparation of the EcoKL insert from 
pHTl for use as a probe. Detailed procedures for the preparation of chromosomes and in 
situ hybridisation have been described previously (Board and Webb, 1987; Board et al., 
1989).
4.5 RESULTS
4.5.1 Southern Blot Analysis
Southern blots of human genomic DNA digested with EcoKL, HindLXL, or BamYLL 
showed a single fragment that hybridised with the coding region of the pHT4 cDNA. 
The smallest hybridising band is a 3.6kb fragment from the ZtamHI-digested DNA, while
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other hybridising bands in the EcoRl- and //m dlll-digested DNA are approximately 
11.7kb and 19.9kb respectively (Figure 4.1). These data suggest that the GSTT2 gene 
may be relatively small, as the exons containing the coding sequence fall within the 3.6kb 
BamHl fragment.
4.5.2 Somatic Cell Hybridisation Analysis —
An intron probe (Figure 3.4) was used to hybridise Southern blots of DNA 
prepared from 24 somatic cell hybrid cell lines predominantly containing single human 
chromosomes (Figure 4.2A, 4.3A). In this study all human chromosomes were 
examined and only one cell line containing chromosome 22 provided evidence of 
hybridisation (Figure 4.2B). The intron probe hybridised to a 3.6kb BamHl fragment 
from the CHO-human cell line GM 10888 bearing chromosome 22. No hybridisation 
was observed from CHO ceils or cell lines bearing other human chromosomes (Figure 
4.3B). The hybridising fragment from the cell line containing chromosome 22 is the 
same size as the single hybridising fragment observed in BamHl digested human 
genomic DNA (Figure 4.1). These data therefore suggest that the GSTT2 gene is located 
on chromosome 22.
4.5.3 In situ Hybridisation
Figure 4.4 features the G-banded chromosome spreads probed with the cDNA 
insert in XHT1. Initial scoring of metaphase chromosomes showed the highest 
accumulation of silver grains over the proximal region of the long arm of chromosome 22 
and only minor background levels on other chromosomes (Figure 4.5). The tallest peak 
of grains was over the subband 22q ll.2 , suggesting that this band is the most likely 
position of the GSTT2 gene. Therefore, prophasic chromosomes 22 were examined and 
detailed plotting of grains confirmed the overall result (Figure 4.6). In this study, 27 
grains were scored over the proximal half and 21 grains over the distal half of a divided 
22ql 1.2; the difference between the two scores is not significant (X2 = 0.75). Therefore, 
the GSTT2 gene cannot be sublocalised within the broad subband 22ql 1.2.
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Figure 4.1 : Southern blot of human genomic DNA digested with BamHl, HindUl, or 
EcoRl and hybridised with the coding region of GSTT2 derived from pHT4.
3.6
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Figure 4.2 : (A) : Southern blot of DNA prepared from somatic cell hybrid cell lines 
was digested with BamHl  and separated on a 0.8% agarose gel. The human 
chromosome in each cell lines is numbered above the lanes. Cell line GM10791 
containing chromosome 7 which did not appear in the lane was reloaded on 
accompanying gel in Figure 4.3A. XHindlll (XH) and XHindlll/EcoRl (XH+HE) 
molecular weight markers are shown. (B ): Cell line 10888 bearing human chromosome 
22 showed a single hybridising band of approximately 3.6kb (indicated by arrow).
2.3
2.0
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Figure 4.3 : (A) : Southern blot of the remaining somatic cell hybrid cell lines which 
was not shown in Figure 4.2A. The DNA prepared from these cell lines was digested 
with BamUl and separated on a 0.8% agarose gel. (B) : No hybridisation was observed 
from the CHO cell line as well as other CHO-human cell lines.
A
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Figure 4.4 : A 872bp cDNA insert of pHTl was nick translated with three tritiated 
bases and hybridised to G-banded metaphase chromosome spreads. The arrows indicate 
silver grains accumulated on chromosome 22 at subband ql 1.2.
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Figure 4.6 : Scores of silver grains over prophasic chromosomes 22, 
probed with the cDNA insert in XHT1. The highest concentration of 
grains is over the faint subband 22ql 1.2.
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4.6 DISCUSSION
4.6.1 Southern Blot Analysis
Southern blots of human genomic DNA digested with EcoRl, BamHl, or Hindlll 
showed a single fragment that hybridised with the coding region of the GSTT2 cDNA, 
suggesting the existence of only one closely related gene. It seems unlikely that the 
767bp GSTT2 cDNA hybridises to GSTT1 sequences or other possible members in the 
Theta class gene family under the stringency conditions of the present experiment. 
Recently, Pemble et al. (1994) showed that a GSTT1 cDNA hybridises only to a single 
7.5kb Hindlll or 18kb EcoRI fragments and neither of these were observed in the 7 
individuals evaluated in this study. This again demonstrated the differences within the 
Theta class GSTs and confirmed the observation that the DNA sequences of individual 
Theta class members do not cross-hybridise with other member(s) under the experimental 
conditions.
4.6.2 Gene Mapping
The chromosomal location of GSTT2 has been investigated by two approaches. 
In studies using somatic hybrid cell lines containing single human chromosomes, a DNA 
fragment from a CHO-human cell line bearing chromosome 22 was found to hybridise 
with an intron probe derived from the GSTT2 gene. The use of an intron probe largely 
avoids cross-hybridisation between the cDNAs and the orthologous rodent gene(s). In 
addition, intron probes do not hybridise with reverse transcribed pseudogenes (Webb et 
al., 1990; Webb et al., 1994). The second approach using in situ hybridisation with the 
GSTT2 cDNA clone, confirmed the chromosome assignment and mapped the precise 
location of the GSTT2 gene to subband 2 2 q ll.2 . The fact that there were no other 
significant peaks of silver grains on other chromosomes indicated that it is unlikely that 
there are reverse transcribed pseudogenes derived from GSTT2 dispersed throughout the 
genome (Webb et al., 1990). Furthermore, the data suggest that if there are other cross- 
hybridising genes, they must be relatively closely clustered on chromosome 22q.
4.6.3 Other Gene Loci on Chromosome 22qll
Chromosome 22q 11 contains several interesting gene loci, among them, genes 
encoding the immunoglobulin lambda constant regions (McBride et al., 1982; Erikson et 
al., 1981), beta-crystallins (Bijlsma et al., 1991), Hulsebos et al., 1991), cytochrome 
P450 subfamily IID gene cluster and related pseudogenes (Kimura et al., 1989), 
y-glutamyl transpeptidase (Bulle et al., 1987), transposable element (Dombroski et al., 
1991) and genes associated with cancer such as breakpoint cluster region (BCR) gene 
family (Heisterkamp and Groffen, 1988). Chromosome 22 is also the site of 
translocation found in Ewing's sarcoma (Aurias et al., 1984), neuroepithelioma (Whang 
et al., 1986) and Burkitt lymphoma (Croce et al., 1983).
4.6.3.1 The Gene Loci for y-Glutamyl Transpeptidases
Like the GSTs, y-glutamyl transpeptidases (GGT, EC 2.3.2.2) are involved in 
glutathione metabolism (Meister et al., 1981). The GGT multigene family consists of at 
least 4 different genes and several pseudogenes (Pawlak et al., 1988; Rajpert-De Meyts 
et al., 1988; Morris et al., 1993). Interestingly, the GGT1 gene was mapped to 
chromosome 22 by in situ hybridisation, at the interface of ql 1.1-11.2 with a minor peak 
in q 13.1 (Bulle et al., 1987). Somatic cell hybrid analysis also mapped the GGT genes 
to chromosome 22 and found other GGT-related sequences on chromosomes 18, 19, and 
20 (Figlewicz et al., 1993). GGT plays an important role in the y-glutamyl cycle. It 
catalyses the transfer of the y-glutamyl moiety of GSH to an appropriate acceptor, such as 
amino acids, peptides or water (to form glutamate) (Meister et al., 1981; Tate and 
Meister, 1981). In this process, amino acids are thought to be transported across cell 
membranes by the transpeptidation of plasma amino acids to form intracellular y-glutamyl 
amino acids. GGT is also involved in converting leukotriene C4 to leukotriene Ü4 
(Hammarstrom, 1983) by hydrolysing the y-glutamyl moiety of LTC4 (see Figure 1.3 of 
Chapter 1). Individuals with GGT deficiency were found to excrete large amounts of 
GSH (glutathionuria), y-glutamylcysteine, and cysteine in their urine (Griffith and 
Meister, 1980). Despite the common association with glutathione metabolism, the lack of
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homology between GGTs and GSTs does not suggest a common genetic origin and it is 
likely that their localisation to the same chromosomal band is a matter of chance.
4.6.3.2 The Gene Loci for beta-Crystallins
The beta-crystallins genes form another interesting gene cluster near the GSTT2 
locus and have been sublocalised to 22qll.2-ql2. In earlier studies, lens crystallins 
from cephalopods are found to be closely related to cephalopod GSTs as well as GSTs 
from invertebrates (Tomarev et al, 1993; Chiou et al, 1995) and recently a vertebrate 
GST (Meyer and Thomas, 1995). In view of their amino acid similarity, the cephalopod 
lens crystallins and other closely related GSTs have been called the Sigma class GSTs 
(see Section 1.2). It has been demonstrated that many major proteins in the lenses 
have their homologues in metabolic enzymes (Wistow and Piatigorsky, 1987; 
Cuthbertson et al, 1992) and they might have been recruited for a structural purpose 
from their enzymatic functions. Recently, the three-dimensional structure of a Sigma 
class GST from squid digestive gland has been solved (Ji et al, 1995). In this study, Ji 
and co-workers proposed that the Sigma class GST diverged from the ancestral Theta 
class gene before the divergence of the Alpha/Mu/Pi precursor presumably by a gene 
duplication event. Although there is a close evolutionary relationship between the squid 
lens crystallins and the Theta class GSTs, the amino acid sequences of human lens 
crystallins are very different from the cytosolic GSTs. They do not appear to have been 
recruited from cytosolic GSTs for a structural purpose. As in the case of the GGT genes, 
the co-location of the beta-crystallin genes and the Theta class GST genes appears to be a 
matter of chance.
4.7 CONCLUSION
Previous studies of the human Alpha and Mu class genes have shown that they 
are grouped in class specific clusters on distinct chromosomes (Board and Webb, 1987; 
Ross et al, 1993). The apparent absence of cross-hybridisation between the GSTT1 and 
the GSTT2 sequences prevents the drawing of any conclusions about the chromosomal 
location of GSTT1 from the present data. However in a recent study, Webb et al,
(Webb et al., 1996) confirmed the chromosomal location of the GSTT1 gene to subband 
22q 11.2. This confirms that the human cytosolic GSTs exist as class specific gene 
clusters which are dispersed through out the human genome. Although the gene loci of 
GSTT1 and GSTT2 are sublocalised on the same chromosomal band, the lack of cross­
hybridisation and differences in DNA sequence between the two, suggest that they have 
not been homogenised by gene conversion. This is in contrast to the Mu class GST gene 
cluster at chromosome 1 p 13, where gene conversion has played an important 
evolutionary role (Ross et al., 1993; Pearson et a l , 1993). The lack of significant silver 
grain accumulation on other chromosomes and the results from Southern blot analysis 
both suggest that it is unlikely that there are reverse transcribed pseudogenes of GSTT2 
dispersed through out the genome. The GSTT2 gene is less that 4kb in length as 
indicated by Southern blot analysis of human genomic DNA.
CHAPTER 5 : HETEROLOGOUS EXPRESSION, PURIFICATION AND 
CHARACTERISATION OF GSTT2-2
5.1 INTRODUCTION
The heterologous expression of cDNAs in prokaryotic or eukaryotic hosts has 
been widely used to produce large amounts of recombinant protein for characterisation as 
well as for commercial purposes. These techniques have been applied extensively to 
express mammalian GSTs (Board and Pierce, 1987; Vorachek et al., 1991; Kong et al., 
1993; Leaver et al., 1993; Ross and Board, 1993). In the case of the human Theta class 
GSTs, knowledge of their substrate specificities has been largely obtained by the 
characterisation of small amounts of protein purified from liver sources (Meyer et al., 
1991; Hussey and Hayes, 1992). Distinct from the Alpha, Mu and Pi class GSTs, the 
mammalian Theta class GSTs are not retained by glutathione or S-hexylglutathione 
affinity matrices. This particular feature of the Theta class GSTs has limited the use of a 
single step GSH-affinity purification and multi-step purification protocols have been 
required (Hiratsuka et al., 1990, Hussey and Hayes, 1992). As a result, the recovery of 
purified proteins from natural sources was usually low. cDNAs encoding the human 
Theta class GSTs have been cloned (Pemble et al., 1994; see Chapter 3) and the 
heterologous expression of their cDNAs will allow more extensive studies of the structure 
and function of the Theta class proteins.
5.2 OBJECTIVES
Little is known about the enzymological properties of GSTT2-2. The objective of 
this chapter is to express recombinant GSTT2-2 in sufficient quantity to enable a more 
extensive characterisation than has been possible previously with enzyme purified from
human tissue.
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5.3 MATERIALS
Details of common materials used in this study have been outlined in Chapter 2. 
Chemicals used in enzyme assays were purchased from Aldrich Chemical Co., 
Wisconsin (USA), Sigma Chemical Co. (St. Louis, MO), and Boehringer Mannheim 
(Australia). Glutathione reductase is a product of Sigma Chemical. Co. (St. Louis, MO). 
1-menapthyl sulphate was synthesised by the method of Clapp and Young (1970) and 
was generously provided by Dr. G. Barlin and Mr S. Ireland (Division of Neuroscience, 
JCSMR, ANU, Canberra, Australia).
5.4 METHODS 
5.4.1 Enzyme Assays
GST assays using trans, rra/is-alka-2,4-dienals and /ra/i5-alk-2-enals were 
described by Brophy et al. (1989). The determination of GST activity with 1-menapthyl 
sulphate was essentially the same as described by Gillham (1971) and glutathione 
peroxidase activity was determined by the procedure described by Beutler (1975). GST 
activity with dichloromethane (DCM) as a substrate was determined at 37°C in a 1.5ml 
eppendorf tube containing 40mM DCM, lOOmM GSH, 0.5M Sodium Phosphate Buffer, 
pH6.5 and 2|ig of purified enzyme. Formaldehyde released after 60 minutes was 
determined spectrophotometrically at 415nm, by the method of Nash (1953), using 
known concentrations of formaldehyde as standards. Glutathione transferase assays 
using l-chloro-2-4-dinitrobenzene (CDNB), 1,2-dichloro-nitrobenzene (DCNB), 
ethacrynic acid (EA), 1,2-epoxy-3-(p-nitro phenoxy)-propane (EPNP), trans-4-pheny\- 
but-3-en-2-one (tPBO) and 2-cyano-1,3-dimethyl-1-nitrosoguanidine as substrates were 
previously described in detail by Mannervik and Widersten (1995). Activity with 7- 
chloro-4-nitrobenzo-2-oxa-1,3-diazole was determined spectrophotometrically at 419nm 
in sodium acetate buffer, pH 5.0 as described by Ricci et al. (1994).
5.4.2 Heterologous Expression of GSTT2-2
GSTT2-2 was expressed in Escherichia coli as a ubiquitin fusion protein and co- 
translationally cleaved from the ubiquitin moiety by a co-expressed yeast ubiquitin 
specific protease (Ubpl) by methods previously described in detail by Baker et al. (Baker 
et al., 1994). Two oligonucleotide primers:-
HT2ExA (5’ GTGCCGCGGTGGTATGGGCCTAGAGCTGT 3’) and 
HTExB (5' GGAAGCTTTTGTTGCTAATCTCCTGG 3’), were designed to amplify the 
coding region of a GSTT2 cDNA clone, pHT4 (See Chapter 3) and create Sadi and 
Hindlll sites at the 5' and 3' ends respectively. PCR was performed on a capillary 
thermal cycler (Corbett Research, Australia) for 30 cycles (95°C lOsec; 50°C lOsec; 
72°C 60sec) in a 20jil reaction mix containing 200ng of pHT4, 200pM dNTPs, lOpmol 
of each primer, 1.5u Taq polymerase (Promega) and lx Taq polymerase buffer 
(Promega). The 790bp PCR product was digested with SacII and Hindlll and cloned 
into a ubiquitin fusion expression vector pRB269 (Baker et al., 1994). The resulting 
plasmid pRBKL3, produced a ubiquitin-GSTT2 fusion protein. The cDNA cloned in 
pRBKL3 was sequenced entirely to confirm that there were no errors introduced during 
the amplification step. When pRBKL3 was transfected into a strain of E. coli expressing 
the yeast ubiquitin specific protease Ubpl (Tobias and Varshavsky, 1991), from the 
plasmid pCGOOl (Gilchrist and Baker, personal communication), the amino terminal 
ubiquitin moiety was co-translationally removed from the fusion protein generating 
recombinant GSTT2-2 without any additional N-terminal residues. A schematic diagram 
showing the detailed ubiquitin-GSTT2 construct is presented in Figure 5.1.
5.4.3 Enzyme Purification
A 40L culture of E. coli containing pRBKL3 and pCGOOl, was grown in a large 
scale fermenter. Growth media contained standard Luria Broth, supplemented with 
glucose to a final concentration of 6.3g/L. Ampicillin and chloramphenicol were added 
for selection to a final concentration of 100p.g/ml and 34}ig/ml respectively. The culture 
was allowed to grow until log phase (OD^ between 0.7 to 0.9) when IPTG was added 
to a final concentration of 0.1 mM and the culture was allowed to grow for another 3
gu
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hours. Bacterial cells were harvested by centrifugation and resuspended in Buffer A 
(lOmM Tris, ImM EDTA, 0.5mM ß-mercaptoethanol, pH 8.25). Cells were lysed by 
passing through a Ribi cell disruptor and stored frozen in 50ml aliquot at -20°C if not 
used immediately.
A 50ml sample of cell lysate was diluted with Buffer A to 150ml and centrifuged 
at 26,000g for 20 minutes. The supernatant was applied to a 29 x 2.5cm DEAE-cellulose 
column equilibrated in Buffer A. The column was developed using a NaCl gradient from 
0-150mM. Fractions containing activity towards cumene hydroperoxide were pooled and 
concentrated on an Amicon concentrator with a Diaflo PM 10 ultrafilter (Amicon Corp., 
Lexington, MA, USA). The concentrated material was loaded onto a 60 x 3cm Sephacryl 
S-200 gel filtration column pre-equilibrated in Buffer B (lOmM sodium phosphate, ImM 
EDTA, 0.5mM ß-mercaptoethanoi, pH 6.8). Fractions containing activity towards 
cumene hydroperoxide were again pooled and loaded onto a 8 x 1.5cm Orange A Matrex 
gel column (Amicon Corp., Lexington, MA, USA) pre-equilibrated in the same buffer. 
The column was developed using a KC1 gradient from 0 to 1M in Buffer B. Fractions 
possessing activity towards cumene hydroperoxide were pooled and concentrated using a 
Diaflo PM 10 ultrafilter. While concentrating, the sample was desalted and the buffer was 
changed to Buffer A. The concentrated material was loaded on to a high resolution Mono 
Q HR 5/5 f.p.l.c. column and developed using two linear salt gradients of 0-20mM and 
20-200mM NaCl in Buffer A. Fractions containing activity towards cumene 
hydroperoxide were pooled. Purified GSTT2-2 was examined on 12% SDS/PAGE by 
the method of Laemmli (Laemmli, 1970) The gels were stained using a Silver Staining 
Plus kit (Biorad, CA. USA), following the manufacturer's protocol. Table 5.1 presents a 
summary of the purification steps.
5.4.4 Enzyme Characterisation
The isoelectric point of GSTT2-2 was estimated by isoelectric focusing on Phast 
gels (Amrad-Pharmacia, Australia). The pH optimum was determined with cumene 
hydroperoxide as a substrate using a previously described range of buffers (Beutler et a l ,
1968). N-terminal amino acid sequencing was performed on an Applied Biosystems 
477A automated protein sequencer.
5.5 RESULTS
5.5.1 Construction of the GSTT2 Expression Vector
The expression of GSTT2 cDNA was initially attempted using the expression 
vector, pKK233-2 (Amrad-Pharmacia, Australia). However, the level of protein 
expression was extremely low. Subsequently, an alternative expression system, utilising 
the ubiquitin protein fusion system was adopted. The expression of proteins as fusions 
with ubiquitin has been shown to enhance the levels of protein expression in a bacterial 
system (Baker et al., 1994). Figure 5.2 outlines the construction of the ubiquitin-GSTT2 
fusion expression vector. The expression vector pRB269 contains a yeast ubiquitin 
cDNA downstream of a tac promoter. A multi-cloning site is available immediately after 
the ubiquitin cDNA for the insertion of cDNAs to be expressed as ubiquitin fusions. The 
coding region of GSTT2 was amplified from the pHT4 clone using a forward primer 
which contained a SacII site and a reverse primer containing a Hindlll site. These 
restriction sites enable the insertion of the GSTT2 cDNA downstream of the ubiquitin 
gene without any additional residues between the carboxy terminal glycine of ubiquitin 
and the amino terminal methionine of GSTT2-2 (Figure 5.1).
Initially, a ubiquitin-GSTT2 fusion expression vector that excluded the initial 
methionine of GSTT2 (using primer-pair HTExA/HTExB) was constructed. However, 
the level of protein expression was extremely low and the initial methionine of GSTT2 
was subsequently encoded in the pRBKL3 expression vector (using primer-pair 
HT2ExA/HTExB). The ubiquitin-fused GSTT2 was cleaved by the co-expressed Ubpl 
at the ubiquitin-GSTT2 junction, yielding a mature GSTT2-2 recombinant protein. 
N-terminal amino acid sequencing of the purified enzyme did not identify any ubiquitin 
sequence suggesting that the ubiquitin moiety of the fusion protein had been completely 
removed by the action of Ubpl. However, the amino acid sequence data yielded two
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Figure 5.2 : Construction of the GSTT2 expression vector
The coding region of GSTT2 cDNA was amplified from the plasmid pHT4, 
containing the GSTT2 cDNA (see Chapter 3). The forward primer 
(HT2ExA) contained a Sacll site and the reverse primer (HTExB) contained 
a Hindlll site for directional cloning of the amplified product into the 
pRB269 expression vector. The recombinant protein was produced as a 
ubiquitin-GSTT2 fusion protein and subsequently cleaved by the co­
expressed ubiquitin protease, Ubpl.
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residues of about equal concentration at each position suggesting two proteins were being 
sequenced. Further analysis of the data indicated that approximately 50% of the 
preparation had an amino terminal methionine residue followed by the expected GSTT2 
sequence (see Chapter 3), while in the remaining 50%, the amino terminal methionine 
had been removed and the GSTT2 sequence started with the second encoded residue. In 
the experience of this laboratory with other recombinant proteins, it is not uncommon for 
a variable proportion of amino terminal methionine residues to be removed during 
expression in E. coli (Baker et al., 1994).
The recombinant GSTT2-2 was expressed at a level of 1.6mg/L of culture. 
Although this rate of expression was able to produce sufficient protein for the present 
studies, the level of protein expression appears to be low when compared with 60mg/L 
for GSTP1-1 in the same expression vector (Baker et al., 1994).
5.5.2 Purification of Recombinant GSTT2-2
Recombinant GSTT2-2 was purified to apparent homogeneity by a series of 
chromatographic steps involving anion exchange on DEAE cellulose, gel filtration on 
Sephacryl S-200, dye-ligand chromatography on Orange A Matrex gel, and high 
resolution anion exchange chromatography on Mono Q f.p.l.c. In all the purification 
steps, protein concentration was monitored by absorbance at 280nm and GSTT2-2 
activity was monitored by the measurement of glutathione peroxidase activity with 
cumene hydroperoxide. Crude bacterial lysate was diluted to 3 vol. and after 
centrifugation was loaded on to an anion exchange DEAE cellulose. The column was 
washed with 4 bed volumes of Buffer A before elution with an NaCl gradient from 
0-150mM (Figure 5.3). Fractions containing activity towards cumene hydroperoxide 
were eluted between 50-66mM NaCl.
Sephacryl S-200 was used to separate protein by size and in this case it also 
served as a convenient step to desalt and exchange buffers (from Buffer A to Buffer B). 
The separation profile from Sephacryl S-200 yielded 4 major protein peaks. Fractions
98
containing activity towards cumene hydroperoxide fell only within peak number 2 (Figure 
5.4). Samples were pooled and loaded to Orange A Matrex gel (Figure 5.5). The Orange 
A retained approximately 15% of the protein which exhibited activity towards cumene 
hydroperoxide. However, about 30% of the protein which was active towards cumene 
hydroperoxide flowed through the column, presumably as a result of overloading. 
Therefore, fractions numbered from 13 to 32, containing the 30% flow through protein 
were rechromatographed after the column had been re-equilibrated. A gradient of KC1 
from 0-1M was used to develop the column. Fractions found to be active with cumene 
hydroperoxide were eluted between 0.26 and 0.52M KC1. The final purification step 
utilised high resolution anion exchange chromatography on a Mono Q f.p.l.c. column. 
The fractions which contained activity towards cumene hydroperoxide were eluted from 
the Mono Q column as a single peak between 4 and 12mM NaCl gradient (Figure 5.6). 
The purity of the protein recovered from Mono Q was analysed on 12% SDS/PAGE. 
Silver staining of the gel showed there were no contaminating proteins (Figure 5.7). The 
purified protein had a molecular mass of about 27kD as compared with the standard 
markers, which was in accordance with the calculated molecular mass of 27,489Da. A 
summary of the purification steps and the yield of purified protein is given in Table 5.1.
The pH optimum of GSTT2-2 as determined with cumene hydroperoxide was 
found to be in the range of pH 7.6 to 8.3 (Figure 5.8). Isoelectric focusing in 
polyacrylamide gels indicated that GSTT2-2 had a isoelectric point between 5.2 to 5.3 
(Figure 5.9). In this experiment, the purified recombinant protein did not migrate as a 
discrete band and was somewhat diffuse suggesting that there was some charge 
heterogeneity in the purified protein.
5.5.3 Substrate Specificity of GSTT2-2
Table 5.2 outlines the specific activity of GSTT2-2 with a variety of substrates. 
GSTT2-2 showed peroxidase activity towards cumene hydroperoxide and terf-butyl 
hydroperoxide. However, there was no detectable activity towards hydrogen peroxide. 
It is notable that GSTT2-2 was active towards unsaturated aldehyde compounds such as 
the alka-2,4-dienals and alk-2-enals. Further more, the activity with these substrates 
increased with the length of the carbonyl carbon chain. In line with the earlier report of 
Hussey and Hayes (1992), the enzyme was also found to be active towards 1-menapthyl 
sulphate. The specific activity of the recombinant GSTT2-2 with both 1-menapthyl 
sulphate and cumene hydroperoxide was comparable with the native enzyme purified 
from human liver. GSTT2-2 has no detectable activity towards dichloromethane (DCM) 
unlike the other human Theta class isoenzyme GSTT1-1 (Pemble et al.t 1994). Finally, 
low but detectable levels of activity were also demonstrated with ethacrynic acid and 7- 
chloro-4-nitrobenzo-2-oxa-1,3-diazole as substrates.
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Figure 5.7 : SDS/PAGE analysis of recombinant GSTT2-2.
Recombinant GSTT2-2 protein was analysed on a 12% SDS/PAGE gel. GSTT2-2 was 
purified to apparent homogeneity. The molecular mass of GSTT2-2 in SDS/PAGE as 
compared with the standard markers is about 27kDa.
14.3
105
100-,
pH
Figure 5.8 : pH profile of GSTT2-2 with cumene hydroperoxide as 
substrate
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Figure 5.9 : Isoelectric focusing of recombinant GSTT2-2
Lane 1 : Recombinant GSTT2-2
Lane 2 : Standard proteins of known isoelectric points

Table 5.2 : Activity of recombinant human GSTT2-2 with various 
substrates
107
Substrate Specific activity
(pmol/min/mg of protein)
Cumene hydroperoxide 6.885 ± 0.482
tert-Butyl hydroperoxide 0.406 ± 0.042
Hydrogen peroxide ND
1- menaphthyl sulphate 0 .317± 0.028
Ethacrynic acid 0.290 ± 0.020
7-chloro-4-nitrobenzo-2-oxa-1,3-diazole 0.057 ± 0.004
Dichloromethane ND
1,2-Dichloro-nitrobenzene ND
1 -Chloro-2-4-dinitrobenzene ND
1,2-Epoxy-3-(4-nitro phenoxy)-propane ND
4-Pheny l-but-3 -en-2-one ND
2-Cyano-1,3-dimethyl-1 -nitrosoguanidine ND
Hexa-2,4-dienal ND
trans, rra«.y-Hepta-2,4-dienal ND
trans, rra«5-Nona-2,4-dienal (50 ± 3) x IO’3
trans, rra«s-Deca-2,4-dienal (113 ± 15) x 10-3
rra/is-Hex-2-enal ND
rrans-Oct-2-enal (68.2 + 4.8) x 10-3
rra/is-Non-2-enal (119.6 + 9 .6) x 10-3
The mean values ± S.D. were calculated from 4 samples. 
N D : Not detectable.
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5.6 DISCUSSION
GSTT2-2 was previously purified from human liver (Hussey and Hayes, 1992). 
A cDNA clone thought to encode GSTT2 was subsequently cloned from a A.gt 11 human 
liver cDNA library (see Chapter 3) and the amino acid sequence derived from the cDNA 
clone was found to be identical to the N-terminal amino acid sequence provided by 
Hussey and Hayes (1992). The GSTT2-2 purified from human liver by Hussey and 
Hayes (1992) was active towards both cumene hydroperoxide and 1-menapthyl sulphate 
and the recombinant enzyme produced in the present study showed similar specific 
activities with these substrates, confirming that the cDNA described in Chapter 3, 
encodes the isoenzyme described by Hussey and Hayes (1992).
5.6.1 Expression and Purification of Recombinant GSTT2-2
Different expression plasmids that have previously achieved high levels of GST 
expression were used to express recombinant GSTT2. The highest expression level was 
obtained in pRBKL3. However, in comparison with the expression levels reported 
previously with other GSTs (Board and Pierce, 1987; Ross and Board, 1993; Baker 
et a l., 1994) the expression of GSTT2 in pRBKL3 was relatively low. In the earlier 
cases, the expressed GSTs were rapidly purified in high yield by glutathione affinity 
chromatography. The apparent low level of GSTT2-2 expression appears to reflect the 
low recovery of the enzyme during the extensive purification steps required for Theta 
class GSTs (see Table 5.1 and Hussey and Hayes, 1992). In the present case, the final 
yield of purified protein does not appear to be a good measure of protein expression in 
bacterial cells.
5.6.2 Role of GSTT2-2 in Detoxifying Products from Lipid Peroxidation
In the present study we tested the catalytic activity of GSTT2-2 with a number of 
compounds that have been shown to be substrates for other GSTs. Of particular interest 
is the activity of GSTT2-2 with secondary lipid peroxidation products such as the alka- 
2,4-dienals and alk-2-enals. Aldehydic products have been identified in rat liver 
microsomes as a result of ADP-Fe2+ stimulated lipid peroxidation (Esterbauer et al.,
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1982). These products are known to inhibit several microsomal and plasma-membrane 
enzymes as well as inhibiting DNA and protein synthesis (Esterbauer et ai, 1982). The 
activity of GSTT2-2 with these lipid peroxidation products together with its glutathione 
peroxidase activity points to an important role of this enzyme in the protection of cells 
against the toxic products of oxygen and lipid peroxidation. The specific activity of 
GSTT2-2 doubled when the carbonyl carbon chain of alka-2,4-dienals and alk-2-enals 
increased from 8 to 9 or 9 to 10 carbons. Appreciable increases in specific activity with 
chain length of alka-2,4-dienals and alk-2-enals were also documented for a GST isolated 
from tapeworm Moniezia expansa (Brophy et al., 1989) and the human Mu class GSTs 
(Ross and Board, 1993). This increased activity may reflect the increased hydrophobicity 
of the longer carbon chain compounds rendering an easier access to the hydrophobic 
active site.
The structure of a Theta class GST from Lucilia cuprina revealed that the insect 
GST has a deeper active site compared to other mammalian GSTs (Wilce et a l , 1995). 
Further more, amino acid sequence alignment has suggested that the extended a-helix 5 in 
the mammalian Theta class isoenzymes would result in an even deeper active site in these 
enzymes (Wilce et al., 1995). Because of the apparent increased affinity of GSTT2-2 for 
substrates with increased carbon chain length, and the inability of GSTT2-2 to bind to 
conventional glutathione/agarose affinity matrices, an attempt was made to purify 
GSTT2-2 using a GSH-agarose matrix with a very long spacer arm, equivalent to 20 
carbon atoms. Unfortunately, this attempt was no more successful than conventional 
glutathione affinity matrices (Tan and Board, unpublished data).
5.6.3 Role of GSTT2-2 in Detoxifying Reactive Sulphate Esters
The conjugating activity of GSTT2-2 with 1-menapthyl sulphate suggests the 
possibility of its action against a wide range of reactive sulphate esters such as, 7,12- 
dihydroxymethylbenz[a]anthracene (DHBA) and 5-hydroxymethylchrysene (HCR) as in 
the case of its rat and mouse orthologues (Hiratsuka et al., 1990; Hiratsuka et al., 1995). 
Conjugation of these compounds may be an important mode of protection against
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hepatocarcinogenesis. The reaction mechanism of GSTT2-2 with sulphate esters will be 
discussed in greater detail in Chapter 7.
5.7 CONCLUSION
Very few of the compounds tested with GSTT2-2 gave significant levels of 
activity and the natural substrates for this enzyme has yet to be identified. However, the 
activities observed with 1-menapthyl sulphate, cumene hydroperoxide, alka-2,4-dienals 
and the alk-2-enals suggest classes of compounds that may include important natural 
substrates. Activity was also detected with ethacrynic acid as a substrate. The level of 
activity obtained appears to be intermediate between that of the human Alpha and Pi class 
GST isoenzymes (Mannervik and Widersten, 1995).
GSTT2-2 did not exhibit dichloromethane (DCM) conjugating activity with GSH. 
DCM conjugating activity was also lacking in the mouse GST Yrs-Yrs (Hiratsuka et al., 
1995). In contrast, the alkyl halides appear to be good substrates for GSTT1-1 and the 
rat 5-5 Theta class isoenzymes (Pemble et al., 1994, Thier et al., 1993). A genetically 
determined deficiency of GSTT1-1 occurs in approximately 16% of European Caucasians 
(Pemble et al., 1994, Warwick et al., 1994, Chenevix-Trench et al., 1995). The absence 
of any activity of GSTT2-2 with alkyl halides may make the deficiency of GSTT1-1 of 
greater physiological significance following exposure to this class of compounds.
The role of GSTT2-2 in cellular metabolism is still largely unknown. Its distinct 
characteristics when compared with GSTT1-1 or members of the other GST classes may 
indicate that it has a novel functional role.
I l l
CHAPTER 6 : TISSUE DISTRIBUTION OF GSTT2-2
6.1 INTRODUCTION
The GST isoenzymes are ubiquitous and distributed in many tissues. Though 
multiple GST isoenzymes can exist in the same tissue, certain GSTs are expressed more 
abundantly than others in a particular tissues. For example, the Alpha class GSTs are the 
predominant GST expressed in human kidney and liver (Wheatley et al., 1994; Meikle 
et al., 1992). The Mu class GSTM2-2 is found most abundantly in skeletal muscle 
(Suzuki et al., 1987; Vorachek et al., 1991) while GSTM3-3 is a brain and testis specific 
GST (Suzuki et al., 1987; Campbell et al., 1990). The tissue distribution of human 
GSTs has been reviewed in Chapter 1 of this thesis.
6.2 OBJECTIVES
While human GSTT2-2 has been purified from liver (Hussey and Hayes, 1992) 
and the cDNA cloned from a human liver library (see Chapter 3), nothing is known 
about its expression in extrahepatic tissues. The objective of this chapter is to gain a 
greater understanding of the tissues in which GSTT2-2 is expressed by the use of 
Northern blot and Western blot analysis of a variety of human tissues.
6.3 MATERIALS
Freund's Adjuvant is a product of Gibco BRL, Life Technologies Inc., NY, 
USA. New Zealand White Rabbit breed at the Animal Services Division of the Australian 
National University, Australia, was used to raise polyclonal antibodies against GSTT2-2. 
Goat anti-rabbit IgG was obtained from Sigma Chemical Co. (USA).
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6.4 METHODS
6.4.1 Preparation of GSTT2-2 Antiserum
Purified GSTT2-2 from the Mono Q f.p.l.c. purification step (see Chapter 5) 
was used to raise polyclonal antibodies in a rabbit. 7|ig of purified GSTT2-2 was mixed 
with Freund's Complete Adjuvant and injected subcutaneously for an initial dose. The 
rabbit was given another 2 booster doses of 7pg GSTT2-2 in Freund's Incomplete 
Adjuvant at weekly intervals. At the end of the 4th and 5th weeks, the rabbit was bled by 
intravenous puncture of the marginal ear veins of the ear and blood was collected into 
10ml sterile glass centrifuge tubes. Approximately 20ml of blood was collected and left 
to clot at room temperature. Upon clotting, the content of the tubes were carefully freed 
from the glass wall by a sealed pasteur pipette. The clot was left to retract to about half of 
its original volume for 2-3 hours at room temperature. Blood serum was aspirated 
carefully from the clotted material into a sterile glass tube and the remainder of the clotted 
material was centrifuged at 1500g for 10min at room temperature. The supernatant 
(serum) was pooled with the previously collected serum and sodium azide was added to a 
concentration of 0.02% to prevent microbial growth. The antisera was aliquoted into 
1.5ml screw cap tubes and stored frozen at -20°C.
6.4.2 Western Blot Analysis
Human tissue samples were obtained at autopsy from individuals who had died 
from accidental causes. Approximately 2g of tissue from brain, placenta, spleen, lung, 
liver and kidney were homogenised in a IKA-Ultra-Turrax T25 homogeniser in 
phosphate buffered saline containing lOmM ß-mercaptoethanol. The homogenised 
samples were centrifuged at 12,000g for 10 minutes and protein concentration of the 
supernatant was quantitated using the method of Bradford (1976). Approximately 2mg 
of total protein from the supernatant was resolved on 12% SDS/PAGE and electroblotted 
onto nitrocellulose membrane as described by Towbin et al. (1979). The membrane was 
probed with rabbit polyclonal antibodies raised against GSTT2-2 and goat anti-rabbit IgG 
alkaline phosphatase as previously described by Board et al. (1984).
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6.4.3 Northern Blot Analysis
A Multiple Tissue Northern (MTN) Blot was purchased from CLONTECH 
Laboratories, Inc., Palo Alto, CA (USA). Each lane of the blot contains approximately 
2|ig of purified Poly-(A) RNA from human heart, brain, placenta, lung, liver, skeletal 
muscle, kidney and pancreas. The probe used in the hybridisation was an 860bp EcoRI 
fragment derived from pHTl (see Chapter 3). The EcoRI fragment of pHTl was 
labelled with [a-32P]dATP by random priming and used as a hybridisation probe. 
Hybridisation, washing and exposure conditions of the blot were carried out according to 
the supplier's protocol.
6.5 RESULTS
6.5.1 Tissue Distribution of GSTT2-2
Northern blot analysis of mRNA, obtained from various tissues identified a 
1.35kb hybridising band. This experiment suggested that GSTT2-2 was expressed at 
varying levels in liver, placenta, kidney, pancreas, lung, heart, and skeletal muscle 
(Figure 6.1, panel A). Although this filter was hybridised on several occasions, only 
weak signals were ever obtained. This may reflect a naturally low level of GSTT2 
message in the tissue samples, or degradation of the fractionated mRNA. Western blots 
using rabbit antiserum raised against recombinant GSTT2-2 also showed weak staining 
suggesting that GSTT2-2 is not expressed abundantly in any of the tissues studied. The 
Western blots confirmed that placenta expressed GSTT2-2 at a level comparable to that in 
liver (Figure 6.1, panel B). There appeared to be little or no expression of GSTT2-2 in 
brain as observed from both the Northern and Western Blot results. This observation is 
rather surprising, in view that the brain is an organ with a high turnover in oxygen 
metabolism. Perhaps other peroxidases with higher catalytic efficiency may play a more 
important role in scavenging the products of lipid peroxidation in the human brain.
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Figure 6.1 : (A) Northern blot and (B) Western blot analysis
(A) Northern blot of Poly-(A) mRNA from various tissues was probed with the GSTT2 
cDNA cloned in pH Tl. Tissues from which mRNA was extracted include:- Lane 1: 
heart; Lane 2: brain; Lane 3: placenta; Lane 4: lung; Lane 5: liver; Lane 6: skeletal muscle; 
Lane 7: kidney; Lane 8: pancreas. Molecular weight markers are indicated on the side.
(B) Western blot of cytosolic extracts from various tissues probed with antiserum to 
recombinant GSTT2-2. Cytosolic extracts were from, Lane 1: purified recombinant 
GSTT2-2; Lane 2: brain; Lane 3: placenta; Lane 4: spleen; Lane 5: lung; Lane 6: liver; 
Lane 7: kidney. Protein size markers are indicated on the side.
The GSTT2 in placenta appears to be a different size to that in other tissues. This 
was a consistent finding in three experiments. This result is probably an artefact 
generated by the presence in placenra of another abundant protein of similar but 
slightly larger molecular size This protein may displace the GSTT2 in the gel forcing 
it out of alignment.
A kb 1 2 3 4 5 6 7 8
B kD 1 2 3 4 5 6 7
46 .0 -
30.0 -
21.5 -
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6.6 DISCUSSION AND CONCLUSION
Despite the poor signal levels on the Northern and Western blots, GSTT2-2 is 
evidently expressed in many tissues. It appears to be predominantly expressed in 
placenta and liver, although detectable amounts of protein or mRNA were also observed 
in kidney, pancreas, lung, spleen, heart, and skeletal muscle but not in brain. Previous 
studies by Guthenberg et a l (1979) have suggested that GSTP1-1 is the major GST 
expressed in placenta. That conclusion was based on the activity of the Alpha, Mu and Pi 
class enzymes with CDNB and their ability to bind to a 5-hexyl glutathione affinity 
matrix. The present study indicates that GSTT2-2 is an additional GST expressed in 
placenta that was previously over looked. Equivalent studies of the distribution of 
GSTT1 have not yet been reported. However, the rat GST Yrs-Yrs (Hiratsuka et a l , 
1990) and mouse GST mYrs-mYrs (Hiratsuka et a l, 1995) that are orthologous to 
hGSTT2 are widely distributed in many tissues.
The broad tissue distribution of GSTT2-2 suggests that its role is probably not 
highly specialised as would be indicated by restricted expression in a specific tissue. 
Therefore, its role in protection against organic hydroperoxides or secondary products of 
lipid peroxidation seems highly probable.
Differences in expression of GSTT2 may occur during development however this 
possibility was not addressed during this study because of a lack of time and the lack 
of the appropriate samples.
CHAPTER 7: SITE-DIRECTED MUTAGENESIS AND FUNCTIONAL
STUDIES OF GSTT2-2
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7.1 INTRODUCTION
Mammalian cytosolic glutathione transferases (GSTs) have been grouped into four 
distinct classes, termed Alpha, Mu, Pi and Theta in a recent consensus nomenclature for 
the human isoenzymes (Mannervik et al., 1992). Amino acid sequence similarity within 
the Alpha, Mu and Pi class tends to be around 70% or greater while inter-class sequence 
similarity is usually less than 30%. The most conserved region lies within the N-terminal 
half of the protein where the common glutathione binding domain is located, while the 
C-terminal half shows greater diversity in each isoenzyme. The diversity in the 
C-terminal sequence is likely to account for the varying specificities for the hydrophobic 
substrates.
The structure and function of GSTs have been studied by various approaches. 
Examples of the many studies in this area include chemical modification (Awasthi et al., 
1987, Meyer et al., 1993; Xia et al., 1993); site directed mutagenesis (Stenberg et al., 
1991, Liu et al., 1992, Kolmar al., 1992, Bjornestedt et al., 1995); construction of 
deletion mutants and chimeric enzymes (Board and Mannervik, 1991, Zhang et al., 1992; 
Bjornestedt et al., 1992); photoaffmity labelling (Hoesch and Boyer, 1989, Barycki and 
Colman, 1993; Cooke et al., 1994); X-ray diffraction studies (Reinemer et al., 1991, 
Reinemer et al., 1992, Ji et al., 1992, Sinning et al., 1993, Wilce et al., 1995) and NMR 
spectroscopy (Penington and Rule, 1992). In general, these studies have suggested that 
the catalytic mechanism of GSTs depends on the ability of the isoenzymes to lower the 
pKa of the thiol group of glutathione (GSH) resulting in the formation of a glutathione 
thiolate anion (GS‘) which acts as a nucleophile to attack the electrophilic centres of 
xenobiotic or endogenous substrates (Chen et al., 1988, Graminski et al., 1989). Studies 
of the three dimensional structure of the Alpha, Mu and Pi class isoenzymes supported by 
site directed mutagenesis have attributed this activation role predominantly to an
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N-terminal domain tyrosine residue which is conserved through out all cytosolic GST 
classes. In lowering the pKa of the sulfhydryl group of enzyme-bound glutathione, the 
hydroxyl group of this tyrosine may function as a general base in abstracting the Sy 
hydrogen (Karshikoff et al., 1993) and subsequently stabilising the thiolate anion (GS")
by hydrogen bonding (Tyr— O H  "SG) (Liu et al., 1992). Site directed mutagenesis
of this tyrosine residue to phenylalanine decreased the CDNB conjugating activity of the 
mutant enzyme to less than 2% compared with the wild type enzymes of the Alpha, Mu 
and Pi classes (Stenberg et al., 1991, Liu et al., 1992, Kolm et al., 1992).
The molecular cloning and expression of a cDNA encoding the human Theta class 
isoenzyme GSTT2-2 has been described in Chapters 3 and 5. The protein sequence as 
translated from the cDNA as well as N-terminal amino acid sequencing (see Chapter 3 
and Hussey and Hayes, 1992) revealed the existence of a phenylalanine at position 9 and 
the absence of a conserved tyrosine residue near the N-terminal domain. This 
observation suggested the possibility that GSTT2-2 may utilise another residue in the 
catalytic mechanism. Recent studies of a Theta-like GST from Lucilia cuprina (Wilce 
et al., 1995, Board et al., 1995) have identified a serine residue that is conserved 
throughout all the Theta class isoenzymes and appears to be within hydrogen bonding 
distance of the glutathionyl sulphur. These studies have also shown that the conserved 
tyrosine in the N-terminal domain (Tyr5) of the L. cuprina GST is positioned away from 
the glutathionyl sulphur and unlike its counterparts in the Alpha, Mu and Pi classes, is 
unlikely to participate in the catalytic mechanism. Site directed mutagenesis of Ser9 in the 
L. cuprina GST has confirmed its importance in catalysis (Board et al., 1995).
7.2 OBJECTIVES
To evaluate the role played by Seri 1 in the catalysis of GSTT2-2 through site- 
directed mutagenesis and the analysis of a GSTT2 homology model, based on the 
co-ordinates of the Theta-like GST from Lucilia cuprina .
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7.3 MATERIALS
Sources of chemicals, reagents and restriction enzymes used in this study have 
been described in Chapter 2. Substrates used in the GST assays were obtained from 
the following sources : Cumene hydroperoxide and l-(chloromethyl)napthalene from 
Aldrich Chemical Co., Wisconsin (USA); reduced glutathione, ethacrynic acid and 
L-cysteine from Sigma Chemical Co. (St. Louis, MO), glutathione reductase from 
Boehringer Mannheim (Australia), ß-mercaptoethanol from BDH Chemicals Ltd 
(England), 1-menapthyl sulphate (MS) was synthesised by the method of Clapp and 
Young (1970). S-methylglutathione was synthesised by the reaction of reduced 
glutathione with methyl iodide at pH9 in an ethanolic solution.
7.4 METHODS 
7.4.1 Enzyme Assays
Glutathione peroxidase activity was determined by the procedure described by 
Beutler (Beutler, 1975). The determination of GST activity with MS was essentially the 
same as described by Gillham (1971), using an extinction coefficient for 
S-O-menapthyOglutathione of 3.9mM-1cm -1. Glutathione transferase assays using 
ethacrynic acid were previously described in detail by Mannervik and Widersten (1995). 
Reaction between L-cysteine or ß-mercaptoethanol with MS in the presence of S- 
methylglutathione and GSTT2-2 was measured spectrophotometrically at 298nm in 0.1 M 
Tris.HCl, pH8.3, containing lOmM S-methylglutathione, 20mM L-cysteine (or 30mM ß- 
mercaptoethanol) and 0.25mM MS, at 37°C. The extinction coefficient for S -(l-  
menapthyl)-L-cysteine is 4.8mM*1c n rI (Gillham, 1971) while the extinction coefficient 
for S-(l-menapthyl)-ß-mercaptoethanol (2.1mM-1cm-1 at 298mn), was determined by 
allowing 50nmol of MS to react to completion with an excess of ß-mercaptoethanol in the 
presence of GSTT2-2. Sulphatase activity was determined by measuring sulphate 
production by a turbidimetric procedure after reaction with BaCl2 in a gelatine solution 
(Dodgson, 1960).
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7.4.2 Site-Directed Mutagenesis
A Bg HU Hindlll fragment of pRBKL3 (see Chapter 3) was subcloned into an 
M13 vector digested with Bam HI and Hindlll to generate single stranded DNA template 
for site-directed mutagenesis. Oligonucleotides for site-directed mutagenesis of the 
N-terminal Seri 1 were :- 
SI 1A 5' GCTGGGCTGGGCCACCAGGTC 3';
SI IT 5' GCTGGGCTGGGTCACCAGGTC 3';
S11Y 5' GCTGGGCTGGTACACCAGGTC 3'.
Mutated residues were underlined. Site-directed mutagenesis was carried out using a 
Sculptor™ in-vitro mutagenesis kit (Amersham, Australia). The resulting mutations were 
confirmed by DNA sequencing using Sequenase™ Version 2.0 DNA sequencing kit 
(USB, USA) after subcloning the Sacll-Hindlll fragment into pRB269 (Baker et al., 
1994). The plasmids bearing the Seri W Ala, Seri 1—►Thr and Seri 1—►Tyr mutations 
were given the name pRBS 11 A, pRBS 1 IT and pRBS 11Y respectively.
7.4.3 Construction of pQE Expression Vectors
A 354bp fragment was amplified from a GSTT2 cDNA cloned in pRBKL3 using 
a forward primer, QET2 (5' GCGGATCCGTACCCCGCGGTATGGGCCTAGAGCTG 
3') and a reverse primer, HTB3 (5' ATACCAAAGGTGCCACGG 3’). Primer QET2 
contained additional BamHl and SacU restriction sites while primer HTB3 was designed 
3’ to a Sphl site, within the GSTT2 cDNA sequence. PCR was performed on a capillary 
thermal cycler (Corbett Research, Australia) in a 20|il reaction mix containing 200ng of 
pRBKL3, 200pM dNTPs, lOpmol of each primer, 1.5u of Taq polymerase (Promega) 
and lx Taq polymerase buffer (Promega). PCR conditions were as follows:- A hot start 
(94°C, lOsec); 20 cycles of (94°C, lOsec; 56°C, 30sec; 72°C, 60sec); 10 cycles of 
(94°C, lOsec; 56°C, 30sec; 72°C, 80sec); and an extra extension cycle of 72°C for 2 
minutes. The amplified product was digested with BamHl and Sphl and cloned into the 
same restriction sites in the QIAexpress System pQE30 (QIAGEN, GmbH, Germany). 
The resulting plasmid, pQE130 was digested with Sadi and Hindlll and ligated with a 
SacU, Hindlll fragment from either pRBKL3, pRBSllA, pRBSllT or pRBSllY to
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generate the wild type and mutant pQE expression vectors. The pQE vector incorporates 
a tract of 6 histidine residues at the amino terminal end of the expressed protein to 
facilitate purification (Figure 7.1). The construction of the pQE(GSTT2) expression 
vectors is described in Figure 7.2 and the expression constructs (wile type and mutants) 
were termed pQEHTl, pQESllA, pQESllT, and pQESllY.
7.4.4 Protein Expression and Purification
For the production of recombinant protein, the wild type or mutant expression 
plasmids were transformed into Escherichia coli host strain TGI and were each grown in 
a 10L fermenter. Standard Luria Broth supplemented with 100|ig/ml of ampicillin was 
used as the growth medium. IPTG was added to a final concentration of O.lmM when 
the density of the cells reached an O D ^ between 0.7-0.9. Bacterial cells were harvested 
by centrifugation and resuspended in Buffer A (50mM sodium phosphate, 300mM NaCl, 
10% glycerol at pH 6.0). The cells were lysed by passage through a Ribi cell disruptor 
and stored frozen in 50ml aliquots at -20°C if not used immediately.
The wild type and mutant GSTT2 isoenzymes were purified by immobilised metal 
ion chromatography. A 50ml sample of cell lysate was diluted with Buffer A to 80ml and 
centrifuged at 26,000g for 20 minutes. The supernatant was mixed with 20ml of a 50% 
slurry of Ni-NTA resin (QIAGEN, GmbH, Germany), pre-equilibrated in Buffer A, and 
allowed to mix overnight on an rotating mixer at 4°C. The resin was washed twice in 
Buffer A by centrifugation then packed into a Pharmacia XK16 column. The resin was 
washed with a continuous flow of Buffer A at a rate of 1.0ml/min at 4°C until the OD280 
of the flow through fraction was less than 0.01. The column was then mounted on to a 
Pharmacia f.p.l.c. system and developed with three linear imidazole gradients of 
0-50mM, 50-100mM and 100-200mM, pH 8.2, formed over a period of 20 minutes 
each. Each gradient was interspersed by elution for 40 minutes with a constant imidazole 
concentration equivalent to the concentration achieved at the end of each gradient. Protein 
concentration was monitored by absorbance at 280nm. Fractions containing the 
recombinant protein were detected by dot blot on nitrocellulose and probed with rabbit
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Figure 7.1 : N-Terminal sequence of pQE expression vector
The intial methionine of the fusion protein is in bold. The pQE expression vector has a 6 
histine residue at the N-terminal. The BamUl and SacII sites were introduced to the 
pQE30 expression vector by the PCR primer QET2. The Sacll and HindUl sites served 
as convenient restriction sites for shuttling the coding region of the respective cDNAs to 
the pQE expression vector. The restriction sites are underlined and the coding sequence 
of the inserted cDNAs and its translated amino acid sequence are in italics.
5* ATG AGA GGA TCG CAT CAC CAT CAC CAT CAC 
M R G S H H H H H H
BamHI S a c l l  H i n d i I I
GGA TCC GTA CCC CGC GGT ATG GGC CTA GAG CTG. . . . AAGCTT 3 '  
G S V P R  G M G L E L
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Bam HI Sphl
Hindlll
§top (frame 0,-1 ,-2)
Digest pQE-30 
with BamHI 
and Sphl
Tag with 
BamHI and 
Sacll QET2 Sphl
'  HTB3
GSTT2 insert in pRBKL3
Digest PCR product 
of QET2, HTB3 with 
BamHI and Sphl
Bam HI Sacll EcoRI Sac II 228
bpm 
/ Hindlll
stop (frame 0,-1,-2)
T5 promoter GSTT2
lindlll 1008
pRBKL3
5330bp /  Amp'
pQE-130
Replace Sacll, Hindll 
fragement of pQE-130 
with Sacll, Hindlll 
fragment of pRBKL3
Bam HI
T5 promoter Hindlll
stop (frame 0,-1,-2)
pQEHTI
Figure 7.2 : Construction of the pQE expression vector
A forward primer QET2 with additional BamHI and Sad I restriction sites and a 
reverse primer HTB3 were used to amplify a 5' coding region of pRBKL3. The 
amplified product (354bp) was digested with BamHI and Sphl and cloned into 
the same restriciton sites in the QIAexpress System pQE30. The resulting 
plasmid pQE-130 was digested with Sadi and Hindlll and ligated with the 
Sadi, Hindlll fragment from either pRBKL3, pRBSHA, pRBSHT or 
pRBSllY
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polyclonal antibodies raised against recombinant GSTT2-2 (Chapter 6) and anti rabbit 
IgG alkaline phosphatase as previously described by Board (1984). Fractions that 
showed a positive signal with the dot blot were pooled and concentrated with Centricon- 
30 ultrafiltration apparatus (Amicon Inc, USA) and buffer change to lOmM Tris/lmM 
EDTA/0.5mM ß-mercaptoethanol/pH8.25. To eliminate minor contaminating protein the 
concentrated samples were loaded on to a Mono Q HR 5/5 f.p.l.c. column equilibrated 
with lOmM Tris/lmM EDTA/0.5mM ß-mercaptoethanol/pH8.25. Under these 
conditions, the His6-tagged recombinant GSTT2-2 passed straight through the column 
while the contaminating proteins were retained.
7.4.5 Determination of Kinetic Parameters and pH Profile
Kinetic parameters for the wild type and mutant enzymes were obtained with 
cumene hydroperoxide and MS as the second substrates. The values for Vmax and Km 
were determined from the rate-saturation curves of GSH and the second substrates when 
the concentration of one was fixed while varying the other. Table 7.1 shows the different 
range of substrate concentrations used in determining the kinetic parameters. The value 
of Kcat/Km was determined as V /[S][E]tot at low substrate concentrations when the rate 
saturation curve degenerates to first-order with respect to the concentration of the varied 
substrate (Mannervik et al.y 1985). The molecular mass of the enzyme used in these 
calculations was 54,978Da Percentage of activity vs pH profiles for the wild type and 
mutant recombinant proteins were determined with cumene hydroperoxide or MS as the 
second substrate, using a previously described range of buffers (Beutler et al.y 1968). 
The non-enzymatic reaction rate at each pH was subtracted from the total recorded 
reaction rate and the results were expressed as a percentage of the maximum enzymatic 
rate.
7.4.6 Construction of a Homology Model of GSTT2-2
A homology model of GSTT2-2 was constructed based on the co-ordinates of the 
recently solved crystal structure of a Theta-like GST from the Australian Blowfly, Lucilia 
cuprina. The computational modelling of GSTT2-2 was carried out in collaboration with
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Dr. Gareth Chelvanayagam of the Human Genetics Group, Division of Molecular 
Medicine, John Curtin School of Medical Research, ANU, Canberra, Australia. Detailed 
procedures in deriving the homology model have been submitted for publication 
(Chelvanayagam et al., 1996).
7.5 RESULTS
7.5.1 Protein Expression in pQE Expression System
The pQE expression system offers a convenient means for the purification of 
recombinant enzymes. The extra 6 histidine residues tagged on the N-terminal of the 
recombinant protein enable it to be rapidly purified by immobilised metal ion affinity 
chromatography. The Hisö-tagged GSTs were eluted from the column between 
100-200mM imidazole, pH8.2. However, there were a few minor contaminating 
proteins in the region of 23kD and between 30-66kD. The minor contaminants were 
removed using a Mono Q f.p.l.c. column where the His6-tagged proteins passed straight 
through while the other contaminants were retained. The existence of contaminating 
proteins that co-elute with recombinant Hisö-tagged proteins were also reported by other 
groups (Hengen, 1995). This method of protein expression and purification was adopted 
because it was anticipated that some mutant proteins would be devoid of GST activity and 
could be difficult to purify by the multiple chromatography steps which have been used 
previously to purify recombinant GSTT2-2 (see Chapter 5). The degree of purity of the 
wild type and mutant proteins was evaluated by SDS/PAGE and is shown if Figure 7.3.
7.5.2 Kinetic Studies and pH Profiles
Wild type recombinant GSTT2-2 expressed in the pQE system was compared 
with the same recombinant protein expressed in a co-translationally cleaved ubiquitin 
fusion protein system previously described in Chapter 5. The GSTT2-2 expressed in 
the latter system has no additional N-terminal residues. However, both recombinant 
proteins showed essentially the same specific activity towards cumene hydroperoxide, 
ethacrynic acid and MS (Table 7.2). This shows that the extra residues on the
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N-terminus of the recombinant GSTT2-2 do not interfere significantly with the activity 
and function of the enzyme. Furthermore, pH curves of GST activity with cumene 
hydroperoxide or MS showed a similar profile for each enzyme (Figure 7.4A, 7.4B). 
With this confirmation, it was possible to proceed to study the catalytic characteristics of 
the wild type and mutant proteins expressed in the pQE system.
The specific activities of each mutant enzyme with cumene hydroperoxide, 
ethacrynic acid or MS as a substrate are shown in Table 7.2. The S11Y mutant was 
inactive with all substrates. In comparison, while the S11A and SI IT mutants were 
inactive with cumene hydroperoxide and ethacrynic acid, they were both active with MS 
as a substrate. In particular the SI 1A mutant had a higher specific activity than that of the 
wild type enzyme (1.5 times higher than the wild type). Several kinetic parameters for 
the wild type enzyme with cumene hydroperoxide as the second substrate are shown in 
Table 7.3 and the same values for the wild type enzyme and the active Seri 1 mutants with 
MS as a substrate are shown in Table 7.4. Mutating Seri 1 to Ala and Thr did not seem to 
impair the affinity of the enzyme for GSH as shown by the apparent Km values of the 
Seri 1 mutants, with MS as the second substrate.
The GSH peroxidase activity of pQE-expressed GSTT2-2 varies with pH and 
adopts the same bell-shaped profile as the recombinant GSTT2-2 expressed in the 
ubiquitin fusion system (see Chapter 5, Figure 5.8), with an optimum pH range 
between 7.6-8.5 (Figure 7.4A). The pH curve of GSH conjugating activity with MS did 
not show a similar bell-shaped profile for recombinant GSTT2-2 expressed in either 
expression system (Figure 7.4B). In this case, the enzyme activity increased as a 
function of the pH. Similar pH profiles with MS were also obtained with the S 11A and 
SI IT mutants. The non-enzymatic rates of reaction that were subtracted from the data in 
Figure 7.4A and 7.4B are shown in Figure 7.4C. Clearly, unlike most GST substrates, 
MS does not show increased non-enzymatic reaction rates at high pH.
The non-enzymatic rate of cumene hydroperoxide as substrate did appear to follow 
a bell-shaped curve with increasing pH. This may have been due to inhibition of the 
linking enzyme , (glutathione reductase) at high pH. In retrospect it would have been 
better to demonstrate the nonenzymatic reaction with ethacrynic acid which does not 
need a separate linking enzyme.
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7.5.3 Thiol Specificity of GSTT2-2
Because the reaction between MS and GSH does not involve Seri 1 and since its 
increasing rate with increasing pH resembles a non-enzymatic chemical reaction, the 
MS-glutathione conjugation reaction was investigated in greater detail. The enzyme 
shows a high specificity for glutathione as a thiol substrate and compounds such as 
L-cysteine or ß-mercaptoethanol are not normally substrates (Table 7.5). However, as 
shown in Table 7.5, the specificity for GSH as the reactive thiol can be relaxed if 
L-cysteine or ß-mercaptoethanol are added in the presence of non-reactive 
S-methylglutathione.
7.5.4 GSTT2-2 as a Sulphatase
Sulphate production from MS was determined in the presence or absence of GSH 
or S-methylglutathione. The data in Figure 7.5 show the production of sulphate in the 
presence of GSH or S-methylglutathione plus ß-mercaptoethanol. Sulphate was also 
released in the presence of S-methylglutathione alone, however, the rate was only a tenth 
of that in the presence of GSH. It is possible that in the absence a nucleophile
, S042- could reassociate with the carbonium ion of 1-methylnapthalene thus 
limiting the appearance of free S042-. Essentially no sulphate was released in the absence 
of GSH or S-methylglutathione.
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Figure 7.3: SDS/PAGE analysis of wild type and mutant recombinant
GSTT2-2 expressed in pQE system
Wild type and mutant recombinant GSTT2-2 proteins were analysed in a 12.5% 
SDS/PAGE gel on a Phamacia Phast Gel System. All recombinant proteins were purified 
to apparent homogeneity. The molecular mass of recombinant GSTT2-2 in SDS/PAGE 
as compared with the standard markers is about 28kD. Lane 1: S11Y mutant. Lane 2: 
SI IT mutant. Lane 3: SI 1A mutant. Lane 4 : wild type GSTT2-2. Lane 5: molecular 
weight marker.
1 2 3 4 5 kD
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Table 7.1 : Substrate concentrations used in determining the kinetic 
parameters.
S econd substrate 
concentration (m M )
G SH  concen tra tion  (m M )
C um ene hydroperox ide 0 .35 0 .1 0 -  15
0.07 - 0 .56 2 .0
E thacrynic acid 0 .04  - 3 .0 0 .2 5
0 .2 0.1 - 2 .0
1-m enapthyl sulphate 0 .05 0.1 - 4 .0
0 .003  - 0 .04 5 .0
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Table 7.2 : Comparison of specific activity between wild type and Serll
mutants
Specific activity (pmol/min/mg protein)
Enzyme 1-menapthyl
sulphate
Cumene
hydroperoxide
Ethacrynic
acid
Wild type (pQE)a 0.237 ± 0.017 5.26 ±0.041 0.159 ±0 .010
Wild type (Ubq)b 0.317 ±0.028 6.89 ± 0.482 0.290 ±0.020
SI 1A 0.352 ± 0.021 n.d. n.d.
SI IT 0.179 ±0.010 n.d. n.d.
S11Y n.d. n.d. n.d.
The mean values ± s.d. were calculated from at least 3 replicates, 
n.d. : non detectable.
a : Wild type recombinant GSTT2-2 expressed in the pQE system. 
b : Wild type recombinant GSTT2-2 expressed in the ubiquitin fusion system.
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Figure 7.4 : pH profiles of recombinant GSTT2-2 activity with MS and 
cumene hydroperoxide as substrates and the effect of pH on non- 
enzymatic reaction rates
Comparison of pH profiles between wild type GSTT2-2 expressed in the 
pQE system and Ubiquitin-GSTT2 fusion system (Chapter 5) with (A) 
cumene hydroperoxide or (B) menapthyl sulphate as substrate. Activity of 
the recombinant enzymes are expressed as a percentage of the highest 
activity obtained. (▲): pQE % activity; (□): Ubq % activity. (C): Non- 
enzymatic rates of GSH with either MS (A ) or cumene hydroperoxide (Q) as 
substrate.
Table 7.5 : Activity of MS with L-cysteine or ß-mercaptoethanol as
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alternative thiol substrate
Reaction mixture Enzymatic activity 
(jimol/min/mg protein)
MS + S-methylglutathione + ß-ME 
+ GSTT2-2
0.3446 ± 0.0249
MS + S-methylglutathione + L-Cys 
+ GSTT2-2
0.1670 ±0.0011
MS + S-methylglutathione + GSTT2-2 n.d.
MS + S-methylglutathione + ß-ME n.d.
MS + S-methylglutathione + L-Cys n.d.
MS + ß-ME + GSTT2-2 n.d.
MS + L-Cys + GSTT2-2 n.d.
MS + GSH n.d.
The reaction was determined at pH8.3, 37°C, in a 1.0ml cuvette. The final concentration 
of the respective components are as follows: 0.25mM MS, 0.1M Tris.HCl, lOmM 
S-methylglutathione and 20mM L-cysteine (or 30mM ß-mercaptoethanol). Reaction rate 
was monitored by absorbance at 298nm.
n.d. : not detectable
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Figure 7.5 : Production of sulphate from MS by GSTT2-2 in the 
presence of GSH (□), S-methylglutathione plus ß-mercaptoethanol 
(O) and S-methylglutathione ( o).
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7.6 DISCUSSION
7.6.1 Purification of Recombinant GSTT2-2 with Ni2+ Matrix
The mammalian Theta class GSTs are distinct from the Alpha, Mu and Pi classes 
because they do not utilise the model substrate CDNB and do not bind to glutathione or 
S-hexylglutathione affinity matrices. Therefore, the purification of the Theta class GSTs 
has been more laborious, taking at least 4 or 5 chromatographic steps to purify the 
enzymes to apparent homogeneity (Hiratsuka et al., 1990, Hussey and Hayes, 1992, and 
Chapter 5). As a multi-step purification scheme would largely preclude the purification 
of mutant enzymes with severely diminished activity an alternative expression system was 
adopted for this study. The QIAexpress system adds 6 histidine residues to the 
N-terminal of the recombinant protein which facilitates its purification on an immobilised 
Ni matrix. Comparison of the wild type His-tagged enzyme with the enzyme produced 
without an N-terminal extension (see Chapter 5) did not indicate any substantial 
differences in enzymatic function. Using the pQE system, wild type and mutant 
GSTT2-2 isoenzymes were purified to apparent homogeneity in two chromatographic 
steps.
7.6.2 The Role of S e r ll in Catalysis
Recently, the crystal structure of a Theta-like GST from Lucilia cuprina was 
solved and a serine residue at position 9 from the N-terminal domain was found to be 
within hydrogen bonding distance of the glutathionyl sulphur atom (Wilce et al., 1995). 
Site directed mutagenesis of this residue to alanine or threonine lead to a marked decrease 
in GSH conjugating activity with CDNB, confirming the importance of Ser9 in catalysis 
(Board et al., 1995). Based on the co-ordinates for the Lucilia cuprina GST structure and 
an alignment of all the Theta class amino acid sequences, a homology model of GSTT2-2 
had been constructed (Chelvanayagam et al., 1996). As shown in Figure 7.6, the 
hydroxyl of Seri 1 appears to be within hydrogen bonding distance of the enzyme-bound 
glutathionyl sulphur. Replacement of Seri 1 by site-directed mutagenesis to Ala, Thr or 
Tyr showed that this serine residue is essential for the GSH peroxidase activity of
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GSTT2-2, as all three mutant enzymes lost activity completely with cumene 
hydroperoxide as the second substrate. A similar loss of activity was also observed for 
all Seri 1 mutants when ethacrynic acid was used as the second substrate (Table 7.2). 
Therefore, it appears that S e rll plays an important role in the catalysis with cumene 
hydroperoxide and ethacrynic acid, presumably by activating the enzyme-bound GSH to 
form a reactive glutathione thiolate anion (GS"), in a similar mechanism to that of the 
N-terminal domain tyrosine found in the Alpha, Mu and Pi class GSTs.
An interesting contrary observation was noted when MS was used as the second 
substrate. The Seri l-*Ala mutant showed a marked increase in specific activity, as well 
as a higher affinity for GSH and MS. When the side chain hydroxyl group of residue 11 
was preserved by replacing S e rll with Thr or Tyr, a decrease in specific activity was 
observed that correlated with the size of the substituting residue. The Seri i->Tnr mutant 
retained 75% of the MS conjugating activity compared to the wild type, while replacement 
of Seri 1 with a bulky residue like tyrosine abolished the conjugating activity of GSH 
with MS completely. These data suggest that the hydroxyl side chain of Seri 1 is of little 
consequence in reaction with MS and that the size of the side chain on residue 11 is 
particularly significant. A favourable conformation of tyrosine substituted in position 11 
in the homology model suggests that this mutation would occupy part of the GSH 
binding site. This may well explain its inactivity with cumene hydroperoxide, ethacrynic 
acid and MS. The Kcat value for MS in the Ser-*Ala mutant was 3 fold higher 
(0.3712 s '1) than the wild type, whereas the Kcat value for the Ser—►Thr mutant is 
comparable to the wild type (~0.1362s-1). This suggests that the high K^/Km  MS value 
for the S 11A mutant is due to a faster product release as well as a higher affinity for MS 
as the second substrate. It is possible that the elimination of the side chain hydroxyl 
group at residue 11 facilitates the entry of substrates as well as the release of products.
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Figure 7.6: A schematic stereo illustration of the N-terminal domain of recombinant 
GSTT2 highlighting the potential interaction between the GSH thiol and side chain of 
Seri 1. The figure was generated by the program MOLSCRIPT (Kraulis, 1991) from the 
co-ordinates of a homology model of GSTT2 (Chelvanayagam et al., 1996) based on the 
structure of a L. cuprina GST (Wilce et al., 1996).
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7.6.3 Reaction Mechanism with MS
The conjugation reaction between GSH and MS may employ a different reaction 
mechanism and clearly involves different residue(s) in the active site. In most cases, 
substrates of GSTs are electrophiles that will react non-enzymatically with the glutathione 
thiolate anion (GS") at high pH. This is clearly not the case with MS, as even at high pH 
when GSH should be fully deprotonised, MS does not react non-enzymatically with 
GSH (Figure 7.4C). However, the conjugation rate between GSH and MS which 
increases as a function of pH in the presence of GSTT2-2 (Figure 7.4B), appears to be 
like a chemical reaction between a thiolate anion and a reactive electrophile. These 
observations suggest that the reaction between GSH and MS is not purely enzymatic. In 
this reaction, the enzyme may modify the MS to a form that is reactive with GS-, which is 
increasingly present at elevated pH approaching the pKa (~9) of glutathione in aqueous 
solution (Jung et al., 1972).
Gillham (1973) reported the purification of a rat liver GST which has GSH 
conjugating activity with MS. This rat GST is likely to be the rat GST Yrs-Yrs 
isoenzyme (Hiratsuka et al., 1990), an orthologue of human GSTT2-2, and the only rat 
liver GST known to utilise MS as a substrate. Gillham suggested the reaction between 
GSH and MS followed an Ordered Bi Bi mechanism in which GSH is first added to the 
enzyme before MS. The order of product release is SO4 2' followed by 
S-(f menaphthyl glutathione. If the reaction of GSTT2-2 also follows an Ordered Bi Bi 
mechanism, then GSH has to be bound with the enzyme before MS. It is proposed in 
this study, that GSH must be added first to the enzyme to induce a conformational 
change. This is followed by the entry of the second substrate, MS. The SO^* group of 
MS is then removed by the enzyme in a mechanism similar to the action of a sulphatase. 
Removal of S0 4 2- releases the newly formed 1-menapthyl carbonium ion which reacts 
with the thiolate anion of GSH to form S I- menaphthyl glutathione. The increase in the 
reaction rate between MS and GSH at elevated pH can therefore be explained by the 
reaction between the carbonium ion and the GS- species which predominates at high pH. 
The reaction between the carbonium ion and the GS- may take place in free solution since
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Seri 1 which stabilises the bound GSH as a thiolate anion appears not to take part in the 
reaction.
7.6.4 Relaxed Thiol Specificity of GSTT2-2
If the proposed GSH-induced conformational change is true, then a GSH 
analogue should be able to fulfil a similar role and the 1-menapthyl carbonium ion 
(electrophile) released following the removal of S0 4 2', should be capable of reacting with 
an alternative thiol substrate (nucleophile). To test this hypothesis, GSH was replaced 
with its analogue, S-methylglutathione, while L-cysteine or ß-mercaptoethanol were used 
as the alternative thiol substrates. As shown in Table 7.5, there was no detectable activity 
in the absence of either S-methylglutathione, L-cysteine, ß-mercaptoethanol or GSTT2-2. 
However, when S-methylglutathione was added in combination with either L-cysteine or 
ß-mercaptoethanol in the presence of MS and GSTT2-2, the formation of MS-thiol 
conjugates could be detected spectrophotometrically. Principato et al. (1988) reported the 
relaxed thiol substrate specificity of the rat GST4-4 which utilised ß-mercaptoethanol as 
an alternative thiol substrate for reaction with l-chloro-2,4-dinitrobenzene (CDNB) in the 
presence of S-methylglutathione. They proposed a glutathione-induced conformation 
change in the enzyme, rendering a relaxed thiol specificity for any sterically acceptable 
thiol substrate(s). However, it is not clear in their studies whether ß-mercaptoethanol and 
the carbonium ion of 2,4-dinitrobenzene were enzyme-bound during this reaction, or if 
the carbonium ion is released to react in free solution. It is unlikely that alternative thiol 
substrates could occupy the common glutathione binding site since glutathione needs to 
reside at this site to induce the proposed conformation change. Therefore, the relaxed
thiol specificity of GSTT2-2 could be explained as the reaction between the carbonium
a\cvd
ion/the alternative thiol substrates in free solution.
7.6.5 GSTT2-2 as a Glutathione Dependent Sulphatase
The removal of the sulphate (SO42-) moiety of MS precedes the formation of the 
1- menaphthyl carbonium ion. As shown in Figure 7.5, GSTT2-2 catalysed the release of 
SO42- from MS in the presence of GSH or S-methylglutathione. The reaction between
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GSH and MS can be regarded as a typical substitution reaction catalysed by GST, with 
the concomitant release of SO42- and the .S-(l-m enapthyl)glutathione conjugate. 
However, when S-methylglutathione was used as a glutathione analogue, GSTT2-2 also 
catalysed the removal of the sulphate moiety of MS. While the standard reaction between 
GSH and MS catalysed  by G STT2-2 resu lts in the p roduction  of 
S-l-menapthyl)glutathione conjugate, the reaction between S-methylglutathione and MS 
does not result in the formation of any glutathione conjugate. In this case, the 
unconjugated products released from the enzyme are the carbonium ion and SC>42*. 
Indeed SO42- release was assayed by direct measurement of SC>42* production and the 
carbonium ion release was measured by an indirect assay through the conjugation with 
alternative thiol substrates. SO42* production was not detected in the absence of GSH or 
S-methylglutathione, suggesting that the sulphatase activity of GSTT2-2 was a 
glutathione (or S-methylglutathione) dependent reaction. This observation was in 
agreement with the GSH- (or S-methylglutathione-) induced conformational change, 
conferring the sulphatase activity of GSTT2-2.
In order to further investigate the function of GSTT2-2 as a glutathione transferase 
and/or as a sulphatase, l-(chloromethyl)napthalene was used as an alternative substrate 
for MS. l-(chloromethyl)napthalene resembles MS in structure but only differs in the 
methyl side chain group, substituting Cl" for the SO42- group. As a GST, GSTT2-2 
should catalyse the removal of the chloride group on the methyl side chain and give rise to 
S-(l-menapthyl)glutathione, in a same fashion as the reaction between MS and GSH. 
However, there was no detectable activity with this substrate, suggesting the removal of 
the sulphate group on the methyl side chain of MS was a specific reaction. Similarly, 
Gillham (1971) demonstrated that a rat liver GST which utilised a range of aralkyl 
sulphate esters as substrates including benzyl sulphate and 1-menapthyl sulphate, did not 
utilise non-sulphate ester substrates such as benzyl orthophosphate, 1-menapthyl acetate 
or 1-menapthyl alcohol.
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In view of the results obtained in the present study, it is proposed that the route 
for inactivation of aralkyl sulphate esters by GSTT2-2 as well as the rat and mouse 
orthologues GST Yrs-Yrs (Hiratsuka et al., 1990; Hiratsuka et a l, 1995) involves 
binding of glutathione, desulphation, formation of a carbonium ion, conjugation with 
GSH or a thiol substrate and the subsequent breakdown of the conjugated product in the 
mercapturic acid pathway (Clapp and Young, 1970). Although it has been shown in vitro 
that there is a relaxed specificity for the nucleophilic substrate in the presence of 
glutathione, it is highly likely that GSH acts as the nucleophile in vivo as it is likely to be 
the most abundant nucleophile in the intracellular environment.
Studies of the Alpha and Mu class GSTs have shown that residues other than the 
conserved tyrosine can contribute significantly to catalysis (Bjomestedt et al., 1995, 
Johnson et al., 1993). In the case of GSTT2-2, residue(s) other than Serll must be 
responsible for its apparent sulphatase activity with MS. Although the homology model 
of GSTT2-2 predicts the position of GSH, the position or orientation of MS in the active 
site cannot be predicted with certainty. This was partly due to the lack of certainty in 
predicting the C-terminal secondary structure of GSTT2-2 in which the C-terminal 
domain of GSTT2-2 extends beyond that of the Theta-like GST of L. cuprina. This 
unfortunately precludes the reliable identification of residues that could contribute to the 
sulphatase activity.
7.6.6 Glutathione-Induced Conformational Change of GSTT2-2
The data suggest the reaction between MS and GSH is preceded by a 
conformation change or change in the electrostatic environment of the active site induced 
by the binding of GSH or S-methylglutathione. An example of a similar substrate 
induced modification is provided by the relatively flexible <x2 helix of the Pi class GSTs 
which appears to undergo a conformational change upon the binding of GSH in the 
G-site (Wilce and Parker, 1994, Lo Bello et al., 1993). Furthermore, the three 
dimensional structural analysis of human GSTA1-1 has suggested that the a9 helix which 
is otherwise disordered in the apo-form, forms a lid over the H-site upon binding of the
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hydrophobic substrate (Sinning et al., 1993). The GSH- (or S-methylglutathione-) 
dependent sulphatase activity of GSTT2-2 and the relaxed thiol specificity of GSTT2 in 
the presence of S-methylglutathione support the GSH-induced conformational change 
hypothesis and the role of GSTT2-2 as a glutathione dependent sulphatase.
7.7 CO NCLUSIO N
Amino acid sequence comparison of the Theta class isoenzymes has identified a 
conserved serine residue in the N-terminal domain (Wilce et al., 1995). This conserved 
serine has been implicated in the activation of the enzyme-bound glutathione (Board et al., 
1995). Mutating the equivalent serine (residue 11) of GSTT2-2 to Ala, Thr or Tyr 
abolished the catalytic properties of GSTT2-2 with cumene hydroperoxide and ethacrynic 
acid. However, with 1-menapthyl sulphate (MS) as the second substrate, the specific 
activity of the SI 1A mutant was elevated 1.5 times, the SI IT mutant retained 75% of the 
wild type specific activity and the S11Y mutant was inactive. The role of S e rll in 
catalysis seems to vary with different second substrates. In the substitution reaction with 
MS, GSTT2-2 activity appears to depend on the size of the Seri 1 replacement rather than 
the presence of a side chain hydroxyl. In addition, the reaction rate appears to be a 
function of pH, and there is no non-enzymatic reaction even at high pH.
As a reaction between MS and an alternative thiol such as L-cysteine or 
ß-mercaptoethanol can take place in the presence of S-methylglutathione and GSTT2-2, it 
is proposed that the catalytic activity of GSTT2-2 with MS is preceded by a 
conformational or charge modification to the enzyme upon the binding of glutathione or 
S-methylglutathione. This is followed by the binding of MS and the subsequent removal 
of the sulphate group, giving rise to the carbonium ion of 1-methylnapthalene as the 
electrophile to react with the nucleophilic species. The reaction mechanism of GSTT2-2 
with MS appears to represent a novel function of GSTT2-2 as a glutathione dependent 
sulphatase.
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CHAPTER 8 : CONCLUDING REMARKS AND FUTURE DIRECTIONS
Much of the knowledge on the mammalian Theta class GSTs comes from the 
work carried out in the laboratories of Ketterer (Meyer et al., 1991; Pemble and Taylor, 
1992; Thier et al., 1993; Pemble et al., 1994; Wiencke et al., 1995), Watabe (Hiratsuka 
et al., 1990; Ogura et al., 1991; Ogura et al., 1994; Hiratsuka et al., 1994; Hiratsuka 
et al., 1995) and Board (Tan et al., 1995; Tan and Board, 1996; Board et al., 1995; 
Board et al., 1994; Wilce et al., 1994; Wilce et al., 1995; Whittington et al., 1996). The 
research conducted in this thesis, has contributed to a greater understanding of the human 
Theta class isoenzyme GSTT2-2. It described the molecular cloning of the cDNA 
encoding the human liver GSTT2*-2* which was first purified by Hussey and Hayes 
(1992). This cDNA with an open reading frame of 732bp, encodes a polypeptide of 244 
amino acids, represents the longest mammalian GST protein characterised to date. The 
isolation of 3 partial cDNA clones of GSTT2-2 showed evidence of alternative splicing in 
GSTT2 mRNA transcripts. As alternative splicing had also been observed in GSTM4, 
the discovery of similar events in GSTT2 suggest that alternative splicing may play a role 
in the regulation of the GST supergene family. It is proposed from the results of this 
study that, alternative splicing may represent a post-transcriptional regulatory mechanism 
for GSTT2. Further investigations need to be carried out to confirm this possibility. 
Studies on gene regulation at the post-transcriptional level should also be extended to the 
other GST classes.
GSTT2 has been mapped to chromosome 22 by somatic cell hybrid analysis and 
sublocalised to q l l . 2  by in situ hybridisation. There was no evidence for reverse 
transcribed pseudogenes of GSTT2 dispersed through out the genome. Southern blot 
analysis of human genomic DNA revealed that the gene of GSTT2 is less that 4kb in 
length. In a current ongoing project in this laboratory, the GSTT2 gene has been isolated 
using the GSTT2 cDNA as a probe and the characterisation of the human GSTT2 gene is 
currently in progress.
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The heterologous expression of the GSTT2 cDNA has allowed a more extensive 
characterisation of its protein. The specific activities of recombinant GSTT2-2 with 
cumene hydroperoxide and 1-menapthyl sulphate (MS) are comparable to those of natural 
GSTT2-2 purified from human liver (Hussey and Hayes, 1992). The most active 
substrate tested with GSTT2-2 was cumene hydroperoxide. GSTT2-2 was also found to 
be active towards the alka-2,4-dienals and alk-2-enals. In view of the peroxidase activity 
of GSTT2-2 and its activity towards aldehydic compounds, which are secondary 
products of lipid peroxidation, the role of GSTT2-2 in protecting cells against the 
products of lipid peroxidation seems probable. Like the other members of subfamily 2 of 
the Theta class, GSTT2-2 exhibits activity towards MS. An area for future studies is to 
investigate the activity of GSTT2-2 with reactive sulphate esters arising from 
carcinogenic arylmethanols such as the 7-hydroxy methyl benz[a]anthracene, 
7-hydroxym ethyl- 12-methyl-BA (7-HM BA), 12-hydroxym ethyl-7-m ethyl-BA  
(12-HMBA), 7,12-dihydroxymethyl-BA (DHBA) and 5-hydroxymethylchrysene 
(5-HCR) and to establish a relationship between the role of GSTT2-2 and the 
carcinogenicity of the reactive sulphate esters. Lipid hydroperoxide substrates such as 
arachidonic acid 15-hydroperoxide, linoleic acid 13-hydroperoxide and linolenic acid 
13-hydroperoxide may represent a category of endogenous substrates of GSTT2-2 which 
can be evaluated in future studies.
The expression of GSTT2-2 is not restricted to a specific tissue but was found to 
be expressed in liver, placenta, kidney, pancreas, lung, spleen, heart and skeletal muscle. 
Liver and placenta were the tissues with the most abundant expression. On the contrary, 
there was no detectable expression in brain. The broad tissue expression of GSTT2-2 is 
consistent with its general protective role in scavenging hydroperoxides and aldehydic 
products arising from oxygen metabolism. Whether GSTT2-2 is subject to sex- 
dependent or developmental-dependent expression is unknown at this stage. The cell 
types in which GSTT2-2 is expressed, in a particular tissue, are also unclear. With the
availability of polyclonal antibodies raised against GSTT2-2, these studies shall be 
undertaken in future investigations.
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Site-directed mutagenesis of a serine (residue 11) at the N-terminal domain of 
GSTT2-2 revealed that, this residue which is conserved through out the Theta class 
GSTs, is not necessarily essential in every catalytic reaction. Mutating Seri 1 to Ala, Thr 
or Tyr produced a mutant enzyme with severely impaired activity towards cumene 
hydroperoxide and ethacrynic acid. However with MS as a substrate, the Seri 1-*Ala 
mutant showed marked increase of specific activity (1.5 times higher than the wild type), 
Seri l~*Thr mutant retained 75% of the wild type activity and the Ser—►Tyr mutant was 
inactived. The varying activities of the mutants which seemed to be dependent on the size 
of the substituting residues, led to further investigations of the mechanism of the reaction 
between GSH and MS catalysed by GSTT2-2. In a series of experiments, it was shown 
that the enzymatic conjugation rate between GSH and MS accelerated with increasing pH, 
while no non-enzymatic reaction between GSH and MS was observed even at high pH. 
Also, GSTT2-2 was shown to exhibit relaxed thiol specificity and the release of sulphate 
(SO42-) from MS was detected in the presence of GSH (or S-methylglutathione) and 
GSTT2-2. As discussed in detail in Chapter 7, this evidence pointed to the ability of 
GSTT2-2 to catalyse the release of the sulphate moiety of MS in a mechanism similar to 
that of a sulphatase. However, the sulphatase activity of GSTT2-2 is glutathione- 
dependent. Presumably, the role of GSH (or S-methylglutathione) in this reaction is to 
induce an enzyme conformational change. In summary, the functional study of GSTT2-2 
has led to the discovery of a novel function of GSTT2-2 as a glutathione-dependent 
sulphatase. In retrospect, GSTs have been found to exhibit many other catalytic 
functions besides their conventional GSH conjugating role. These functions which have 
been reviewed in Chapter 1 include, reduction, isom erisation, thiolysis and 
denitrosation. The findings in this current study suggest that there may be other novel 
roles within the supergene family of GSTs which have yet to be discovered and the 
glutathione dependent sulphatase activity of GSTT2-2 is just one of them.
The determination of the crystal structure of GSTT2-2 is a high priority for future 
study. The construction of a Hiss-tagged GSTT2-2 expression vector (pQEHTl), has 
shown that the recombinant protein can be produced and purified by two simple 
chromatographic steps in sufficient quantity for crystallographic study. S - ( l-  
menapthyl)glutathione and l-(chloromethyl)napthalene may be a useful substrate-product 
analogues for co-crystallisation studies to investigate the residues involved in substrate 
binding and the sulphatase reaction of GSTT2-2.
In conclusion, the studies carried out in this thesis have contributed to the overall 
understanding of the GST supergene family and in particular to the knowledge of the 
human Theta class GSTs, of which little was known at the commencement of this study. 
These studies have provided the knowledge and means by which many additional studies 
of GSTT2-2 can be undertaken in the future.
146
REFERENCES :
Abramovitz, M., Homma, H., Ishigaki, S., Tansey, F., Cammer, W. and Listowsky, I. 
(1988). Characterization and localization of glutathione 5-transferases in rat brain 
and binding of hormones, neurotransmitters and drugs. J.Neurochem. 50: 50-57
Ahmad, H., Wilson, D. E., Fritz, R. R., Singh, S. V., Medh, R. D., Nagle, G. T., 
Awasthi, Y. C. and Kurosky, A. (1990). Primary and secondary structural analyses 
of glutathione 5-transferase pi from human placenta. Arch. Biochem. Biophys. 
278: 398-408
Alin, P., Danielson, U. H. and Mannervik, B. (1985). 4-Hydroxyalk-2-enals are 
substrates for glutathione transferase. FEBS Lett. 179: 267-270
Anders, M. W. (1995). Mitochondrial bioactivation of cysteine 5-conjugates and
4- thiaalkanoates: implications for mitochondrial dysfunction and mitochondrial 
diseases. Biochim. Biophys. Acta. 1271: 51-57
Andreadis, A., Gallego, M. E. and Nadal Ginard, B. (1987). Generation of protein 
isoform diversity by alternative splicing: mechanistic and biological implications. 
Annu. Rev. Cell. Biol. 3: 207-242
Aniya, Y. and Anders, M. W. (1989). Regulation of rat liver microsomal glutathione
5- transferase activity by heating. J. Pathol. 12: 235-240
Anttila, S., Hirvonen, A., Vainio, H., Husgafvel-Pursiainen, K., Hayes, J. D. and 
Ketterer, B. (1993). Immunohistochemical localization of glutathione 5-transferase 
in human lung. Cancer Res. 53: 5643-5648
Armstrong, R. N. (1994). Glutathione 5-transferäses: structure and mechanism of an 
archetypical detoxication enzyme. Adv. Enzymol. Rela. Areas Mol. Biol. 69: 1-44
Aurias, A., Rimbaut, C., Buffe, D., Zucker, J. M. and Mazabraud, A. (1984). 
Translocation involving chromosome 22 in Ewing's sarcoma. A cytogenetic study 
of four fresh tumors. Cancer Genet. Cytogenet. 12: 21-25
Awasthi, Y. C., Dao, D. D. and Saneto, R. P. (1980). Interrelationship between anionic 
and cationic forms of glutathione 5-transferases of human liver. Biochem. J. 191: 
1-10
Awasthi, Y. C., Bhatnagar, A. and Singh, S. V. (1987). Evidence for the involvement of 
histidine at the active site of glutathione 5-transferase psi from human liver. 
Biochem. Biophys. Res. Commun. 143: 965-970
Awasthi, S., Srivastava, S. K., Ahmad, F., Ahmad, H. and Ansari, G. A. S. (1993).
Interactions of glutathione 5-transferase-7C with ethacrynic acid and its glutathione 
conjugate. Biochim. Biophys. Acta. 1164: 173-178
Baker, R. T., Smith, S. A., Marano, R., McKee, J. and Board, P. G. (1994). Protein 
expression using cotranslational fusion and cleavage of ubiquitin. Mutagenesis of 
the glutathione-binding site of human Pi class glutathione 5-transferase. J Biol. 
Chem. 269: 25381-25386
Bakke, J. and Gustafsson, J.-A. (1984). Mercapturic acid pathway metabolites of 
xenobiotics: generation of potentially toxic metabolites during enterohepatic 
circulation. Trends. Pharmacol. Sei. 5: 517-521
Bartling, D., Radzio, R., Steiner, U. and Weiler, E. W. (1993). A glutathione 
S-transferase with glutathione-peroxidase activity from Arabidopsis thaliana. Eur. J. 
Biochem. 216: 579-586
147
Barycki, J. J. and Colman, R. F. (1993). Affinity labeling of glutathione 5-transferase, 
isozyme 4-4, by 4-(fluorosulfonyl)benzoic acid reveals Tyrl 15 to be an important 
determinant of xenobiotic substrate specificity. Biochemistry 32: 13002-13011
Bass, N. M., Kirsh, R. E., Tuff, S. A, Marks, Land Saimders, S. J. (1977). Ligandin 
heterogeneity : evidence that the two non-identical subunits are the monomers of 
two distinct proteins. Biochim. Biophys, Acta. 492: 163-175.
Beckett, G. J. and Hayes, J. D. (1993). Glutathione 5-transferases: biomedical 
applications. Adv. Clin. Chem. 30: 281-380
Benson, A. M., Talalay, P., Keen, J. H. and Jakoby, W. B. (1977). Relationship 
between the soluble glutathione-dependent delta 5-3-ketosteroid isomerase and the 
glutathione 5-transferases of the liver. Proc. Natl. Acad. Sei. U SA  74: 158-162
Benson, A. M., Batzinger, R. P., Ou, S. Y., Bueding, E., Cha, Y. N. and Talalay, P. 
(1978). Elevation of hepatic glutathione 5-transferase activities and protection 
against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants. Cancer 
Res. 38: 4486-4495
Benton, W. D. and Davis, P. W. (1977). Screening kgt recombinant clones by 
hybridization to single plaques in situ. Science 196: 180-182
Berhane, K., Widersten, M., Engstrom, A., Kozarich, J. W. and Mannervik, B. (1994). 
Detoxication of base propenals and other a-ß-unsaturated aldehyde products of 
radical reactions and lipid peroxidation by human glutathione transferases. Proc. 
Natl. Acad. Sei. U SA  91: 1480-1484
Beutler, E., Mathai, C. K. and Smith, J. E. (1968). Biochemical variants of glucose-6- 
phosphate dehydrogenase giving rise to congenital non-spherocytic hemolytic 
disease. Blood 31: 131-150
Beutler, E. (1975). Red Blood Cell: A Manual of Biochemical Methods, (ed. 2nd), 
Grune and Stratton, New York.
Bijlsma, E. K., Geurts van Kessel, A. H., Westerveld, A. and Hulsebos, T. J. (1991). 
Physical mapping of the beta B crystallin genes on chromosome 22. Cy to genet. Cell 
Genet. 58: 2045
Bjomestedt, R., Widersten, M., Board, P. G. and Mannervik, B. (1992). Design of two 
chimaeric human-rat class alpha glutathione transferases for probing the contribution 
of C-terminal segments of protein structure to the catalytic properties. Biochem. J. 
282: 505-510
Bjomestedt, R., Stenberg, G., Widersten, M., Board, P. G., Sinning, I., Jones, T. A. 
and Mannervik, B. (1995). Functional significance of arginine 15 in the active site 
of human class alpha glutathione transferase Al-1. J. Mol. Biol. 247: 765-773
Black, S. M., Beggs, J. D., Hayes, J. D., Bartoszek, A., Muramatsu, M., Sakai, M., 
and Wolf, C. R. (1990). expression of human glutathione 5-transferase in 5. 
cerevisiae confers resistance to anticancer drugs. Biochem. J. 268: 309-315.
Blake, C. C. F. (1978). Do genes-in-pieces imply proteins-in-pieces? Nature 273: 267
Blocki, F. A., Ellis, L. B. and Wackett, L. P. (1993). MIF protein are theta-class 
glutathione 5-transferase homologs. Protein Sei. 2: 2095-102
Board, P. G. (1981a). Biochemical genetics of glutathione-5-transferase in man. Am. J. 
Hum. Genet. 33: 36-43
148
Board, P. G. (1981b). Transport of glutathione 5-transferase conjugate from human 
erythrocytes. FEBS Lett. 124: 163-165
Board, P. G. (1984). Genetic heterogeneity of the B subunit of coagulation factor XIII: 
resolution of type 2. Ann. Hum. Genet. 48: 223-228
Board, P. G. and Webb, G. C. (1987a). Isolation of a cDNA clone and localization of 
human glutathione 5-transferase 2 genes to chromosome band 6pl2. Proc. Natl. 
Acad. Sei. U SA  84: 2377-2381
Board, P. G. and Pierce, K. (1987b). Expression of human glutathione 5-transferase 2 
in Escherichia coli. Immunological comparison with the basic glutathione 
S-transferases isoenzymes from human liver. Biochem. J. 248: 937-941
Board, P. G., Webb, G. C. and Coggan, M. (1989). Isolation of a cDNA clone and 
localization of the human glutathione 5-transferase 3 genes to chromosome bands 
1 lq 13 and 12ql3-14. Ann. Hum. Genet. 53: 205-213
Board, P., Coggan, M., Johnston, P., Ross, V., Suzuki, T. and Webb, G. (1990). 
Genetic heterogeneity of the human glutathione transferases: a complex of gene 
families. Pharmac. Ther. 48: 357-369
Board, P. G., Johnston, P. N., Ross, V. L., Webb, G. C., Coggan, M. and Suzuki, T. 
(1990). Molecular genetics of the human glutathione 5-transferase. Princess- 
Takamatsu-Symp 21: 199-211
Board, P. G. and Mannervik, B. (1991). The contribution of the C-terminal sequence to 
the catalytic activity of GST2, a human alpha-class glutathione transferase. 
Biochem. J. 275: 171-174
Board, P. G., Coggan, M. and Woodcock, D. M. (1992). The human Pi class 
glutathione transferase sequence at 12ql3-ql4 is a reverse-transcribed pseudogene. 
Genomics 14: 470-473
Board, P., Smith, S., Green, J., Coggan, M. and Suzuki, T. (1993). Evidence against a 
relationship between fatty acid ethyl ester synthase and the Pi class glutathione 5- 
transferase in humans. J. Biol. Chem. 268: 15655-15658
Board, P., Russell, R. J., Marano, R. J. and Oakeshott, J. G. (1994). Purification, 
molecular cloning and heterologous expression of a glutathione 5-transferase from 
the Australian sheep blowfly (Lucilia cuprina). Biochem. J. 299: 425-430
Board, P. G., Coggan, M. and Parker, M. W. (1995). Evidence for an essential serine 
residue in the active site of the Theta class glutathione transferases. Biochem. J. 
311: 247-250
Bogaards, J. J. P., van Ommen, B. and van Bladeren, P. J. (1993). Interindividual 
differences in the in vitro conjugation of methylene chloride with glutathione by 
cytosolic glutathione 5-transferase in 22 human liver samples. Biochemical 
Pharmacology 45: 2166-2169
Booth, J., Boyland, E. and Sims, P. (1961). An enzyme from rat liver catalysing 
conjugations with glutathione. Biochem. J. 79: 516-524
Bora, P. S., Spilburg, C. A. and Lange, L. G. (1989). Metabolism of ethanol and 
carcinogens by glutathione transferases. Proc. Natl. Acad. Sei. U S A  86: 
4470-4473
149
Bora, P. S., Bora, N. S., Wu, X. L. and Lange, L. G. (1991). Molecular cloning, 
sequencing, and expression of human myocardial fatty acid ethyl ester synthase-III 
cDNA. J. Biol. Chem. 266: 16774-16777
Boyer, T. D., Vessey, D. A. and Kempner, E. (1986). Radiation inactivation of 
microsomal glutathione 5-transferase. J. Biol. Chem. 261: 16963-16968
Boyland, E. and Williams, K. (1965). An enzyme catalysing the conjugation of epoxides 
with glutathione. Biochem. J. 94: 190-197
Boyland, E. and Chasseaud, L. F. (1967). Enzyme-catalysed conjugations of glutathione 
with unsaturated compounds. Biochem. J. 104: 95-102
Boyland, E. and Chasseaud, L.F. (1969). The role of glutathione and glutathione 
5-transferase in mercapturic acid biosynthesis. Adv. Enzymol. 32: 173-219
Bradford, M. M. (1976). A rapid and sensitive method for quantitation of microgram 
quantities of protein utilizing the principles of protein dye binding. Anal. Biochem. 
72: 248-254
Bray, H. G., Franklin, T. J. and James, S. P. (1959). The formation of mercapturic 
acids. 3. N-Acetylation of 5-substituted cysteines in the rabbit, rat and guinea pig. 
Biochem. J. 73: 465-473
Brophy, P. M., Southan, C. and Barrett, J. (1989). Glutathione transferases in the 
tapeworm Moniezia expansa. Biochem. J. 262: 939-946
Buckle, V. J. and Craig, I. W. (1986). In situ hybridization. In: Human Genetic Disease 
- a practical approach, (Davies, K. E., ed), Washington: IRL Press, pp. 85-100
Bulle, F., Mattei, M. G., Siegrist, S., Pawlak, A., Passage, E., Chobert, M. N., 
Laperche, Y. and Guellaen, G. (1987). Assignment of the human gamma-glutamyl 
transferase gene to the long arm of chromosome 22. Hum. Genet. 76: 283-286
Burgess, J. R., Chow, N. W. I., Reddy, C. C. and Tu, C. P. D. (1989). Amino acid 
substitutions in the human glutathione 5-transferases confer different specificities in 
the prostaglandin endoperoxide conversion pathway. Biochem. Biophys. Res. 
Com. 158: 497-502
Caceres, J. F., Stamm, S., Helfman, D. M. and Krainer, A. R. (1994). Regulation of 
alternative splicing in vivo by overexpression of antagonistic splicing factors. 
Science 265: 1706-1709
Cagen, L. M., Pisano, J. J., Ketley, J. N., Habig, W. H. and Jakoby, W. B. (1975). 
The conjugation of prostaglandin At and glutathione catalyzed by homogeneous 
glutathione 5-transferases from human and rat liver. Biochim. Biophys. Acta. 398: 
205-208
Campbell, E., Takahashi, Y., Abramovitz, M., Peretz, M. and Listowsky, I. (1990). A 
distinct human testis and brain mu-class glutathione 5-transferase. Molecular 
cloning and characterization of a form present even in individuals lacking hepatic 
type mu isoenzymes. J. Biol. Chem. 265: 9188-9193
Carmichael, J., Forrester, L. M., Lewis, A. D., Hayes, J. D., Hayes, P. C. and Wolf, 
C. R. (1988). Glutathione 5-transferase isoenzymes and glutathione peroxidase 
activity in normal and tumour samples from human lung. Carcinogenesis 9: 
1617-1621
Casey, J., Shalloe, F. and Sheehan, D. (1991). Subunit structure of fungal glutathione- 
5-transferases. Biochem. Soc. Trans. 19: 17S
Chaudhari, A., Anderson, M. W. and Eling, T. E. (1978). Conjugathion of 15-keto- 
prostaglandins by glutathione 5-transferases. Biochim. Biophys. Acta. 531: 56-64
150
Chelly, J., Concordet, J. P., Kaplan, J. C. and Kahn, A. (1989). Illegitimate 
transcription: transcription of any gene in any cell type. Proc. Natl. Acad. Sei. USA 
86: 2617-2621
Chelvanayagam, G., Wilce, M. C. J., Parker, M. W., Tan, K. L. and Board, P. G. 
(1996). Homology model for the human GSTT2 Theta class glutathione transferase: 
Submitted
Chen, W. J., Graminski, G. F. and Armstrong, R. N. (1988). Dissection of the catalytic 
mechanism of isozyme 4-4 of glutathione 5-transferase with alternative substrates. 
Biochemistry 27: 647-654
Chenevix-Trench, G., Young, J., Coggan, M. and Board, P. (1995). Glutathione 
5-transferase Ml and T1 polymorphisms: susceptibility to colon cancer and age of 
onset. Carcinogenesis 16: 1655-1657
Chiou, S. H., Yu, C. W., Lin, C. W., Pan, F. M., Lu, S. F., Lee, H. J. and Chang, G. 
G. (1995). Octopus 5-crystallins with endogenous glutathione 5-transferase (GST) 
activity: sequence comparison and evolutionary relationships with authentic GST 
enzymes. Biochem. J. 309: 793-800
Chomczynski, P. and Sacchi, N. (1987). Single-step method of RNA isolation by acid 
guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 
156-159
Christ-Hazelhof, E., Nugteren, D. H. and Van Dorp, D. A. (1976). Conversions of 
prostaglandin endoperoxides by glutathione 5-transferases and serum ablumins. 
Biochim. Biophys. Acta. 450-461:
Clapp, J. J. and Young, L. (1970). Formation of mercapturic acids in rats after the 
administration of aralkyl ester. Biochem. J. 118: 765-771
Clapper, M. L., Everley, L. C., Strobel, L. A., Townsend, A. J. and Engstrom, P. F. 
(1994). Coordinate induction of glutathione 5-transferase alpha, mu, and pi 
expression in murine liver after a single administration of oltipraz. Mol. Pharmacol. 
45: 469-474
Coles, B. and Ketterer, B. (1990). The role of glutathione and glutathione transferases in 
chemical carcinogenesis. CRC Crit. Rev. Biochem. Mol. Biol. 25: 47-70
Combes, B. and Stakelum, G. S. (1961). A liver enzyme that conjugates 
sulfobromophthalein sodium with glutathione. J. Clin. Invest. 40: 981-988
Comstock, K. E., Johnson, K. J., Rifenbery, D. and Henner, W. D. (1993). Isolation 
and analysis of the gene and cDNA for a human Mu class glutathione 5-transferase, 
GSTM4. J. Biol. Chem. 268: 16958-16965
Cooke, R. J., Bjomestedt, R., Douglas, K. T., McKie, J. H., King, M. D., Coles, B., 
Ketterer, B. and Mannervik, B. (1994). Photoaffinity labelling of the active site of 
the rat glutathione transferase 3-3 and 1-1 and human glutathione transferase A1-1. 
Biochem. J. 302: 383-390
Cooper, D. Y., Levine, S., Narashimhulu, S., Rosenthal, O. and Estabrook, R. W. 
(1965). Photochemical action spectrum of the terminal oxidase of mixed function 
oxidase systems. Science 147: 400-402
151
Coschigano, P. W. and Magasanik, B. (1991). The URE2 gene product of 
Saccharomyces cerevisiae plays an important role in the cellular response to the 
nitrogen source and has homology to glutathione 5-transferases. Mol. Cell. Biol. 
11: 822-832
Croce, C. M., Thierfelder, W., Erikson, J., Nishikura, K., Finan, J., Lenoir, G. M. and 
Nowell, P. C. (1983). Transcriptional activation of an unrearranged and 
untranslocated c-myc oncogene by translocation of a C lambda locus in Burkitt 
lymphoma cells. Proc. Natl. Acad. Sei. U SA  80: 6922-6926
Cuthbertson, R. A., Tomarev, S. I. and Piatigorsky, J. (1992). Taxon-specific 
recruitment of enzymes as major soluble proteins in the comeal epithelium of three 
mammals, chicken, and squid. Proc. Natl. Acad. Sei. U SA  89: 4004-4408
DeJong, J. L., Chang, C. M., Whang-Peng, J., Knutsen, T. and Tu, C. P. (1988a). The 
human liver glutathione 5-transferase gene superfamily: expression and 
chromosome mapping of an Hb subunit cDNA. Nucleic Acid Res. 16: 8541-8554
DeJong, J. L., Morgenstern, R., Jornvall, H., DePierre, J. W. and Tu, C. P. (1988b). 
Gene expression of rat and human microsomal glutathione 5-transferases. J. Biol. 
Chem. 263: 8430-8436
DeJong, J. L., Mohandas, T. and Tu, C. P. (1990). The gene for the microsomal 
glutathione 5-transferase is on human chromosome 12. Genomics 6: 379-382
DeJong, J. L., Mohandas, T. and Tu, C. P. (1991). The human Hb (mu) class 
glutathione 5-transferases are encoded by a dispersed gene family. Biochem. 
Biophys. Res. Commun. 180: 15-22
Dekant, W. and Vamvakas, S. (1993). Glutathione-dependent bioactivation of 
xenobiotics. Xenobiotica 23: 873-887
Del Boccio, G., Di Ilio, C., Alin, P., Jornvall, H. and Mannervik, B. (1987). 
Identification of a novel glutathione transferase in human skin homologous with 
class alpha glutathione transferase 2-2 in the rat. Biochem. J. 244: 21-25
Ding, S., Lake, B. G., Friedberg, T. and Wolf, C. R. (1995). Expression and alternative 
splicing of the cytochrome P-450 CYP2A7. Biochem. J. 306: 161-166
Dirr, H., Reinemer, P. and Huber, R. (1994). X-ray crystal structures of cytosolic 
glutathione 5-transferases. Implications for protein architecutre, substrate 
recognition and catalytic function. Eur. J. Biochem. 220: 645-661
Dodgson, K. S. (1960). Determination of inorganic sulphate in studies on the enzymatic 
and non-enzymatic hydrolysis of carbohydrate and other sulphate esters. Biochem. 
J. 78: 312-319
Dombroski, B. A., Mathias, S. L., Nanthakumar, E., Scott, A. F. and Kazazian, H. J. 
(1991). Isolation of an active human transposable element. Science 254: 1805-1808
Duncan, H., Swan, C., Green, J., Jones, P., Brannigan, K., Alldersea, J., Fryer, A. A. 
and Strange, R. C. (1995). Susceptibility to ulcerative colitis and Crohn's disease: 
interactins between glutathione 5-transferse GSTM1 and GSTT1 genotypes. 
Clinica. Chimica. Acta. 240: 53-61
Egaas, E., Falls, J. G., Svendsen, N. O., Ramstad, H., Skaare, J. U. and Dauterman, 
W. C. (1995). Strain- and sex-specific differences in the glutathione 5-transferase 
class pi in the mouse examined by gradient elution of the glutathione-affinity matrix 
and reverse-phase high performance liquid chromatography. Biochim. Biophys. 
Acta. 1243: 256-264
152
Elexpuru-Camiruaga, J., Buxton, N., Kandula, V., Dias, P. S., Campbell, D., 
McIntosh, J., Broome, J., Jones, P., Inskip, A., Alldersea, J., Fryer, A. A. and 
Strange, R. (1995). Susceptibility to Astrocytoma and Meningioma: Influence of 
allelism at glutathione 5-transferase (GSTT1 and GSTM1) and Cytochrome P-450 
(CYP2D6) loci. Cancer Res. 55: 4237-4239
Elfarra, A. A. and Anders, M. W. (1984). Renal processing of glutathione conjugates: 
role in nephrotoxicity. Biochem. Pharmacol 33: 3729-3732
Epp, O., Ladenstein, R. and Wendel, A. (1983). The refined structure of the 
selenoenzyme glutathione peroxidase at 0.2-nm resolution. Eur. J. Biochem. 133: 
51-69
Esterbauer, H., Cheeseman, K. H., Dianzani, M. U., Poli, G. and Slater, T. F. (1982). 
Separation and characterization of the aldehydic products of lipid peroxidation 
stimulated by ADP-Fe2+ in rat liver microsomes. Biochem. J. 208: 129-140
Erikson, J., Martinis, J. and Croce, C. M. (1981). Assignment of the genes for human 
lambda immunoglobulin chains to chromosome 22. Nature 294: 173-175
Figlewicz, D. A., Delattre, O., Guellaen, G., Krizus, A., Thomas, G., Zucman, J. and 
Rouleau, G. A. (1993). Mapping of human gamma-glutamyl transpeptidase genes 
on chromosome 22 and other human autosomes. Genomics 17: 299-305
Gilbert, W. (1978). Why genes in pieces? Nature 271: 501
Gillham, B., Clapp, J. J., Morrison, A. R. and Young, L. (1970). The interaction of 
sulphate esters and glutathione in vivo. Biochem. J. 118: 24P-25P
Gillham, B. (1971). The reaction of aralkyl sulphate esters with glutathione catalysed by 
rat liver preparations. Biochem. J. 121: 667-672
Gillham, B. (1973). The mechanism of the reaction between glutathione and 
1-menaphthyl sulphate catalysed by a glutathione 5-transferase from rat liver. 
Biochem. J. 135: 797-804
Graminski, G. F., Kubo, Y. and Armstrong, R. N. (1989a). Spectroscopic and kinetic 
evidence for the thiolate anion of glutathione at the active site of glutathione 
S-transferase. Biochemistry 28: 3562-3568
Graminski, G. F., Zhang, P. H., Sesay, M. A., Ammon, H. L. and Armstrong, R. N. 
(1989b). Formation of the l-(5-glutathionyl)-2,4,6-trinitrocyclohexadienate anion at 
the active site of glutathione 5-transferase: evidence for enzymic stabilization of 
sigma-complex intermediates in nucleophilic aromatic substitution reactions. 
Biochemistry 28: 6252-6258
Green, J. A., Robertson, L. J. and Clark, A. H. (1993). Glutathione 5-transferase 
expression in benign and malignant ovarian tumours. Br. J. Cancer 68: 235-239
Griffith, O. W. and Meister, A. (1980). Excretion of cysteine and gamma- 
glutamylcysteine moieties in human and experimental animal gamma-glutamyl 
transpeptidase deficiency. Proc. Natl. Acad. Sei. U S A 77: 3384-3387
Grover, P. L. and Sims, P. (1964). Conjugations with glutathione. Distribution of 
glutathione 5-aryltransferase in vertebrates species. Biochem. J. 90: 603-606
Grunebaum, L., Cazenave, J. P., Camerino, G., Kloepfer, C., Mandel, J. L., 
Tolstoshev, P., Jaye, M., De La Salle, H. and Lecocq, J. P. (1984). Carrier
153
detection of hemophilia B by using a retriction site polymorphism associated with 
the coagulation factor IX gene. J. .Clin. Invest. 73: 1491-1495
Guthenberg, C., Akerfeldt, K. and Mannervik, B. (1979). Purification of glutathione 
S-transferase from human placenta. Acta. Chem. Scand. Ser B33: 595-597
Guthenberg, C. and Mannervik, B. (1981). Glutathione 5-transferase (transferase n) 
from human placenta is identical or closely related to glutathione 5-transferase 
(transerase rho) from erythrocytes. Biochim. Biophys. Acta. 661: 255-260
Habig, W. H., Pabst, M. J., Fleischner, G., Gatmaitan, Z., Arias, I. M. and Jakoby, 
W. B. (1974a). The identity of glutathione 5-transferase B with ligandin, a major 
binding protein of liver. Proc. Nat. Acad. Sei USA 71: 3879-3882
Habig, W. H., Pabst, M. J. and Jaboky, W. B. (1974b). Glutathione 5-transferases : 
The first enzymatic step in mecapturic acid formation. J. Biol. Chem. 249: 7130- 
7139
Hales, B. F. and Neims, A. H. (1976). Developmental aspects of glutathione 
5-transferase B (ligandin) in rat liver. Biochem. J. 160: 231-236
Hales, B. F. and Neims, A. H. (1977). Induction of rat hepatic glutathione 5-transferase 
B by phenobarbitaland 3-methylcholanthrene. Biochem. Pharmacol. 26: 555-556.
Halber, £., Schroder, K. R., Asmuth, K., Dommemuth, A., Aust, B. and Goergens, H. 
W. (1994). Metabolism of dichloromethane (methylene chloride) to formaldehyde in 
human erythrocytes: influence of polymorphism of glutathione transferase Theta 
(GST Tl-1). Arch. Toxicol. 68: 423-427
Halber, E., Langhof, T., Dannappel, D., Leutbecher, M., Schroder, K., Goergens, H. 
W., Muller, A. and Bolt, H. M. (1993). Polymorphism of glutathione conjugation 
of methyl bromide, ethylene oxide and dichloromethane in human blood: influence 
on the induction of sister chromatid exchanges (SCE) in lymphocytes. Arch. 
Toxicol. 67: 173-178
Hammarstrom, S. (1983). Leukotrienes. Annu. Rev. Biochem. 52: 355-377
Harris, J., Coles, B., Meyer, D. J. and Ketterer, B. (1991a). The isolation and 
characterization of the major glutathione 5-transferase from the squid Loligo 
vulgaris. Comp. Biochem. Physiol. B. 98: 511-515
Harris, J. M., Meyer, D. J., Coles, B. and Ketterer, B. (1991b). A novel glutathione 
transferase (13-13) isolated from the matrix of rat liver mitochondria having 
structural similarity to class theta enzymes. Biochem. J. 278: 137-141
Harvey, J. W. and Beutler, E. (1982). Binding of heme by glutathione 5-transferase: a 
possible role of the erythrocyte enzyme. Blood 60: 1227-1230
Hayes, J. D., Strange, R. C. and Percy-Robb, I. W. (1979). Identification of two 
lithocholic acid binding proteins: separation of ligandin from glutathione 
S-transferase. Biochem. J. 181: 699-708
Hayes, J. D., Kerr, L. A. and Cronshaw, A. D. (1989). Evidence that glutathione 
S-transferases B1B1 and B2B2 are the products of separate genes and that their 
expression in human liver is subject to inter-individual variation. Molecular 
relationships between the B1 and B2 subunits and other Alpha class glutathione 
S-transferases. Biochem. J. 264: 437-445
Hayes, J. D., Judah, D. J., McLellan, L. I., Kerr, L. A., Peacock, S. D. and Neal, G. 
E. (1991). Ethoxyquin-induced resistance to aflatoxin Bi in the rat is associated
154
with the expression of a novel Alpha-class glutathione 5-transferase subunit, Yc2, 
which possesses high catallytic activity for aflatoxin Bi-8,9-epoxide. Biochem. J. 
279: 385-398
Hayes, J. D., Judah, D. J., Neal, G. E. and Nguyen, T. (1992). Molecular cloning and 
heterologous expression of a cDNA encoding a mouse glutathione 5-transferase Yc 
subunit possessing high catalytic activity for aflatoxin Bi-8,9-epoxide. Biochem. J. 
285: 173-180
Hayes, J. D. and Pulford, D. J. (1995). The glutathione 5-transferase supergene family : 
regulation of GST and the contribution of the isoenzymes to cancer chemoprotection 
and drug resistance. CRC Rev. Biochem. Mol. Biol. 30: 445-600
Heisterkamp, N. and Groffen, J. (1988). Duplication of the bcr and gamma-glutamyl 
transpeptidase gene. Nucleic Acid Res. 16: 8045-8056
Hengen, P. N. (1995). Purification of His-Tag fusion proteins from Escherichia coli. 
Trends in Biological Science 20: 285-286
Henkle, K. J., Davern, K. M., Wright, M. D., Ramos, A. J. and Mitchell, G. F. 
(1990). Comparison of the cloned genes of the 26- and 28-kilodalton glutathione 
S-transferases of Schistosoma japonicum and Schistosoma mansoni. Mol. 
Biochem. Parasitol. 40: 23-34
Heppel, L. A. and Hiimore, R. J. (1950). Metabolism of inorganic nitrite and nitrate 
esters. II. The enzymatic reduction of nitroglycerin and erythritol tetranitrate by 
glutathione. J. Biol. Chem. 183: 129-138
Hiratsuka, A., Sebata, N., Kawashima, K., Okuda, H., Ogura, K., Watabe, T., Satoh, 
K., Hatayama, I., Tsuchida, S., Ishikawa, T. and Sato, K. (1990). A new class of 
rat glutathione 5-transferase Yrs-Yrs inactivating reactive sulfate esters as 
metabolites of carcinogenic arylmethanols. J. Biol. Chem. 265: 11973-11981
Hiratsuka, A., Okada, T., Nishiyama, T., Fujikawa, M., Ogura, K., Okuda, H., 
Watabe, T. and Watabe, T. (1994). Novel theta class glutathione 5-transferases 
Yrs-Yrs' and Yrs'-Yrs' in rat liver cytosol: their potent activity toward 
5-sulfoxymethylchrysene, a reactive metabolite of the carcinogen 
5-hydroxymethylchrysene. Biochem. Biophys. Res. Commun. 202: 278-284
Hiratsuka, A., Kanazawa, M., Nishiyama, T., Okuda, H., Ogura, K. and Watabe, T. 
(1995). A subfamily 2 homo-dimeric glutathione 5-transferase mYrs-mYrs of class 
theta in mouse liver cytosol. Biochem. Biophys. Res. Commun. 212: 743-750
Hoesch, R. M. and Boyer, T. D. (1989). Localization of a portion of the active site of 
two rat liver glutathione 5-transferases using a photoaffinity label. J. Biol. Chem. 
264: 17712-17717
Holmgren, A., Soderberg, B. O., Eklund, H. and Branden, C. I. (1975). Three- 
dimensional structure of Escherichia coli thioredoxin-S2 to 2.8 A resolution. Proc. 
Natl. Acad. Sei. U SA  72: 2305-2309
Hulsebos, T. J., Bijlsma, E. K., Geurts van Kessel, A. H., Brakenhoff, R. H. and 
Westerveld, A. (1991). Direct assignment of the human beta B2 and beta B3 
crystallin genes to 22qll.2— ql2: markers for neurofibromatosis 2. Cytogenet. 
Cell. Genet. 56: 171-175
Huskey, S. E. W., Huskey, W. P. and Lu, A. Y. H. (1991). Contributions of thiolate 
'desolvation' to catalysis by glutathione 5-transferase isoenzymes 1-1 and 2-2: 
evidence from kinetic solvent isotope effects. J. Am. Chem. Soc. 113: 2283-2290
155
Hussey, A. J., Kerr, L. A., Cronshaw, A. D., Harrison, D. J. and Hayes, J. D. (1991). 
Variation in the expression of Mu-class glutathione 5-transferase isoenzymes from 
human skeletal muscle. Evidence for the existence of heterodimers. Biochem. J. 
273: 323-332
Hussey, A. J. and Hayes, J. D. (1992). Characterization of a human class-Theta 
glutathione 5-transferase with activity towards 1-menaphthyl sulphate. Biochem. J. 
286: 929-935
Hussey, A. J. and Hayes, J. D. (1993). Human Mu-class glutathione 5-transferases 
present in liver, skeletal muscle and testicular tissue. Biochim. Biophys. Acta. 
1203: 131-141
Iida, Y. and Sasaki, F. (1983). Recognition patterns for exon-intron junctions in higher 
organisms as revealed by a computer search. J. Biochem. Tokyo 94: 1731-1738
Ishikawa, T. (1992). The ATP-dependent glutathione 5-conjugate export pump. Trends. 
Biochem. Sei. 17: 463-468
Islam, M. Q., Platz, A., Szpirer, J., Szpirer, C., Levan, G. and Mannervik, B. (1989). 
Chromosomal localization of human glutathione transferase genes of classes alpha, 
mu and pi. Hum. Genet. 82: 338-42
Jakoby, W. B. (1978). The glutathione 5-transferases: A group of multifunctional 
detoxification proteins. Adv. Enzymol. 46: 383-414
Jensen, D. E. and Stelman, G. J. (1987). Evidence for cytosolic glutathione transferase- 
mediated denitrosation of nitrosocimetidine and l-methyl-2-nitro-l- 
nitrosoguanidine. Carcinogenesis 8: 1791-1800
Jensson, H., Guthenberg, C., Alin, P. and Mannervik, B. (1986). Rat glutathione . 
transferase 8-8, an enzyme efficiently detoxifying 4-hydroxyalk-2-enals. FEBS 
Lett. 203: 207-209
Ji, X., Zhang, P., Armstrong, R. N. and Gilliland, G. L. (1992). The three-dimensional 
structure of a glutathione 5-transferase from the mu gene class. Structural analysis 
of the binary complex of isoenzyme 3-3 and glutathione at 2.2-A resolution. 
Biochemistry 31: 10169-10184
Ji, X., von, R. E., Johnson, W. W., Tomarev, S. I., Piatigorsky, J., Armstrong, R. N. 
and Gilliland, G. L. (1995). Three-dimensional structure, catalytic properties, and 
evolution of a sigma class glutathione transferase from squid, a progenitor of the 
lens 5-crystallins of cephalopods. Biochemistry 34: 5317-5328
Johnson, M. K. (1966). Studies on glutathione 5-alkyltransferase of the rat. Biochem. J.
98:
Johnson, W. W., Liu, S., Ji, X., Gilliland, G. L. and Armstrong, R. N. (1993). 
Tyrosine 115 participates both in chemical and physical steps of the catalytic 
mechanism of a glutathione 5-transferase. J. Biol. Chem. 268: 11508-11511
Jung, G., Breitmaier, E. and Voelter, W. (1972). Dissociation equilibrium of 
glutathione. A Fourier transform-13C-NMR spectroscopic study of pH-dependence 
and of charge densities. Eur. J. Biochem. 24: 438-445
Kamisaka, K., Habig, W. H., Ketley, J. N. and Jakoby, W. B. (1975). Multiple forms 
of human glutathione 5-transferase and their affinity for bilirubin. Eur. J. Biochem. 
60: 153-161
156
Kano, T., Sakai, M. and Muramatsu, M. (1987). Structure and expression of a human 
class pi glutathione 5-transferase messenger RNA. Cancer Res. 47: 5626-5630
Kantor, R. R., Giardina, S. L., Bartolazzi, A., Townsend, A. J., Myers, C. E., Cowan, 
K. H., Longo, D. L. and Natali, P. G. (1991). Monoclonal antibodies to 
glutathione 5-transferase pi-immunohistochemical analysis of human tissues and 
cancers. Int. J. Cancer. 47: 193-201
Karshikoff, A., Reinemer, P., Huber, R. and Ladenstein, R. (1993). Electrostatic 
evidence for the activation of the glutathione thiol by Tyr7 in pi-class glutathione 
transferases. Eur. J. Biochem. 215: 663-670
Keen, J. H. and Jakoby, W. B. (1987). Glutathione transferase: catalysis of nucleophilic 
reactions of glutathione. J. Biol. Chem. 253:
Ketley, J. N., Habig, W. H. and Jakoby, W. B. (1975). Binding of nonsubstrate ligands 
to the glutathione 5-transferases. J. Biol. Chem 250: 8670-8673
Ketterer, B., Ross-Mansell, P. and Whitehead, J. K. (1967). The isolation of 
carcinogen-binding protein from livers of rats given 4-dimethylaminoazobenzene. 
Biochem. J. 103: 316-324
Ketterer, B. and Christodoulides, L. (1968). Identification of the amino acid residues that 
bind azo-dye in the soluble azo-dye carcinogen-binding proteins of the rat liver. 
Biochem. J. 109: 37P
Ketterer, B. (1971). Amino-azo-dye-binding protein in the soluble cytoplasm of the rat 
liver. Biochem. J. 122: 53P-54P
Ketterer, B. and Meyer, D. J. (1989). Glutathione transferases: a possible role in the 
detoxication and repair of DNA and lipid hydroperoxides. Mutat. Res. 214: 33-40
Ketterer, B., Meyer, D. J. and Tan, K. H. (1988). The role of glutathione transferase in 
the detoxication and repair of lipid and DNA hydroperoxides. Basic Life Sei. 49: 
669-674
Kimura, S., Umeno, M., Skoda, R. C., Meyer, U. A. and Gonzalez, F. J. (1989). The 
human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of 
the polymorphic CYP2D6 gene, a related gene, and a pseudogene. Am. J. Hum. 
Genet. 45: 889-904
Klone, A., Hussnatter, R. and Sies, H. (1992). Cloning, sequencing and characterization 
of the human alpha glutathione 5-transferase gene corresponding to the cDNA clone 
pGTH2. Biochem. J. 285: 925-928
Kolm, R. H., Sroga, G. E. and Mannervik, B. (1992). Participation of the phenolic 
hydroxyl group of Tyr-8 in the catalytic mechanism of human glutathione 
transferase Pl-1. Biochem. J. 285: 537-540
Kong, K. H., Takasu, K., Inoue, H. and Takahashi, K. (1992). Tyrosine-7 in human 
class Pi glutathione 5-transferase is important for lowering the pKa of the thiol 
group of glutathione in the enzyme-glutathione complex. Biochem. Biophys. Res. 
Commun. 184: 194-197
Kong, K. H., Inoue, H. and Takahashi, K. (1993). Site-directed mutagenesis study on 
the roles of evolutionally conserved aspartic acid residues in human glutathione 5- 
transferase Pl-1. Protein Eng. 6: 93-99
Kraulis, J. P. (1991). MOLSCRIPT : a program to produce both detailed and schematic 
plots of protein structures. J. App. Crystal. 24: 946-950.
157
Kuzmich, S., Vanderveer, L. A., Walsh, E. S., LaCreta, F. P. and Tew, K. D. (1992). 
Increased levels of glutathione 5-transferase pi transcript as a mechanism of 
resistance to ethacrynic acid. Biochem. J. 281: 219-224
Laisney, V., Van Chong, N., Gross, M. S. and Frezal, J. (1984). Human genes for 
glutathione 5-transferases. Hum. Genet. 68: 221-227
Lam, B. K., Penrose, J. F., Freeman, G. J. and Austen, K. F. (1994). Expression 
cloning of a cDNA for human leukotriene C4 synthase, an integral membrane 
protein conjugating reduced glutathione to leukotriene A4. Proc. Natl. Acad. Sei. U 
S A 91: 7663-7667
Laemmli, U. K. (1970). Cleavage of structural protein during the asembly of the head of 
bacteriophage T4. Nature (London) 227: 680-685
Lawrence, R. A. and Burk, R. F. (1976). Glutathione peroxidase activity in selenuim- 
deficient rat liver. Biochem. Biophys. Res. Commun. 76: 952-958
Leaver, M. J., Scott, K. and George, S. G. (1993). Cloning and characterization of the 
major hepatic glutathione 5-transferase from a marine teleost flatfish (Pleuronectes 
platessä), with structural similarities to plant, insect and mammalian Theta class 
isoenzymes. Biochem. J. 292: 189-195
Liebau, E., Schonberger, O. L., Walter, R. D. and Henkle, D. K. (1994a). Molecular 
cloning and expression of a cDNA encoding glutathione 5-transferasc from Ascaris 
suum. Mol. Biochem. Parasitol. 63: 167-170
Liebau, E., Walter, R. D. and Henkle, D. K. (1994b). Isolation, sequence and 
expression of an Onchocerca volvulus glutathione 5-transferase cDNA. Mol. 
Biochem. Parasitol. 63: 305-309
Litwack, G., Ketterer, B. and Arias, I. M. (1971). Ligandin: a hepatic protein which 
binds steroids, bilirubin, carcinogens and a number of exogenous organic anions. 
Science 234: 466-467
Liu, S., Zhang, P., Ji, X., Johnson, W. W., Gilliland, G. L. and Armstrong, R. N. 
(1992). Contribution of tyrosine 6 to the catalytic mechanism of isoenzyme 3-3 of 
glutathione 5-transferase. J. Biol. Chem. 267: 4296-4299
Lo Bello, M., Pastore, A., Petruzzelli, R., Parker, M. W., Wilce, M. C. J., Federici, G. 
and Ricci, G. (1993). Conformational states of human placental glutathione 
transferase as probed by limited proteolysis. Biochem. Biophys. Res. Commun. 
194: 804-810
Lundqvist, G., Yucel, L. T. and Morgenstern, R. (1992). The oligomeric structure of rat 
liver microsomal glutathione transferase studied by chemical cross-linking. 
Biochim. Biophys. Acta. 1159: 103-108
Mannervik, B. and Jensson, H. (1982). Binary combinations of four protein subunits 
with different catalytic specificities explain the relationship between six basic 
glutathione 5-transferaes in rat liver cytosol. J. Biol. Chem. 257: 9909-9912
Mannervik, B., Jensson, H., Alin, P., Oming, L. and Hammarstrom, S. (1984). 
Transformation of leukotriene A4 methyl ester to leukotriene C4 monomethyl ester 
by cytosolic rat glutathione 5-transferase. FEBS Lett. 175: 289-293
Mannervik, B. (1985a). The isoenzymes of glutathione transferase. Adv. Enzymol. 
Relat. Areas Mol. Biol. 57: 357-417
158
Mannervik, B., Alin, P., Guthenberg, C , Jensson, H., Tahir, M. K., Warholm, M. and 
Jomvall, H. (1985b). Identification of three classes of cytosolic glutathione 
transferase common to several mammalian species: correlation between structural 
data and enzymatic properties. Proc. Natl. Acad. Sei. U SA  82: 7202-7206
Mannervik, B. and Danielson, U. H. (1988). Glutathione transferases—structure and 
catalytic activity. CRC. Crit. Rev. Biochem. 23: 283-337
Mannervik, B., Awasthi, Y. C., Board, P. G., Hayes, J. D., Di, I. C., Ketterer, B., 
Listowsky, I., Morgenstern, R., Muramatsu, M., Pearson, W. R., Pickett, C. B., 
Sato, K., Widersten, M. and Wolf, C. R. (1992). Nomenclature for human 
glutathione transferases [letter]. Biochem. J. 282: 305-306
Mannervik, B. and Widersten, M. (1995). Human glutathione transferases: classification, 
tissue distribution, structure, and functional properties. In: Advances in Drug 
Metabolosm in Man, (Pacific, G. M. and Fracchia, G.N, ed.), Luxemburg: 
Commission of the European Communities, pp. 407-459
Marcus, C. J., Habig, W. H. and Jakoby, W. B. (1978). Glutathione transferase from 
human erythrocytes. Nonidentical with the enzymes from liver. Arch. Biochem. 
Biophys. 188: 287-293
McBride, O. W., Hieter, P. A., Hollis, G. F., Swan, D., Otey, M. C. and Leder, P. 
(1982). Chromosomal location of human kappa and lambda immunoglobulin light 
chain constant region genes. .J. Exp. Med. 155: 1480-1490
McLellan, L. I., Wolf, C. R. and Hayes, J. D. (1989). Human microsomal glutathione 
5-transferase. Its involvement in the conjugation of hexachlorobuta-1,3-diene with 
glutathione. Biochem. J. 258: 87-93
Meikle, I., Hayes, J. D. and Walker, S. W. (1992). Expression of an abundant alpha- 
class glutathione 5-transferase in bovine and human adrenal cortex tissues. J. 
Endocrinol. 132: 83-92
Meister, A., Tate, S. S. and Griffith, O. W. (1981). Gamma-glutamyl transpeptidase. 
Methods Enzymol. 77: 237-253
Meyer, D. J., Christodoulides, L. G., Hong, T. K. and Ketterer, B. (1984). Isolation, 
properties and tissue distribution of rat glutathione transferase E. FEBS Lett. 173: 
327-330
Meyer, D. J., Coles, B., Pemble, S. E., Gilmore, K. S., Fraser, G. M. and Ketterer, B. 
(1991). Theta, a new class of glutathione transferases purified from rat and man. 
Biochem. J. 274: 409-414
Meyer, D. J., Xia, C., Coles, B., Chen, H., Reinemer, P., Huber, R. and Ketterer, B. 
(1993). Unusual reactivity of Tyr-7 of GSH transferase Pl-1. Biochem. J. 293: 
351-356
Meyer, D. J. and Thomas, M. (1995). Characterization of rat spleen prostaglandin H 
D-isomerase as a sigma class GSH transferase. Biochem. J. 311: 739-742
Moore, R. E., Davies, M. S., O'Connell, K. M., Harding, E. I., Wiegand, R. C. and 
Tiemeier, D. C. (1986). Cloning and expression of a cDNA encoding a maize 
glutathione 5-transferase in E. coli. Nucleic Acids Res. 14: 7227-7235
Morey, K. S. and Litwack, G. (1969). Isolation and properties of cortisol metabolite 
binding proteins of rat liver cytosol. Biochemistry 8: 4813-4821
159
Morgenstern, R., DePierre, J. W. and Ernster, L. (1979). Activation of microsomal 
glutathione 5-transferase activity by sulfhydryl reagents. Bichem. Biophys. Res. 
Commun. 87: 657-663
Morgenstern, R., Meijer, J., Depierre, J. W. and Ernster, L. (1980). Characterization of 
rat-liver microsomal glutathione 5-transferase activity. Eur. J. Biochem. 104: 
167-174
Morgenstern, R., Guthenberg, C. and Depierre, J. W. (1982). Microsomal glutathione 
5-transferase. Purification, initial characterization and demonstration that it is not 
identical to the cytosolic glutathione 5-transferases A, B and C. Eur. J. Biochem. 
128: 243-248
Morgenstern, R. and DePierre, J. W. (1983). Microsomal glutathione transferase. 
Purification in unactivated form and further characterization of the activation 
process, substrate specificity and amino acid composition. Eur. J. Biochem. 134: 
591-597
Morgenstern, R., Lundqvist, G., Andersson, G., Balk, L. and DePierre, J. W. (1984). 
The distribution of microsomal glutathione transferase among different organelles, 
different organs, and different organisms. Biochem. Pharmacol. 33: 3609-3614
Morgenstern, R., DePierre, J. W. and Jomvall, H. (1985). Microsomal glutathione 
transferase. Primary structure. J. Biol. Chem. 260: 13976-13983
Morgenstern, R., Lundquist, G., Jomvall, H. and DePierre, J. W. (1989). Activation of 
rat liver microsomal glutathione transferase by limited proteolysis. Biochem. J. 
260: 577-582
Morris, C., Courtay, C., Geurts van Kessel, A., ten Hoeve, J., Heisterkamp, N. and 
Groffen, J. (1993). Localization of a gamma-glutamyl-transferase-related gene 
family on chromosome 22. Hum. Genet. 91: 31-36
Morrow, C. S., Chiu, J. and Cowan, K. H. (1992). Posttranscriptional control of 
glutathione 5-transferase pi gene expression in human breast cancer cells. J. Biol. 
Chem. 267: 10544-10550
Moscow, J. A., Townsend, A. J., Goldsmith, M. E., Whang-Peng, J., Vickers, P., 
Poisson, R., Legault-Poisson, S., Myers, C. E. and Cowan, K. H. (1988). 
Isolation of the human anionic glutathione 5-transferase cDNA and the relation of its 
gene expression to estrogen-receptor content in primary breast cancer. Proc. Natl. 
Acad. Sei. USA 85: 6518-6522
Murphy, R. C., Hammarstrom, S. and Samuelsson, B. (1979). Leukotriene C: A slow- 
reacting substance from murine mastocytoma cells. Proc. Natl. Acad. Sei. USA 76: 
4275-4279
Mount, S. M. (1982). A catalogue of splice junction sequences. Nucleic Acids Res. 10: 
459-472
Nakagawa, K., Saijo, N., Tsuchida, S., Sakai, M., Tsunokawa, M., Yokota, J., 
Muramatsu, M., Sato, K., Terada, M. and Tew, K. D. (1990). Glutathione 
S-transferase n as a determinant of drug resistance in transfectant cell lines. J. Biol. 
Chem. 265: 4296-4301
Nash, T. (1953). The colorimetric estimation of formaldehyde by Means of the Hantzsch 
Reaction. Biochem. J. 55: 416-421
160
Nasmyth, K. A. (1982). The regulation of yeast mating-type chromatin structure by SIR: 
An action at a distance affecting both transcription and transposition. Cell 30: 
567-578
Nazar-Stewart, V., Motulsky, A. G., Eaton, D. L., White, E., Hornung, S. K., Leng, 
Z. T., Stapleton, P. and Weiss, N. S. (1993). The glutathione S-transferase p 
polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res. 53: 
2313-2318
Nelson, H. H., Wiencke, J. K., Christiani, D. C , Cheng, T. J., Zuo, Z. F., Schwartz, 
B. S., Lee, B. K., Spitz, M. R., Wang, M. and Xu, X. a. e. a. (1995). Ethnic 
differences in the prevalence of the homozygous deleted genotype of glutathione 
S-transferase theta. Carcinogenesis 16: 1243-1245
Nicholson, D. W., Ali, A., Vaillancourt, J. P., Calaycay, J. R., Mumford, R. A., 
Zamboni, R. J. and Ford, H. A. (1993). Purification to homogeneity and the 
N-terminal sequence of human leukotriene C4 synthase: a homodimeric glutathione 
5-transferase composed of 18-kDa subunits. Proc. Natl. Acad. Sei. U S A  90: 
2015-2019
Nishida, M., Kong, K. H., Inoue, H. and Takahashi, K. (1994). Molecular cloning and 
site-directed mutagenesis of glutathione 5-transferase from Escherichia coli. The 
conserved tyrosyl residue near the N terminus is not essential for catalysis. J. Biol. 
Chem. 269: 32536-32541
Ogura, K., Nishiyama, T., Okada, T., Kajital, J., Narihata, H., Watabe, T., Hiratsuka, 
A. and Watabe, T. (1991). Molecular cloning and amino acid sequencing of rat liver 
class theta glutathione 5-transferase Yrs-Yrs inactivating reactive sulfate esters of 
carcinogenic arylmethanols. Biochem. Biophys. Res. Commun. 181: 1294-1300
Ogura, K., Nishiyama, T., Hiratsuka, A., Watabe, T. and Watabe, T. (1994). Isolation 
and characterization of the gene encoding rat class theta glutathione 5-transferase 
subunit Yrs. Biochem Biophys Res Commun 205: 1250-6
Ohkawa, H. and Casida, J. E. (1971). Glutathione 5-transferase liberate hydrogen 
cyanide from organic thiocyanates. Biochemical Pharmacology 20: 1708-1711
Ohshima, Y. and Gotoh, Y. (1987). Signals for the selection of a splice site in 
pre-mRNA: Computer analysis of splice junction sequences and like sequences. J. 
Mol. Biol. 195: 247-259
Ostlund-Farrants, A. K., Meyer, D. J., Coles, B., Southan, C., Aitken, A., Johnson, P. 
J. and Ketterer, B. (1987). The separation of glutathione transferase subunits by 
using reverse-phase high-pressure liquid chromatography. Biochem. J. 245: 423- 
428
Pabst, M. J., Habig, W. H. and Jakoby, W. B. (1973). Mercapturic acid formation: The 
several glutathione transferases of rat liver. Biochme. Biophys. Res. Commun. 52: 
1123-1128
Pabst, M. J., Habig, W. H. and Jakoby, W. B. (1974). Glutahione 5-transferase A. A 
Novel kinetic mechanism in which the major reaction pathway depends on substrate 
concentration. J. Biol. Chem. 249: 7140-7150
Pawlak, A., Lahuna, O., Bulle, F., Suzuki, A., Ferry, N., Siegrist, S., Chikhi, N., 
Chobert, M. N., Guellaen, G. and Laperche, Y. (1988). gamma-Glutamyl 
transpeptidase: a single copy gene in the rat and a multigene family in the human 
genome. J. Biol. Chem. 263: 9913-9916
161
Pearson, W. R., Vorachek, W. R., Xu, S. J., Berger, R., Hart, I., Vannais, D. and 
Patterson, D. (1993). Identification of class-mu glutathione transferase genes 
GSTM1-GSTM5 on human chromosome lp 13. Am. J. Hum. Genet. 53: 220-233
Pelkonen, O. and Nebert, D. W. (1982). Metabolism of polycyclic aromatic 
hydrocarbons: etiologic role in carcinogenesis. Pharmacol. Rev. 34: 189-222
Pemble, S. E. and Taylor, J. B. (1992). An evolutionary perspective on glutathione 
transferases inferred from class-Theta glutathione cDNA sequences. Biochem. J. 
287: 957-963
Pemble, S., Schroeder, K. R., Spencer, S. R., Meyer, D. J., Halber, E., Bolt, H. M., 
Ketterer, B. and Taylor, J. B. (1994). Human glutathione 5-transferase Theta 
(GSTT1): cDNA cloning and the characterization of a genetic polymorphism. 
Biochem. J. 300: 271-276
Penington, C. J. and Rule, G. S. (1992). Mapping the substrate-binding site of a human 
class mu glutathione transferase using nuclear magnetic resonance spectroscopy. 
Biochemistry 31: 2912-2920
Pickett, C. B., Donohue, A. M., Lu, A. Y. and Hales, B. F. (1982). Rat liver 
glutathione 5-transferase B: the functional mRNAs specific for the Ya Yc subunits 
are induced differentially by phenobarbital. Arch. Biochem. Biophys. 215: 
539-543
Pickett, C. B. and Lu, A. Y. H. (1989). Glutathione 5-transferase: Gene structure, 
regulation, and biological function. Annu. Rev. Biochem. 58: 743-764
Polidoro, G., Di Ilio, C., Del Boccio, G., Zulli, P. and Federici, G. (1980). Glutathione 
5-tranferase activity in human placenta. Biochemical Pharmacology 29: 1677-1680
Principato, G. B., Danielson, U. H. and Mannervik, B. (1988). Relaxed thiol substrate 
specificity of glutathione transferase effected by a non-substrate glutathione 
derivative. FEBS. Lett. 231: 155-158
Prohaska, J. R. and Canther, H. E. (1977). Glutathione peroxidase activity of 
glutathione-5-transferases purified from rat liver. Biochem. Biophys. Res. 
Commun. 76: 437-445
Raghunathan, S., Chandross, R. J., Kretsinger, R. H., Allison, T. J., Penington, C. J. 
and Rule, G. S. (1994). Crystal structure of human class mu glutathione transferase 
GSTM2-2. Effects of lattice packing on conformational heterogeneity. J. Mol. Biol. 
238: 815-832
Rajpert-De Meyts, E., Heisterkamp, N. and Groffen, J. (1988). Cloning and nucleotide 
sequence of human gamma-glutamyl transpeptidase. Proc. Nat. Acad. Sei. 85: 
8840-8844
Ramsdell, H. S. and Eaton, D. L. (1990). Mouse liver glutathione 5-transferase 
isoenzyme activity toward aflatoxin Bi-8,9-epoxide and benzo[a]pyrene-7,8- 
dihydrodiol-9,10-epoxide. Toxicol. Appl. Pharmacol. 105: 351-363
Ramsey, J. C., Park, C. N., Ott, M. G. and Gehring, P. J. (1979). Carcinogenesis risk 
assessment: Ethylene dibromide. Toxicol. Appl. Pharmacol. 47: 411-414
Raney, K. D., Meyer, D. J., Ketterer, B., Harris, T. M. and Guengerich, F. P. (1992). 
Glutathione conjugation of aflatoxin B1 exo- and endo-peroxides by rat and human 
gluathione 5-transferases. Chem. Res. Toxicol. 5: 470-478
162
Reed, K. C. and Mann, D. A. (1985). Rapid transfer of DNA from agarose gels to nylon 
membranes. Nucleic Acids Res. 13: 7207-7221
Reinemer, P., Dirr, H. W., Ladenstein, R., Schaffer, J., Gallay, O. and Huber, R. 
(1991). The three-dimensional structure of class pi glutathione 5-transferase in 
complex with glutathione sulfonate at 2.3 A resolution. EMBO J. 10: 1997-2005
Reinemer, P., Dirr, H. W., Ladenstein, R., Huber, R., Lo, B. M., Federici, G. and 
Parker, M. W. (1992). Three-dimensional structure of class pi glutathione 
S-transferase from human placenta in complex with 5-hexylglutathione at 2.8 A 
resolution. J. Mol. Biol. 227: 214-226
Reyes, H., Levi, A. J., Gatmaitan, Z. and Arias, I. M. (1971). Studies of Y and Z 
hepatic cytoplasmic organic anion-binding proteins: effectof durgs, chemicals, 
hormones, and cholestasis. J. Clin. Invest. 50: 2242-2252
Rhoads, D. M., Zarlengo, R. P. and Tu, C. P. (1987). The basic glutathione 
S-transferases from human livers are products of separate genes. Biochem. 
Biophys. Res. Commun. 145: 474-481
Ricci, G., Caccuri, A. M., Lo Bello, M., A., P., Piemonte, F. and Federici, G. (1994). 
Colorimetric and fluorometric assays of glutathione transferase based on 7-chloro-4- 
nitorbenzo-2-oxa- 1,3-diazole. Anal. Biochem. 218: 463-465
Ross, V. L. and Board, P. G. (1993). Molecular cloning and heterologous expression of 
an alternatively spliced human Mu class glutathione 5-transferase transcript. 
Biochem. J. 294: 373-380
Ross, V. L., Board, P. G. and Wei j , G. C. (1993). Chromosomal mapping of the 
human Mu class glutathione 5-transferases to lpl3. Genomics 18: 87-91
Rozen, F., Nguyen, T. and Pickett, C. B. (1992). Isolation and characterization of a 
human glutathione 5-transferase Hal subunit gene. Arch. Biochem. Biophys. 292: 
589-593
Ryberg, D., Hewer, A., Phillips, D. H. and Haugen, A. (1994). Different susceptibility 
to smoking-induced DNA damage among male and female lung cancer patients. 
Cancer Res. 54: 5801-5803
Sambrook, J., Fritsch, E. F. and Maniatis, T. (1989). Molecular Cloning A Laboratory 
Manual. New York. Cold Spring Laboratory Press, Cold Spring Harbor.
Sanger, F., Nicklen, S. and Coulson, A. R. (1977). DNA sequencing with chain­
terminating inhibitors. Proc. Natl. Acad. Sei. U SA  74: 5463-5467
Sanger, F., Coulson, A. R., Barrell, B. G., Smith, A. J. and Roe, B. A. (1980). 
Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J. 
Mol. Biol. 143: 161-178
Sarrif, A. M., Bertram, J. S., Kamarck, M. and Heidelberger, C. (1975). The isolation 
and characterization of polycyclic hydrocarbon-binding proteins from mouse liver 
and skin cytosols. Cancer Res. 35: 816-824
Schroder, K. R., Halber, R., Peter, H. and Bolt, H. M. (1992). Dissociation of a new 
glutathione 5-transferase activity in human erythrocytes. Biochem. Pharmacol. 43: 
1671-1674
Seidegard, J. and Pero, R. W. (1985). The hereditary transmission of high glutathione 
transferase activity towards trans-stilbene oxide in human mononuclear leukocytes. 
Hum. Genet. 69: 66-68
163
Seidegard, J., Guthenberg, C., Pero, R. W. and Mannervik, B. (1987). The trans- 
stilbene oxide-active glutathione transferase in human mononuclear leucocytes is 
identical with the hepatic glutathione transferase p. Biochem. J. 246: 783-785
Seidegard, J., Vorachek, W. R., Pero, R. W. and Pearson, W. R. (1988). Hereditary 
differences in the expression of the human glutathione transferase active on trans- 
stilbene oxide are due to a gene deletion. Proc. Natl. Acad. Sei. U S A 85: 
7293-7297
Seidegard, J., Pero, R. W. and Stille, B. (1989). Identification of the trans-stilbene 
oxide-active glutathione transferase in human mononuclear leukocytes and in liver 
as GST1. Biochem. Genet. 27: 253-261
Seidegard, J., Pero, R. W., Markowitz, M. M., Roush, G., Miller, D. G. and Beattie, 
E. J. (1990). Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the 
susceptibility to lung cancer: a follow up study. Carcinogenesis 11: 33-36
Senjo, M., Ishibashi, T. and Imai, Y. (1985). Purification and characterization of 
cytosolic liver protein facilitating heme transport into apocytochrome b5 from 
mitochondria. Evidence for identifying the heme transfer protein as belonging to a 
group of glutathione 5-transferases. J. Biol. Chem. 260: 9191-9196
Singh, S. V., Kurosky, A. and Awasthi, Y. C. (1987). Human liver glutathione 
S-transferase \J/. Chemical characterization and secondary-structure comparison 
with other mammalian glutathione 5-transferase. Biochem. J. 243: 61-67
Singhal, S. S., Ahmad, H., Sharma, R., Gupta, S., Haque, A. K. and Awasthi, Y. C. 
(1991). Purification and characterization of human muscle glutathione 5-
transferases: evidence that glutathione 5-transferase £ corresponds to a locus distinct 
from GST1, GST2, and GST3. Arch. Biochem. Biophys. 285: 64-73
Singhal, S. S., Zimniak, P., Awasthi, S., Piper, J. T., He, N. G., Teng, J. I., Petersen, 
D. R. and Awasthi, Y. C. (1994a). Several closely related glutathione 5-transferase 
isozymes catalyzing conjugation of 4-hydroxynonenal are differentially expressed in 
human tissues. Arch. Biochem. Biophys. 311: 242-250
Singhal, S. S., Zimniak, P., Sharma, R., Srivastava, S. K., Awasthi, S. and Awasthi, 
Y. C. (1994b). A novel glutathione 5-transferase isozyme similar to GST 8-8 of rat 
and mGSTA4-4 (GST 5.7) of mouse is selectively expressed in human tissues. 
Biochim. Biophys. Acta. 1204: 279-286
Singhal, S. S., Awasthi, S., Srivastava, S. K., Zimniak, P., Ansari, N. H. and 
Awasthi, Y. C. (1995). Novel human ocular glutathione 5-transferases with high 
activity toward 4-hydroxynonenal. Invest. Ophthalmol. Vis. Sei. 36: 142-150
Sinning, L, Kleywegt, G. J., Cowan, S. W., Reinemer, P., Dirr, H. W., Huber, R., 
Gilliland, G. L., Armstrong, R. N., Ji, X., Board, P. G., Olin, B., Mannervik, B. 
and Jones, T. A. (1993). Structure determination and refinement of human alpha 
class glutathione transferase A1-1, and a comparison with the Mu and Pi class 
enzymes. J. Mol. Biol. 232: 192-212
Soderberg, B. O., Sjoberg, B. M., Sonnerstam, U. and Branden, C. I. (1978). Three- 
dimensional structure of thioredoxin induced by bacteriophage T4. Proc. Natl. 
Acad. Sc.i U S ATS: 5827-5830
Söderström, M., Mannervik, B., Orning, L. and Hamarstrom, S. (1985). Leukotriene 
C4 formation catalyzed by three distinct froms of human cytosolic glutathione 
transferase. Biochem. Biophys. Res. Com. 128: 265-270
164
Söderström, M., Hammarstrom, S. and Mannervik, B. (1988). Leukotriene C syntase in 
mosue mastocytoma cells. Biochem. J. 250: 713-718
Southern, E. M. (1975). Detection of specific sequences among DNA fragments 
separated by gel electrophoresis. J. Mol Biol 98: 503-517
Stenberg, G., Board, P. G. and Mannervik, B. (1991). Mutation of an evolutionarily 
conserved tyrosine residue in the active site of a human class Alpha glutathione 
transferase. FEBS Lett. 293: 153-155
Stockman, P. K., Beckett, G. J.,Hayes, J. D. (1985). Identification of a basic hybrid 
glutathione 5-transferase from human liver. Glutathione 5-transferase delta is 
composed of two distinct subunits (B1 and B2). Biochem. J. 227: 457-465
Stockman, P. K., McLellan, L. I. and Hayes, J. D. (1987). Characterization of the basic 
glutathione 5-transferase B1 and B2 subunits from human liver. Biochem. J. 244: 
55-61
Strange, R. C., Faulder, C. G., Davis, B. A., Hume, R., Brown, J. A. H., Cotton, W. 
and Hopkinson, D. A. (1984). The human glutathione 5-transferase: Studies on the 
distribution and genetic variation of GST1, GST2, and GST3 isozymes. Ann. 
Hum. Genet. 48: 11-20
Strange, R. C., Davis, B. A., Faulder, C. G., Cotton, W., Bain, A. D., Hopkinson, D. 
A. and Hume, R. (1985). The human glutathione 5-transferase: Development 
aspects of the GST1, GST2, and GST3 loci. Biochem. Genet. 23: 1011-1028
Suzuki, T. and Board, P. (1984). Glutathione-5-transferase gene mapped to 
chromosome 11 is GST3 not GST1 [letter]. Somat. Cell. Mol Genet. 10: 319-320
Suzuki, T., Coggan, M., Shaw, D. C. and Board, P. G. (1987). Electrophoretic and 
immunological analysis of human glutathione 5-transferase isozymes. Ann. Hum. 
Genet. 51: 95-106
Suzuki, T., Shaw, D. C. and Board, P. G. (1991). Purification and characterization of 
acidic glutathione 5-transferase 6 from human brain. Biochem. J. 274: 405-408
Suzuki, T., Johnston, P. N. and Board, P. G. (1993). Structure and organization of the 
human alpha class glutathione 5-transferase genes and related pseudogenes. 
Genomics 18: 680-686
Tahir, M. K. and Mannervik, B. (1986). Simple inhibition studies for distinctio between 
homodimeric and heterodimeric isoenzymes of glutathione transferase. J. Biol 
Chem. 261: 1048-1051
Takahashi, Y. and Nagata, T. (1992). parB: an auxin-regulated gene encoding 
glutathione 5-transferase. Proc. Natl. Acad. Sei. U SA  89: 56-59
Takahashi, Y., Campbell, E. A., Hirata, Y., Takayama, T. and Listowsky, I. (1993). A 
basis for differentiating among the multiple human Mu-glutathione 5-transferases 
and molecular cloning of brain GSTM5. J. Biol. Chem. 268: 8893-8898
Tan, K. H., Meyer, D. J., Belin, J. and Ketterer, B. (1984). Inhibition of microsomal 
lipid peroxidation by glutathione and glutathione transferases B and AA. Biochem. 
J. 220: 243-252
Tan, K. H., Meyer, D. J., Coles, B. and Ketterer, B. (1986). Thymide hydroperoxide, a 
substrate for rat Se-dependent glutathione peroxidase and glutathione transferase 
isoenzymes. FEBS Lett. 207: 231-233
165
Tan, K. H., Meyer, D. J., Gillies, N. and Ketterer, B. (1988). Detoxification of DNA 
hydroperoxide by glutathione transferases and the purification and characterization 
of glutathione transferases of the rat liver nucleus. Biochem. J. 254: 841-845
Tan, K. L., Webb, G. C., Baker, R. T. and Board, P. G. (1995). Molecular cloning of a 
cDNA and chromosomal localization of a human Theta-class glutathione 
S-transferase gene (GSTT2) to chromosome 22. Genomics 25: 381-387
Tan, K. L. and Board, P. G. (1996). Purification and characterisation of a recombinant 
human Theta class glutathione transferase (GsTT2-2). Biochem. J. : In Press.
Tate, S. S. and Meister, A. (1981). gamma-Glutamyl transpeptidase: catalytic, structural 
and functional aspects. Mol. Cell. Biochem. 39: 357-368
Thier, R., Taylor, J. B., Pemble, S. E., Griffith Humphreys, W., Persmark, M., 
Ketterer, B. and Guengerich, F. P. (1993). Expression of mammalian glutathione 
5-transferase 5-5 in Salmonella typhimurium TA1535 leads to base-pair mutations 
upon exposure to dihalomethanes. Proc. Natl. Acad. Sei. U SA  90: 8576-8580
Tipping, E. and Ketterer, B. (1981). The influence of soluble binding proteins on 
lipophile transport and metabolism in hepatocytes. Biochem. J. 195: 441-452
Tobias, J. W. and Varshavsky, A. (1991). Cloning and functional analysis of the 
ubiquitin-specific protease gene UBP1 of Saccharomyces cerevisiae. J. Biol. Chem. 
266: 12021-12028
Toffoli, G., Viel, A., Tumiotto, L., Giannini, F., Volpe, R., Quaia, M. and Boiocchi, 
M. (1992). Expression of glutathione-5-transferase-pi in human tumours. Eur. J. 
Cancer. 28A: 1441-1446
Tomarev, S. I. and Zinovieva, R. D. (1988). Squid major lens polypeptides are 
homologous to glutathione 5-transferases subunits. Nature 336: 86-88
Tomarev, S. I., Zinovieva, R. D., Guo, K. and Piatigorsky, J. (1993). Squid 
glutathione 5-transferase. Relationships with other glutathione 5-transferases and 
S-crystallins of cephalopods. J. Biol. Chem. 268: 4534-4542
Toung, Y. P., Hsieh, T. S. and Tu, C. P. (1991). The Drosophila glutathione 
S-transferase 1-1 is encoded by an intronless gene at 87B. Biochem. Biophys. Res. 
Commun. 178: 1205-1211
Towbin, H., Staehelin, T. and Gordon, J. (1979). Electrophoretic transfer of protein 
from polyacrylamide gels to nitrocellulose sheets : Procedure and some application. 
Proc. Natl. Acad. Sei. U SA  76: 4350-4354
Traut, T. W. (1988). Do exons code for structural or functional units in proteins? Proc. 
Natl. Acad. Sei. U S A  85: 2944-2948
Tsuchida, S., Maki, T. and Sato, K. (1990). Purification and characterization of 
glutathione transferases with an activity toward nitroglycerin from human aorta and 
heart. Multiplicity of the human class Mu forms. J. Biol. Chem. 13: 7150-7157
Tu, C. P. and Qian, B. (1986). Human liver glutathione 5-transferases: complete primary 
sequence of an Ha subunit cDNA. Biochem. Biophys. Res. Commun. 141: 
229-237
Vorachek, W. R., Pearson, W. R. and Rule, G. S. (1991). Cloning, expression, and 
characterization of a class-mu glutathione transferase from human muscle, the 
product of the GST4 locus. Proc. Natl. Acad. Sei. U SA  88: 4443-4447
166
Wang, J. Y., McCommas, S. and Syvanen, M. (1991). Molecular cloning of a 
glutathione 5-transferase overproduced in an insecticide-resistant strain of the 
housefly (Musca domestica). Mol. Gen. Genet. 227: 260-266
Wang, R. W., Newton, D. J., Huskey, S. E., McKeever, B. M., Pickett, C. B. and Lu, 
A. Y. (1992). Site-directed mutagenesis of glutathione 5-transferase YaYa. 
Important roles of tyrosine 9 and aspartic acid 101 in catalysis. J. Biol. Chem. 267: 
19866-19871
Wang, Y., Teicher, B. A., Shea, T. C., Holden, S. A., W., R. K., Al-Achi, A. and 
David Henner, W. (1989). Cross-resistance and glutathione 5-transferase k  levels 
among four human melanoma cell lines selected for aklylating agent resistance. 
Cancer Res. 49: 6185-6192
Warholm, M., Guthenbert, C., Mannervik, B. and von Bhar, C. (1981). Purification of 
a new glutathione 5-transferase (transferase p.) from human liver having high 
activity with benzo[a]pyrene-4,5-oxide. Biochem. Biophys. Res. Commun. 98: 
512-519
Warholm, M., Guthenberg, C. and Mannervik, B. (1983). Molecular and catalytic 
properties of glutathione transferase mu from human liver: an enzyme efficiently 
conjugating epoxides. Biochemistry 22: 3610-3617
Warwick, A., Sarhanis, P., Redman, C., Pemble, S., Taylor, J. B., Ketterer, B., Jones, 
P., Alldersea, J., Gilford, J., Yengi, L., Fryer, A. and Strange, R. C. (1994). 
Theta class glutathione 5-transferase GSTT1 genotypes and susceptibility to cervical 
neoplasia: interactions with GSTM1, CYP2D6 and smoking. Carcinogenesis 15: 
2841-2845
Watabe, T., Hiratsuka, A., Ogura, K., Okuda, H. and Nishiyama, T. (1995). 
Xenobiotica : In Press
Webb, G. C., Baker, R. T., Fagan, K. and Board, P. G. (1990). Localization of the 
human UbB polyubiquitin gene to chromosome band 17p 11.1- 17p 12. Am. J. 
Hum. Genet. 46: 308-315
Webb, G. C., Baker, R. T., Coggan, M. and Board, P. G. (1994). Localization of the 
human UBA52 ubiquitin fusion gene to chromosome band 19pl3.1-pl2. Genomics 
19: 567-569
Webb, G., Vaska, V., Coggan, M. and Board, P. G. (1996). Chromosomal localization 
of the gene for the human Theta class glutathione transferase GSTT1. Genomics. 
(In Press)
Welsch, D. J., Creely, D. P., Hauser, S. D., Mathis, K. J., Krivi, G. G. and Isakson, 
P. C. (1994). Molecular cloning and expression of human leukotriene-C4 synthase. 
Proc. Natl. Acad. Sei. U SA  91: 9745-9749
Whang, P. J., Triche, T. J., Knutsen, T., Miser, J., Kao, S. S., Tsai, S. and Israel, M. 
A. (1986). Cytogenetic characterization of selected small round cell tumors of 
childhood. Cancer Genet. Cytogenet. 21: 185-208
Wheatley, J. B., Kelley, M. K., Montali, J. A., Berry, C. O. and Schmidt, D. J. (1994). 
Examination of glutathione 5-transferase isoenzyme profiles in human liver using 
high-performance affinity chromatography. J. Chromatogr. A. 663: 53-63
White, R. E. and Coon, M. J. (1980). Oxygen activation by cytochrome P-450. Ann. 
Rev. Biochem. 49: 315-356
167
Whittington, A. T., Webb, G. C., Baker, R. T. and Board, P. G. (1996). 
Characterization of a cDNA and gene encoding a mouse Theta class glutathione 
transferase mGSTT2 and its localization to chromosome 10B5-C1. Genomics : In 
Press
Wiencke, J. K., Pemble, S., Ketterer, B. and Kelsey, K. T. (1995). Gene deletion of 
glutathione 5-transferase theta: correlation with induced genetic damage and 
potential role in endogenous mutagenesis. Cancer Epidemiol. Biomarkers Prev. 4: 
253-259
Wilce, M. C. J. and Parker, M. W. (1994). Structure and function of glutathione 
S-transferases. Biochim. Biophys. Acta. 1205: 1-18
Wilce, M. C. J., Feil, S. C., Board, P. G. and Parker, M. W. (1994). Crystallization 
and preliminary X-ray diffraction studies of a glutathione 5-transferase from the 
Australian Blowfly, Lucilia cuprina. J. Mol. Biol. 236: 1407-1409
Wilce, M. C. J., Board, P. G., Feil, S. C. and Parker, M. W. (1995). Crystal structure 
of a theta-class glutathione transferase. EMBO J. 14: 2133-2143
Wistow, G. and Piatigorsky, J. (1987). Recruitment of enzymes as lens structural 
proteins. Science 236: 1554-1556
Wolf, C. R., Berry, P. N., Nash, J. A., Green, T. and Lock, E. A. (1984). Role of 
microsomal and cytosolic glutathine 5-transferases in the conjugation of hexachloro- 
1,3-butadiene and its possible relevance to toxicity. J. Pharmacol. Exp. Ther. 228: 
202-208
Wolkoff, A. W., Goresky, C. A., Sellin, J., Gatmaitan, Z. and Arias, I. M. (1979). 
Role of ligandin in transfer of bilirubin from plasma into liver. Am. J. Physiol. 
236: E638-E648
Wong, L. C. K., Winston, J. M., Hong, C. B. and Plotnick, H. (1982). Carcinogenicity 
and toxicity of 1,2-dibromoethane in the rat. Toxicol. Appl. Pharmacol. 63: 
155-165
Xia, C., Meyer, D. J., Chen, H., Reinemer, P., Huber, R. and Ketterer, B. (1993). 
Chemical modification of GSH transferase Pl-1 confirms the presence of Arg-13, 
Lys-44 and one carboxylate group in the GSH-binding domain of the active site. 
Biochem. J. 293: 357-362
Zhang, P., Liu, S., Shan, S. O., Ji, X., Gilliland, G. L. and Armstrong, R. N. (1992). 
Modular mutagenesis of exons 1, 2, and 8 of a glutathione 5-transferase from the 
mu class. Mechanistic and structural consequences for chimeras of isoenzyme 3-3. 
Biochemistry 31: 10185-10193
Zhong, S., Howie, A. F., Ketterer, B., Taylor, J., Hayes, J. D., Beckett, G. J., 
Wathen, C. G., Wolf, C. R. and Spurr, N. K. (1991). Glutathione 5-transferase p, 
locus: use of genotyping and phenotyping assays to assess association with lung 
cancer susceptibility. Carcinogenesis 12: 1533-1537
Zhong, S., Spurr, N. K., Hayes, J. D. and Wolf, C. R. (1993). Deduced amino acid 
sequence, gene structure and chromosomal location of a novel human class Mu 
glutathione 5-transferase, GSTM4. Biochem. J. 291: 41-50
Zimniak, P., Eckles, M. A., Saxena, M. and Awasthi, Y. C. (1992). A subgroup of 
class alpha glutathione 5-transferases. Cloning of cDNA for mouse lung glutathione 
5-transferase GST 5.7. FEBS Lett. 313: 173-176
